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A B S T R A C T
Background
International dietary recommendations include guidance on healthy eating and weight management for people who have survived cancer;
however dietary interventions are not provided routinely for people living beyond cancer.
Objectives
To assess the effects of dietary interventions for adult cancer survivors on morbidity and mortality, changes in dietary behaviour, body
composition, health-related quality of life, and clinical measurements.
Search methods
We ran searches on 18 September 2019 and searched the Cochrane Central Register of Controlled trials (CENTRAL), in the Cochrane Library;
MEDLINE via Ovid; Embase via Ovid; the Allied and Complementary Medicine Database (AMED); the Cumulative Index to Nursing and Allied
Health Literature (CINAHL); and the Database of Abstracts of Reviews of Effects (DARE). We searched other resources including reference
lists of retrieved articles, other reviews on the topic, the International Trials Registry for ongoing trials, metaRegister, Physicians Data
Query, and appropriate websites for ongoing trials. We searched conference abstracts and WorldCat for dissertations.
Selection criteria
We included randomised controlled trials (RCTs) that recruited people following a cancer diagnosis. The intervention was any dietary
advice provided by any method including group sessions, telephone instruction, written materials, or a web-based approach. We included
comparisons that could be usual care or written information, and outcomes measured included overall survival, morbidities, secondary
malignancies, dietary changes, anthropometry, quality of life (QoL), and biochemistry.
Data collection and analysis
We used standard Cochrane methodological procedures. Two people independently assessed titles and full-text articles, extracted data,
and assessed risk of bias. For analysis, we used a random-effects statistical model for all meta-analyses, and the GRADE approach to rate
the certainty of evidence, considering limitations, indirectness, inconsistencies, imprecision, and bias.
Main results
We included 25 RCTs involving 7259 participants including 977 (13.5%) men and 6282 (86.5%) women. Mean age reported ranged from 52.6
to 71 years, and range of age of included participants was 23 to 85 years. The trials reported 27 comparisons and included participants
who had survived breast cancer (17 trials), colorectal cancer (2 trials), gynaecological cancer (1 trial), and cancer at mixed sites (5 trials).
Dietary interventions for adult cancer survivors (Review)
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For overall survival, dietary intervention and control groups showed little or no difference in risk of mortality (hazard ratio (HR) 0.98, 95%
confidence interval (CI) 0.77 to 1.23; 1 study; 3107 participants; low-certainty evidence). For secondary malignancies, dietary interventions
versus control trials reported little or no difference (risk ratio (RR) 0.99, 95% CI 0.84 to 1.15; 1 study; 3107 participants; low-certainty evi-
dence). Co-morbidities were not measured in any included trials.
Subsequent outcomes reported after 12 months found that dietary interventions versus control probably make little or no difference in
energy intake at 12 months (mean difference (MD) -59.13 kcal, 95% CI -159.05 to 37.79; 5 studies; 3283 participants; moderate-certainty
evidence). Dietary interventions versus control probably led to slight increases in fruit and vegetable servings (MD 0.41 servings, 95% CI
0.10 to 0.71; 5 studies; 834 participants; moderate-certainty evidence); mixed results for fibre intake overall (MD 5.12 g, 95% CI 0.66 to 10.9;
2 studies; 3127 participants; very low-certainty evidence); and likely improvement in Diet Quality Index (MD 3.46, 95% CI 1.54 to 5.38; 747
participants; moderate-certainty evidence).
For anthropometry, dietary intervention versus control probably led to a slightly decreased body mass index (BMI) (MD -0.79 kg/m2, 95%
CI -1.50 to -0.07; 4 studies; 777 participants; moderate-certainty evidence). Dietary interventions versus control probably had little or no
effect on waist-to-hip ratio (MD -0.01, 95% CI -0.04 to 0.02; 2 studies; 106 participants; low-certainty evidence).
For QoL, there were mixed results; several different quality assessment tools were used and evidence was of low to very low-certainty. No
adverse events were reported in any of the included studies.
Authors' conclusions
Evidence demonstrated little effects of dietary interventions on overall mortality and secondary cancers. For comorbidities, no evidence
was identified. For nutritional outcomes, there was probably little or no effect on energy intake, although probably a slight increase in
fruit and vegetable intake and Diet Quality Index. Results were mixed for fibre. For anthropometry, there was probably a slight decrease
in body mass index (BMI) but probably little or no effect on waist-to-hip ratio. For QoL, results were highly varied. Additional high-quality
research is needed to examine the effects of dietary interventions for different cancer sites, and to evaluate important outcomes including
comorbidities and body composition. Evidence on new technologies used to deliver dietary interventions was limited.
P L A I N   L A N G U A G E   S U M M A R Y
Dietary intake in people living beyond cancer
Background
Diet has been linked to cancer, and dietary guidelines are available for cancer prevention. People after cancer have been found to have
higher rates of other conditions including cardiovascular disease, diabetes, and other cancers. It is therefore sensible for people after
cancer to look at changing their diet. It was important to undertake this review to assess the evidence on dietary advice for people who
have survived cancer.
Aim of the review
This review evaluates evidence on dietary interventions for people after cancer.
Quality of evidence
The quality of evidence is generally low to very low. Most studies did not evaluate dietary interventions for key review outcomes, particu-
larly mortality and morbidity. However, a few study outcomes with moderate-certainty evidence focused on dietary intake and physical
measurements. Included studies compared dietary interventions versus control or usual care. We pooled data from similar randomised
controlled trials (RCTs) to provide a summary estimate of the effects of an intervention, and we judged how confident (certain) we were
of these findings by using an established method (GRADE).
Main findings
We identified 25 RCTs involving 27 different comparisons. For some outcomes, we found absence of evidence for dietary interventions. We
found some evidence showing that dietary interventions probably did not modify energy intake; however, some evidence shows what is
probably a slight increase in fruit and vegetable intake (moderate-certainty evidence). Evidence on dietary fibre was mixed for different
advice on weight reducing or healthy eating. Dietary interventions compared to control probably improved the Diet Quality Index (mod-
erate-certainty evidence). For physical measurements, we found a probable reduction in body mass index (BMI) with dietary interventions
compared to controls (moderate-certainty evidence) but little evidence showing any change in waist-to-hip ratio (low-certainty evidence).
For quality of life (QoL), results were mixed due to the wide variety of tools used. No adverse events were reported.
Conclusion
Available evidence shows that dietary interventions can be helpful in modifying fruit and vegetable servings and diet quality; modification
of fibre intake was variable, and some benefits were seen for anthropometric measurements, including BMI. Most of the evidence is based
on women with breast cancer, so more research is needed for patients with other cancers. Gaps identified in the evidence involved the
use of new technologies, comorbidities, and body composition data.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings for the main comparison.   Dietary intervention compared to control for people living beyond cancer
Dietary intervention compared to control for people living beyond cancer
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Mean fibre intake was 15.6 g MD 5.12 g higher









Mean Diet Quality Index was 64.7 MD 3.46 higher
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*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; HR: hazard ratio; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence.
High-certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate-certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low-certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low-certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aInability to rate consistency as only one study.
bConfidence intervals are not narrow.
cDowngraded one level due to indirectness.
dDowngraded two levels for high level of inconsistency between studies.
eDowngraded one level for risk of bias.
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B A C K G R O U N D
Description of the condition
It is estimated that globally 18.1 million new cases of cancer and
9.6 million cases of death were due to cancer in 2018 (Bray 2018).
It is estimated that 15.5 million Americans with a diagnosis of can-
cer were alive in 2016, and this number is anticipated to reach 20.3
million by 2026 (Miller 2016). In the UK, the number of cancer sur-
vivors has been growing over the last 30 years (Elliott 2011), and
survival has increased steadily from 61.2% to 72.3% for patients di-
agnosed from 2000 to 2015 (Broggio 2019). Furthermore, survival
estimation for most cancer sites was above 75% after one year and
50% after five years, with the exception of lung and stomach cancer
(Broggio 2019). The proportion of people who survive cancer may
be attributed to an increase in the aging population and advance-
ments in anti-cancer therapies (chemotherapy and radiotherapy),
which have improved the outcomes of treatment (Aziz 2003; Lancet
2004). Over 60% of those living beyond a cancer diagnosis are over
65 years of age (Ravasco 2003), approximately 60% are female, and
most are diagnosed initially with breast, prostate, or colorectal ma-
lignancy (Maddams 2009). However, negative factors influencing
cancer survival have been highlighted and include lower socioeco-
nomic status combined with higher levels of coexisting conditions
and unhealthy lifestyle choices (Louwman 2010). It is now recog-
nised that as survival increases, associated long-term health issues
of cancer will emerge as a significant public health concern (Mosh-
er 2009), and this is reflected in healthcare strategies (Department
2010; Lippman 2004).
Health promotion initiatives aimed at improving the well-being of
people who have survived cancer are now essential to decrease co-
morbidities and improve quality of life (QoL). Focus groups have re-
ported that people who have survived cancer are often confused
regarding future strategies to improve their health and well-being
(Armes 2009; Marbach 2011).
For the purpose of this review, cancer survivors are defined as peo-
ple living beyond a diagnosis of cancer after all treatment interven-
tions have been discontinued, when treatment interventions may
include surgery, chemotherapy, radiotherapy, and active hormone
therapy. This review does not include patients with cancer who are
undergoing active or palliative treatment.
Description of the intervention
International recommendations on how to maintain a healthy
lifestyle are currently available from the World Cancer Research
Fund (WCRF) and the American Institute for Cancer Research (AICR)
for prevention of cancer and for guidance for those who are living
beyond a cancer diagnosis (WCRF/AICR 2018; Kushi 2012). Healthy
lifestyle changes recommended by WCRF/AICR 2018 have been
linked to longevity. From a large European study, those who fol-
lowed a higher proportion of healthy lifestyle recommendations
had 34% reduced risk of mortality compared to those who adhered
to fewer recommendations (Vergnaud 2013). Low compliance with
the WCRF/AICR recommendations was significantly associated with
increased hazard ratios (HRs) of dying from cancer or circulatory
and respiratory disease (Vergnaud 2013). Healthy lifestyle recom-
mendations for those living beyond cancer include maintaining a
healthy weight throughout life; adopting an active lifestyle; con-
suming a healthy diet with emphasis on plant foods; and limiting al-
coholic beverages (WCRF/AICR 2018). Dietary interventions include
any method that is aimed at altering an individual’s food or drink
intake.
How the intervention might work
Lifestyle factors predispose people to development of chronic dis-
ease and cancer. These include overweight or obesity, lack of phys-
ical activity, and high saturated fat intake combined with low intake
of fruits and vegetables (Daar 2007). A plethora of data have linked
chronic diseases, including diabetes and cardiovascular and respi-
ratory disease, to lifestyle factors, so it would seem reasonable that
these comorbidities among people who have survived cancer could
be reduced by modifying lifestyle factors (Kushi 2012). Those who
live beyond cancer have an elevated incidence of recurrent disease
and other cancers, so they would potentially benefit from modify-
ing their behaviour to adhere to the recommendations for cancer
prevention. Furthermore, patients have been found to have a high-
er level of motivation to change lifestyle behaviours after a cancer
diagnosis than they had before the diagnosis (Demark-Wahnefried
2005; Ganz 2005; Satia 2004). A survey of modifications in health-re-
lated behaviours demonstrated that two-thirds of people surviving
breast, colorectal, and prostate cancer made positive health-relat-
ed changes to their diet and changed usage of supplements up to
two years after their cancer diagnosis (Patterson 2003). Others have
reported that patients are willing to change their behaviour after
receiving a diagnosis of cancer and that they have already made
changes (Demark-Wahnefried 2000).
Why it is important to do this review
Those who have survived cancer have not only an increased risk of
secondary malignancies but also a higher incidence of comorbidi-
ties compared to the general population (Nord 2005). An increased
incidence of cardiovascular disease, diabetes, and osteoporosis
has been reported among survivors of cancer (Demark-Wahne-
fried 2009; Hawkes 2013; Janssen-Heijnen 2009). Genotype and
lifestyle are considered significant contributory factors that lead to
increased morbidity and cancer recurrence in people who have sur-
vived cancer (Daar 2007; Demark-Wahnefried 2009). Furthermore,
survivors of cancer use healthcare services and receive social wel-
fare benefits more frequently than others (Nord 2005). In addition,
it has been shown that those who have survived cancer visit their
general practitioners more frequently than their non-cancer coun-
terparts (Khan 2011). Research has demonstrated that the poorer
health status identified among survivors of cancer detrimentally in-
fluences QoL (Baker 2003). Among older people who have survived
cancer, improved diet and enhanced physical activity have been
shown to be associated with better vitality and functioning (Hewitt
2003).
This systematic review is important to determine which dietary in-
terventions are effective for those who have survived cancer. Avail-
able evidence supports exercise initiatives for cancer survivors, in
relation to health-related QoL (Mishra 2012). In promoting lifestyle
behaviours, it is difficult to unravel the contributions of individual
components to overall health and well-being. However, it would
be useful to determine the most appropriate dietary interventions
that are effective in people who have survived cancer to inform clin-
ical practitioners, and to assist in improving the long-term health
of people who have survived cancer. Evidence on dietary interven-
tions for survivors of cancer is now developing, so it is timely to
review the literature to summarise the research, to inform clinical
Dietary interventions for adult cancer survivors (Review)
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practice and policy development, and to identify gaps in the litera-
ture for further research.
O B J E C T I V E S
To assess the effects of dietary interventions for adult cancer sur-
vivors on morbidity and mortality, changes in dietary behaviour,
body composition, health-related quality of life, and clinical mea-
surements.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) and cluster RCTs
published in peer-reviewed journals that compared a dietary inter-
vention versus a control consisting of no intervention or written in-
formation.
Types of participants
All adult cancer survivors, defined as those who have lived beyond
a cancer diagnosis that occurred after the age of 18 years and have
completed all active anti-cancer interventions, such as surgery, ra-
diotherapy, chemotherapy, or hormone therapy. People with pre-
cancerous lesions were not included. People who had survived re-
current cancers were included if they had completed all anti-can-
cer therapies.
Types of interventions
All dietary interventions were provided for healthy eating and
weight loss or weight maintenance. Specific nutritional interven-
tions, including those based only on food, were included. Dietary
interventions needed to include multiple nutrients, fat, carbohy-
drate, protein, vitamins, and minerals. Dietary interventions based
on a single food group were excluded. Oral supplements, includ-
ing those with single or multiple nutrients, were excluded. Probiot-
ic supplements were excluded, along with all intravenous nutrient
solutions containing single or multiple nutrient administrations. All
enteral feedings were also excluded.
Types of outcome measures
Primary outcomes
• Overall survival (e.g. time to death from any cause)
• Incidence of secondary malignancy or other cancer
• Incidence of all comorbidities
Secondary outcomes
• Dietary intake measured by dietary analysis using food frequen-
cy questionnaires, dietary recall, or food diaries, or assessed by
dietary assessment methods
• Body weight or anthropometric measurements including hip-
to-waist ratios, skin fold thickness, or functional capacity mea-
surements
• Patient outcomes, including quality of life (QoL) questionnaires
(e.g. EuroQoL Group Quality of Life Questionnaire based on 5 di-
mensions (EQ-5D) (Szende 2014), Short Form (SF)-36 (Bowling
1999))
• Biochemical measurements, which may include lipid profiles
or serum glucose as a surrogate marker (blood glucose levels,
serum cholesterol, serum triglyceride levels)
• Number of healthy eating changes made to habitual eating pat-
terns




• Fruit and vegetable intake.
• Fibre intake.
• Diet Quality Index.
• Body mass index (BMI).
• Waist-to-hip ratio.
Search methods for identification of studies
Electronic searches
We searched the following electronic databases.
• Cochrane Central Register of Controlled Trials (CENTRAL; 2019,
Issue 9), in the Cochrane Library (Appendix 1).
• MEDLINE via Ovid (1946 to September week 1 2019) (Appendix
2).
• Embase via Ovid (1980 to 2019 week 37) (Appendix 3).
• Allied and Complementary Medicine Database (AMED) (Ovid)
(1985 to 31 October 2018) (Appendix 4).
• Cumulative Index to Nursing and Allied Health Literature (CI-
NAHL) (EBSCO host) (1937 to 31 October 2018) (Appendix 5).
• Database of Abstracts of Reviews of Effects (DARE) (1994 to
March 2015) (Appendix 6).
We identified all relevant articles on PubMed; we used the 'related
articles' feature to carry out further searches for newly published
articles. Reports in all languages were sought and translations car-
ried out when necessary.
Searching other resources
We reviewed the reference lists of all retrieved articles and oth-
er reviews on the topic. We also searched the World Health Or-
ganization (WHO) International Clinical Trials Registry Platform
(www.who.int/ictrp/en).
We searched metaRegister (www.isrctn.com/), Physicians Da-
ta Query (www.cancer.gov/publications/pdq), www.clinicaltrial-
s.gov, and www.cancer.gov/about-cancer/treatment/clinical-trials
for ongoing trials. If through these searches we identified ongoing
trials that had not been published, we approached the principal in-
vestigators to ask for relevant data. We searched conference pro-
ceedings and abstracts through ZETOC (zetoc.mimas.ac.uk) and
WorldCat Dissertations (www.worldcat.org/).
We handsearched abstracts from meetings held by the American
Institute for Cancer Research (www.aicr.org/).
We also contacted investigators of eligible unpublished studies
identified from the abstracts of conference proceedings to ask for
relevant unpublished data, and we searched trial registries for ad-
ditional studies.
Dietary interventions for adult cancer survivors (Review)
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Data collection and analysis
Selection of studies
Three review authors (DG, AMS, JS) independently assessed titles
and abstracts retrieved from the searches to determine study rele-
vance and eligibility. We excluded all papers that failed to meet the
eligibility criteria. Two review authors retrieved and independently
reviewed full-text articles for potentially relevant studies, to assess
whether they met the inclusion criteria. We recorded the selection
process in sufficient detail to complete a PRISMA flow diagram and
Characteristics of included studies and Characteristics of excluded
studies tables. A third review author was called upon to resolve any
conflicts that arose during study selection. Multiple reports of the
same study were linked. We translated any non-English articles be-
fore assessment, as required.
Data extraction and management
We devised a standardised data collection form to facilitate collec-
tion of data from the included studies; we have provided this data
extraction form in Appendix 7. We piloted and modified the data
extraction form as required. Two review authors (DJ, SB) indepen-
dently extracted data and discussed any discrepancies with a third
review author (CT). We recorded the following information for each
trial.
• Year of publication, country of origin, source of funding, number
of participants.
• Study population: age, gender, location of tumour, previous
therapy, cancer staging or classification.
• Other baseline characteristics, including proportion of over-
weight or obese survivors (defined by body mass index > 25 kg/
m2 or nutrition status assessment derived from a validated tool),
alcohol intake, smoking status, current physical activity, and so-
cioeconomic group.
We expressed measurement of treatment effect as follows. For di-
chotomous variables, we calculated risk ratios (RRs) and expressed
them with 95% confidence intervals (CIs). For continuous data ex-
pressed as means with standard deviations (SDs), we used mean
differences (MDs) to show effect size. For data presented as time-
to-event, if they were dichotomous, we used a log rank approach to
calculate hazard ratios (HRs).
Assessment of risk of bias in included studies
We assessed risk of bias in included studies using the Cochrane tool
(Higgins 2011). This included assessment of the following.
• Selection bias.
* Random sequence generation.
* Allocation concealment.
• Performance bias.
* Blinding of participants and personnel (patients and treat-
ment providers), although this may not be possible due to the
nature of some of the interventions.
• Detection bias.
* Blinding of outcome assessment.
• Attrition bias.
* Incomplete outcome data: we recorded the proportion of
participants whose outcomes were not reported at the end
of the study and categorised them as follows.
□ Low risk of bias, if less than 80% of patients were assessed
and reasons for loss to follow-up or inadequate responses
were similar in both treatment arms.
□ High risk of bias, if more than 80% of patients were as-
sessed or reasons for loss to follow-up or inadequate re-
sponses differed between treatment arms.
□ Unclear risk of bias, if the number of patients assessed was
not reported.
• Reporting bias.
* Selective reporting of outcomes.
• Other possible sources of bias.
Two review authors independently applied the 'Risk of bias' tool
and resolved differences by discussion or by appeal to a third re-
view author. We summarised results in both a 'Risk of bias' graph
and a 'Risk of bias' summary. We interpreted results of meta-analy-
ses in light of the findings with respect to risk of bias.
Measures of treatment e7ect
• Overall survival
• Incidence of secondary malignancy or other cancer
• Incidence of comorbidities
• Dietary changes measured by dietary analysis using food fre-
quency questionnaires, dietary recall, or food diaries, or as-
sessed by dietary assessment methods
• Changes in body weight or anthropometric measurements in-
cluding hip-to-waist ratios, skin fold thickness, or functional ca-
pacity measurements
• Patient outcomes, including QoL questionnaires
• Biochemical measurements, which may include lipid profiles or
serum glucose as a surrogate marker
• Number of healthy eating changes made to habitual eating pat-
terns
• Details of type of intervention, including nutritional education,
change behaviour techniques employed, and delivery method
of the intervention (written, telephone, face-to-face, or Inter-
net-based)
Unit of analysis issues
We included cluster randomised trials. In these trials, individuals
were randomised as a block, from one centre or one clinic, so we
dealt with this on a trial-by-trial basis, depending on the study de-
sign.
Dealing with missing data
An intention-to-treat analysis was planned and we contacted study
authors for any missing 'Risk of bias' information or outcome data
required, if appropriate. We reported on levels of loss to follow-up/
inadequate follow-up and assessed these as a source of potential
bias. We planned to investigate, through sensitivity analyses, the
effects of any imputed data on pooled effect estimates; however,
we did not impute any data in the analysis, so we did not do this.
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Assessment of heterogeneity
We assessed the heterogeneity of any combined studies in the
meta-analysis using I2. If I2 was greater than 30%, we examined pos-
sible reasons for heterogeneity in relation to clinical setting, study
participants, and similarity of clinical parameters in studies.
Assessment of reporting biases
We searched multiple sources including trial registries as detailed
above. We considered whether trials were undertaken and report-
ed according to their trial protocol. We found an insufficient num-
ber of included studies to assess publication bias using a funnel
plot, as detailed in Section 10.4 of the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011).
Data synthesis
We used Review Manager 2014 for data synthesis. We conducted
meta-analyses only if we found studies reporting similar compar-
isons for the same outcomes. We performed meta-analyses using
the Mantel-Haenszel random-effects method for synthesis of di-
chotomous data due to the anticipated level of heterogeneity in
these studies.
For continuous variables, we used inverse variance in a random-ef-
fects model for suitable data for a meta-analysis. One study report-
ed time-to-event data, and we used the HR with the inverse vari-
ance fixed-effect model. If we established that heterogeneity be-
tween studies was significant (I2 > 30%), we explored possible caus-
es of heterogeneity. If a meta-analysis could not be undertaken, we
provided a descriptive review of the studies.
'Summary of findings' for assessing certainty of evidence
We will present the overall certainty of evidence for each outcome
according to the Grading of Recommendations Assessment, Devel-
opment and Evaluation (GRADE) approach, which takes into ac-
count issues related not only to internal validity (risk of bias, incon-
sistency, imprecision, publication bias) but also to external validity
(e.g. directness of results) (Langendam 2013; Schünemann 2011).
We will create a 'Summary of findings' table based on the methods
described in the Cochrane Handbook for Systematic Reviews of In-
terventions (Higgins 2011), and we will use GRADEPro GDT 2014. We
will use the GRADE checklist and GRADE Working Group certainty
of evidence definitions (Meader 2014). We will downgrade the evi-
dence from 'high-certainty' by one level for serious (or by two levels
for very serious) concerns for each limitation.
• High-certainty: we are very confident that the true effect lies
close to that of the estimate of the effect.
• Moderate-certainty: we are moderately confident in the effect
estimate: the true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different.
• Low-certainty: our confidence in the effect estimate is limited:
the true effect may be substantially different from the estimate
of the effect.
• Very low-certainty: we have very little confidence in the effect
estimate: the true effect is likely to be substantially different
from the estimate of effect.
Subgroup analysis and investigation of heterogeneity
When data allowed, we planned and undertook subgroup analy-
sis on different cancer types and on different dietary intervention
methods delivered for specific interventions. This included sub-
group analysis of interventions for weight management or analysis
that looked at interventions delivered by different methods.
Sensitivity analysis
We undertook sensitivity analysis to evaluate effects of bias on the
results by investigating the impact of trials that had a high or un-
clear level of bias. We evaluated separately each of the items as-
sessed to indicate bias.
R E S U L T S
Description of studies
Results of the search
See Characteristics of included studies, Characteristics of exclud-
ed studies, Characteristics of ongoing studies, and Studies awaiting
classification.
Searches were performed up to 26 October 2018; we identified a to-
tal of 11,092 articles from databases, registers, and other sources as
pre-specified in the Search methods for identification of studies. Af-
ter we had removed 1772 duplicates and had excluded 9154 records
by title and abstract screening, because studies did not meet the
inclusion criteria, or because they were reports of ongoing studies,
we assessed 166 full-text articles for eligibility. After full-text screen-
ing, we identified 78 reports from 25 studies that met the inclusion
criteria (Figure 1).
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Figure 1.   PRISMA flow diagram for study selection.
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Figure 1.   (Continued)
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We performed a top-up search from 1 November 2018 to 18
September 2019, and we searched the main databases (MEDLINE,
Embase, and CENTRAL). We identified 527 studies, of which 125
were duplicates. After title and abstract screening, we excluded an-
other 391 records. After full-text screening of the remaining 11 stud-
ies, we excluded five additional studies (Goodwin 2019; Hagemann
2019; Koutoukidis 2019; Ligibel 2019; Park 2019), and we identified
six studies for inclusion in the review. Of those studies, three are on-
going studies (Demark-Wahnefried 2019; Groarke 2018; O'Connor
2018), and three are awaiting classification (Brown 2018; Parekh
2018; Zuniga 2019).
In total, through all the searches, we found 25 included studies, 26
ongoing studies, and three studies awaiting classification. After re-
view of the results of studies awaiting classification, we concluded
that their current inclusion would not change any conclusions of
the review at this time (Figure 1).
We identified only one trial report for 10 studies (Bloom 2008;
Bourke 2011; Kanera 2017; Kim 2011; Mefferd 2007; Park 2016;
Sheppard 2016; Swisher 2015; Yun 2017; Zick 2017), and we found
15 studies with more than one trial report (Befort 2016; De-
mark-Wahnefried 2006; Demark-Wahnefried 2007; Demark-Wahne-
fried 2014; Djuric 2002; Ghavami 2017; Greenlee 2013; Greenlee
2015; Gruenigen 2012; Harrigan 2016; Hawkes 2013; Morey 2009;
Pierce 2007; Reeves 2017; Scott 2013). All additional reports are in-
cluded under the main report in the reference list. The reports iden-
tified for each study are shown in Appendix 8.
Included studies
See Characteristics of included studies. All data for study outcomes
were derived from published sources.
Study design
All included studies were RCTs that randomised participants to con-
trol or intervention arms. However, one RCT also incorporated pre-
and post-design, whereby women were randomised to delayed in-
tervention as the control group (Bloom 2008). We included six re-
ports of pilot studies (Bourke 2011; Djuric 2002; Greenlee 2013; Kim
2011; Reeves 2017; Zick 2017), along with one report of a feasibility
study (Sheppard 2016).
Mortality and secondary cancers were recorded in one study (Pierce
2007). Dietary changes including total energy intake from dietary
assessment and fruit and vegetable intake were reported. This out-
come was reported as servings of fruits or vegetables separately
per day, or as fruit and vegetable servings per day combined, or
as the number of participants eating more than five portions of
fruits or vegetables. Fibre intake was also reported along with the
Diet Quality Index. Changes in anthropometric measures includ-
ing body weight, body mass index, body composition, waist-to-hip
ratio, waist circumference, and hip circumference, were reported.
Quality of life was reported as Functional Assessment of Cancer
Therapy - General (FACT-G), Functional Assessment of Cancer Ther-
apy - Breast (FACT-B), Functional Assessment of Cancer Therapy -
Colorectal (FACT-C), or Short Form (SF)-36 with physical and men-
tal health domains. Some studies also reported global health sta-
tus using the European Organisation for Research and Treatment
of Cancer (EORTC) questionnaire. One study reported biochemistry
including total cholesterol and triglycerides (Mefferd 2007).
Participants
A total of 7259 participants were randomised in the 25 included
studies, including 977 (13.5%) men and 6282 (86.5%) women. Most
studies included women with breast cancer (Befort 2016; Bloom
2008; Demark-Wahnefried 2014; Djuric 2002; Ghavami 2017; Green-
lee 2013; Greenlee 2015; Harrigan 2016; Kim 2011; Mefferd 2007;
Park 2016; Pierce 2007; Reeves 2017; Scott 2013; Sheppard 2016;
Swisher 2015; Zick 2017). Two studies had discrepancies between
total numbers of participants and genders reported (Kanera 2017;
Yun 2017). Two studies included only participants with colorec-
tal cancer (Bourke 2011; Hawkes 2013), one study included only
women with uterine cancer (Gruenigen 2012), and three studies in-
cluded a mixture of participants after survival of prostate, breast, or
colorectal cancer (Demark-Wahnefried 2006; Demark-Wahnefried
2007; Morey 2009). Two studies reported mixed cancer sites (Kanera
2017; Yun 2017). Mean age reported ranged from 52.6 to 71 years,
and range of age of included participants was 23 to 85 years.
Three studies recruited participants from ethnic minority groups.
One study recruited black women (Sheppard 2016), and the oth-
er two recruited Hispanic and black women (Greenlee 2013; Green-
lee 2015). Two studies targeted older adults (Demark-Wahnefried
2006; Morey 2009). However, in total, mean participant age was re-
ported as above 60 years in five studies (Demark-Wahnefried 2006;
Demark-Wahnefried 2014; Hawkes 2013; Morey 2009; Zick 2017).
Eleven studies recruited participants based on nutritional status
measurements in which body mass index (BMI) was greater than or
equal to 25 kg/m2 (Befort 2016; Demark-Wahnefried 2014; Ghava-
mi 2017; Greenlee 2013; Gruenigen 2012; Harrigan 2016; Mefferd
2007; Reeves 2017; Scott 2013; Sheppard 2016; Swisher 2015); one
study incorporated lifestyle behaviours into the inclusion criteria
(Hawkes 2013); and one study incorporated nutritional intake into
the inclusion criteria (Kim 2011). One study included participants
who consumed fewer than five portions of fruits and vegetables
daily (Greenlee 2015).
Most interventions were provided in participants' own homes or in
a community setting. In one instance, the intervention was provid-
ed at a university rehabilitation centre (Bourke 2011). In three in-
stances, intervention was provided in a hospital or clinic environ-
ment (Mefferd 2007; Pierce 2007; Sheppard 2016), and one study
provided the intervention at an exercise facility (Swisher 2015).
Interventions
The dietary interventions provided varied in relation to the person
providing the intervention, the mode of provision (web, print, tele-
phone, group, or face-to-face), and the frequency of contact with
participants. For each study, these factors have been outlined in
Table 1. Studies recorded dietary intake in different ways; some
reported energy intake and nutrients, and others reported food
groups or scales. In the results, we report dietary intake using en-
ergy intake, fruit servings per day, vegetable servings per day, fruit
and vegetable servings per day in combination, fibre intake, and
Diet Quality Index. The way dietary intake was recorded varied
between studies, as did the methods of assessing dietary intake.
Assessment methods included food diaries that were monitored
by participants, three-day diet recalls, diet history questionnaires,
food frequency questionnaires, and three-day diet diaries. All di-
etary assessment methods used are recorded in Table 1. Dietary
intake was also reported over differing lengths of time; these are
shown in Table 1. Due to lack of standardised methods of recording
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and assessing dietary intake, only a few studies could be incorpo-
rated into meta-analyses, so we have given a narrative summary of
results when appropriate.
Kim 2011 assessed the Diet Quality Index using a scale on which
a lower score indicated better diet quality (Patterson 1994). Two
studies - Demark-Wahnefried 2006 and Demark-Wahnefried 2014 -
used a Diet Quality Index score for which a higher score indicated
better diet quality (Haines 1999).
Types of anthropometry measurements recorded were body
weight, body mass index, weight loss, and hip-to-waist ratio. Study
authors measured outcomes at different time points.
Quality of life was measured via FACT-G, which has 27 questions,
each of which is answered on a five-point Likert scale ranging from
zero (Not at all) to four (Very much). Questions are phrased such
that higher numbers indicate a better health state. For over 20 can-
cer-specific scales, such as FACT-B for breast cancer and FACT-C for
colorectal cancer, higher scores are indicative of a better state of
health.
The SF-36 was also used to measure quality of life and consists of
eight scaled scores, which are the weighted sums of the questions
in each section. Each scale is directly transformed into a 0 to 100
scale on the assumption that each question carries equal weight.
Lower score means greater disability. Higher score means less dis-
ability.
Comparators
The comparisons included in this review were usual care, written
materials, or waiting list compared to dietary intervention. Two in-
cluded studies had more than two arms meeting the inclusion cri-
teria (Djuric 2002; Harrigan 2016). In these studies, the interven-
tion arms were amalgamated when possible, using the guidance
provided in Chapter 9 of the Cochrane Handbook for Systematic Re-
views of Interventions for obtaining a joint mean, a standard devia-
tion, and a comparison with control (Deeks 2011). When this was
not possible, we provided a narrative account in the results.
Funding sources
Funding sources were the US National Institute of Health Research
or the American Institute of Cancer Research in 13 studies (Befort
2016; Bloom 2008; Demark-Wahnefried 2006; Demark-Wahnefried
2007; Demark-Wahnefried 2014; Djuric 2002; Greenlee 2015; Harri-
gan 2016; Mefferd 2007; Morey 2009; Pierce 2007; Sheppard 2016;
Zick 2017). For two studies, funding was provided by the Ameri-
can Cancer Society (Gruenigen 2012; Swisher 2015). Three stud-
ies procured funding from personal foundations (Demark-Wahne-
fried 2006; Greenlee 2013; Pierce 2007). For one study, funding was
awarded from the National Institute for Health Research (NIHR)
in the UK (Bourke 2011), and for another study from Germany,
funding was provided by the National Cancer Institute (NCI) (Park
2016). Two studies received funding from the National Cancer Re-
search Centre in South Korea (Kim 2011; Yun 2017), and two studies
received funding from the Australian Government (Hawkes 2013;
Reeves 2017). Commercial funding was stated only in Djuric 2002.
Some studies received funding from more than one source (De-
mark-Wahnefried 2006; Pierce 2007), and only one study did not
state the funding source (Ghavami 2017).
Excluded studies
See Characteristics of excluded studies.
We excluded 70 articles after full-text screening: 13 were not RCTs,
10 were editorials or protocols only with no follow-up publications,
eight were interventions using supplementation or enriched diet,
six were reviews, six included participants who were still receiving
treatment when randomised, one included participants who were
not cancer survivors, 11 provided interventions that were not di-
etary, eight used single food groups only in the intervention, two
had outcomes that were not focused on diet or nutritional status,
one used quasi-randomisation, one did not involve humans, one
did not separate data for cancer survivors from data for carers, one
conducted secondary analysis for only one arm, and the interven-
tion for one study did not meet review inclusion criteria.
Risk of bias in included studies
We summarised risk of bias in the included studies in Figure 2 and
displayed this information graphically in Figure 3.
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Figure 2.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
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Figure 2.   (Continued)
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Figure 3.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
 
Allocation
We assessed selection bias in the form of the risk of bias domains
of random sequence generation and allocation concealment.
Random sequence generation
In relation to random sequence generation, we identified 21 studies
with low risk of bias because randomisation by computer was used
in seven studies (Bourke 2011; Gruenigen 2012; Hawkes 2013; Kan-
era 2017; Reeves 2017; Yun 2017; Zick 2017); block randomisation
was used in seven studies (Demark-Wahnefried 2006; Demark-Wah-
nefried 2007; Greenlee 2013; Harrigan 2016; Morey 2009; Park 2016;
Pierce 2007); an oG-site statistician was used in four studies (Befort
2016; Demark-Wahnefried 2014; Greenlee 2015; Swisher 2015); a
random numbers table was used in two studies (Ghavami 2017; Kim
2011); and an independent researcher carried out randomisation
in one study (Scott 2013). Unclear risk was demonstrated in four
studies, which lacked detail around the explanation of randomisa-
tion (Mefferd 2007; Sheppard 2016), and in one study, which provid-
ed no information in relation to randomisation (Bloom 2008; Djuric
2002).
Allocation concealment
We found unclear allocation concealment in eight studies, which
provided little - Mefferd 2007 and Yun 2017 - or no detail - Bloom
2008, Demark-Wahnefried 2006, Djuric 2002, Kim 2011, Park 2016,
Sheppard 2016. For 16 studies, risk was considered low as randomi-
sation was undertaken independently (Befort 2016; Bourke 2011;
Greenlee 2013; Gruenigen 2012; Hawkes 2013; Kanera 2017; Morey
2009; Pierce 2007; Reeves 2017; Scott 2013; Swisher 2015); the
study staG involved with randomisation was blinded (Demark-Wah-
nefried 2007; Harrigan 2016; Hawkes 2013); or sealed envelopes
marked with a numerical code were used (Greenlee 2015; Zick
2017). One study was considered high risk as a random numbers
table was used (Ghavami 2017).
Blinding
For evaluating performance bias, we assessed blinding of partici-
pants and personnel for both objective and subjective outcomes.
Blinding of participants and personnel
We identified unclear risk for objective outcomes in three studies
in which no blinding took place due to the nature of the interven-
tion (Demark-Wahnefried 2006; Hawkes 2013; Morey 2009). For sev-
en studies, we deemed the risk as unclear for objective outcomes
because no information was provided (Bloom 2008); or no objec-
tive outcomes were reported (Demark-Wahnefried 2007; Ghavami
2017; Kanera 2017; Kim 2011; Park 2016; Yun 2017). For the remain-
ing 15 studies, we considered risk as low for objective outcomes,
as it was clearly stated that blinding had been used or the out-
come was not influenced by blinding (Befort 2016; Bourke 2011; De-
mark-Wahnefried 2014; Djuric 2002; Greenlee 2013; Greenlee 2015;
Gruenigen 2012; Harrigan 2016; Mefferd 2007; Pierce 2007; Reeves
2017; Scott 2013; Sheppard 2016; Swisher 2015; Zick 2017).
For subjective outcomes, risk of bias was high in 22 studies, which
could not be blinded due to the nature of the study (Bloom 2008;
Bourke 2011; Demark-Wahnefried 2006; Demark-Wahnefried 2007;
Djuric 2002; Ghavami 2017; Greenlee 2013; Greenlee 2015; Gru-
enigen 2012; Hawkes 2013; Kanera 2017; Kim 2011; Mefferd 2007;
Morey 2009; Park 2016; Pierce 2007; Reeves 2017; Scott 2013; Swish-
er 2015; Yun 2017; Zick 2017), or for which no further details were
given (Demark-Wahnefried 2014). Bias was unclear in three studies
because subjective outcomes were not reported (Befort 2016; Har-
rigan 2016; Sheppard 2016). No study had low risk for subjective
outcomes.
Blinding of outcome assessment
We identified high risk of bias for objective outcomes in three stud-
ies, which stated no blinding had been in place (Demark-Wahne-
fried 2006; Hawkes 2013; Morey 2009). For seven studies, risk was
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unclear; for two of these studies, blinding of outcome assessment
was not stated (Bloom 2008; Kim 2011); for one study, blinding
was suggested but not enough detail was included (Demark-Wah-
nefried 2007); and for four studies, objective measures were not
reported (Ghavami 2017; Kanera 2017; Park 2016; Yun 2017). The
remaining 15 studies were considered low risk as study authors
clearly stated that blinding had been in place for the outcome
assessment (Befort 2016; Bourke 2011; Demark-Wahnefried 2014;
Djuric 2002; Greenlee 2013; Greenlee 2015; Gruenigen 2012; Harrig-
an 2016; Mefferd 2007; Pierce 2007; Reeves 2017; Scott 2013; Shep-
pard 2016; Swisher 2015; Zick 2017).
Risk of bias for subjective outcomes was high in 22 studies because
no blinding of outcomes assessment was reported and/or outcome
measurement was patient self-reported (Bloom 2008; Bourke 2011;
Demark-Wahnefried 2006; Demark-Wahnefried 2007; Djuric 2002;
Ghavami 2017; Greenlee 2013; Greenlee 2015; Gruenigen 2012;
Hawkes 2013; Kanera 2017; Kim 2011; Mefferd 2007; Morey 2009;
Park 2016; Pierce 2007; Reeves 2017; Scott 2013; Swisher 2015; Yun
2017; Zick 2017), or no further details were reported (Demark-Wah-
nefried 2014). In three studies, risk was deemed to be unclear be-
cause no subjective outcomes were reported (Befort 2016; Harrig-
an 2016; Sheppard 2016). No study was considered at low risk for
subjective outcomes.
Incomplete outcome data
Attrition bias was assessed in the form of incomplete outcome data
for both objective and subjective outcomes.
Eight studies were considered to have high attrition bias for objec-
tive outcomes: uneven dropout between groups was reported in
two studies - in one study, dropout rates were 61% control and 16%
intervention (Mefferd 2007), and in another study, dropout rates
were 0% control and 18% intervention (Swisher 2015); and a large
attrition rate was reported at between 21% and 49% in six studies
(Demark-Wahnefried 2006; Gruenigen 2012; Harrigan 2016; Hawkes
2013; Reeves 2017; Sheppard 2016). Ten studies were considered at
low risk as the attrition rate was low or was similar between groups
(Befort 2016; Bourke 2011; Demark-Wahnefried 2014; Djuric 2002;
Greenlee 2013; Greenlee 2015; Morey 2009; Pierce 2007; Scott 2013;
Zick 2017).
Nine studies were considered to have high attrition bias for subjec-
tive outcomes due to unequal or high attrition rates (Demark-Wah-
nefried 2006; Gruenigen 2012; Hawkes 2013; Kanera 2017; Mefferd
2007; Park 2016; Reeves 2017; Swisher 2015; Yun 2017). Unclear at-
trition bias was identified in three studies that did not report on
subjective outcomes (Befort 2016; Harrigan 2016; Sheppard 2016).
The remaining 13 studies were considered to be at low risk with low
dropout rates, good adherence levels, and use of intention-to-treat
analysis (Bloom 2008; Bourke 2011; Demark-Wahnefried 2007; De-
mark-Wahnefried 2014; Djuric 2002; Ghavami 2017; Greenlee 2013;
Greenlee 2015; Kim 2011; Morey 2009; Pierce 2007; Scott 2013; Zick
2017).
Selective reporting
For evaluating reporting bias, we assessed selective reporting.
We found eight studies at low risk of bias as a protocol was avail-
able (Befort 2016; Demark-Wahnefried 2006; Demark-Wahnefried
2007; Demark-Wahnefried 2014; Greenlee 2015; Pierce 2007; Scott
2013; Swisher 2015), and all primary and secondary outcomes of
interest to the review were reported in the pre-specified way. We
judged most studies to have unclear reporting bias. For 14 studies,
we found insufficient information to permit judgement as no pro-
tocol was available (Bloom 2008; Bourke 2011; Djuric 2002; Ghava-
mi 2017; Greenlee 2013; Harrigan 2016; Kim 2011; Mefferd 2007;
Morey 2009; Park 2016; Reeves 2017; Sheppard 2016; Yun 2017; Zick
2017). We found that two studies reported on primary outcome
measures but did not report on all secondary outcome measures
or at the time points specified in the protocol (Gruenigen 2012;
Hawkes 2013), and one study did not report on all primary out-
comes (Kanera 2017).
Other potential sources of bias
We judged two studies to have low risk of other bias (Demark-Wah-
nefried 2007; Harrigan 2016), as reports provided sufficient detail
for the review authors to have no other concerns regarding sources
of bias. In the remaining 23 studies, information was insufficient
to permit a judgement, so the risk of bias is unclear. Some stud-
ies used self-reporting and thus may have been open to recall
bias (Bourke 2011; Demark-Wahnefried 2006; Hawkes 2013; Reeves
2017).
E7ects of interventions
See: Summary of findings for the main comparison Dietary inter-
vention compared to control for people living beyond cancer
Comparisons were dietary intervention versus control or usual
care. Two studies reported more than one comparison (Djuric 2002;
Harrigan 2016). See Summary of findings for the main comparison
for details about these studies regarding dietary interventions, fol-
low-up, and outcomes as well as certainty of evidence.
Primary outcomes
Overall survival
One study reported on mortality in participants with breast cancer
(Pierce 2007). GRADE ratings for overall survival and for secondary
malignancies or other cancers are shown in Summary of findings
for the main comparison.
Rates of death in groups receiving dietary intervention compared to
groups given control were similar (hazard ratio (HR) 0.98, 95% con-
fidence interval (CI) 0.77 to 1.23; n = 3107; low-certainty evidence;
Analysis 1.1; heterogeneity was not applicable as only one study
reported the number of deaths after 7.3 years' follow-up among
participants after breast cancer (Pierce 2007)). We downgraded the
quality of evidence by one level for inability to assess consistency as
there was only one study and one level, as the CIs were not narrow.
Incidence of secondary malignancy or other cancer
Dietary intervention compared to control may make little or no dif-
ference in secondary malignancies or other cancers (risk ratio (RR)
0.99, 95% CI 0.84 to 1.15; 3107 participants; low-certainty evidence;
Analysis 1.2; heterogeneity was not applicable as there was only
one study) occurring within 7.3 years' follow-up (Pierce 2007). We
downgraded the quality of evidence by one level for inability to as-
sess consistency as there was only one study and one level, as the
CIs were not narrow.
Incidence of morbidities
This outcome was not reported in any of the included studies.
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Secondary outcomes
Dietary changes
GRADE ratings for dietary changes are shown in Summary of find-
ings for the main comparison.
Energy intake
A total of 11 studies reported total energy intake from dietary
assessment (Bourke 2011; Demark-Wahnefried 2014, Djuric 2002;
Greenlee 2013; Greenlee 2015; Gruenigen 2012; Pierce 2007; Reeves
2017; Scott 2013; Sheppard 2016; Zick 2017).
• We are uncertain if dietary intervention compared to control has
any effect on energy intake at three months measured in kilo-
calories (mean difference (MD) -52.61 kcal, 95% CI -209.23 to
104.02; 115 participants; heterogeneity I2 = 0%; very low-certain-
ty evidence) from three studies (Bourke 2011; Gruenigen 2012;
Zick 2017). We downgraded the quality of evidence by one level
due to risk of bias, one level for imprecision, and one level due
to wide variation in effect estimates across studies.
• Dietary intervention compared to control probably makes lit-
tle or no difference in energy intake at six months measured
in kilocalories (MD -47.67 kcal, 95% CI -142.33 to 46.99; 3236
participants; heterogeneity I2 = 25%; moderate-certainty evi-
dence) from four studies (Demark-Wahnefried 2014; Greenlee
2013; Gruenigen 2012; Pierce 2007). We downgraded the quality
of evidence by one level due to wide variation in effect estimates
across studies.
• Dietary intervention compared to control probably makes little
or no difference in energy intake at 12 months measured in kilo-
calories (MD -59.13 kcal, 95% CI -156.05 to 37.79; 3283 partici-
pants; heterogeneity I2 = 42%; moderate-certainty evidence) re-
ported in five studies (Demark-Wahnefried 2014; Greenlee 2013;
Greenlee 2015; Gruenigen 2012; Pierce 2007). The data for ener-
gy intake are displayed in Analysis 2.1. We downgraded the qual-
ity of evidence by one level due to wide variation in effect esti-
mates across studies.
Subgroup analyses of studies on body mass index (BMI) greater
than 25 kg/m2 at three months - Gruenigen 2012 and Zick 2017 -
and at six months - Gruenigen 2012 and Greenlee 2013 - showed
very low-certainty of evidence, and we are uncertain if dietary in-
tervention has any effect on energy intake in this subgroup (Table
2). Greenlee 2015 presented energy intake as adjusted means at
three months and at six months, and we are uncertain if dietary in-
tervention has any effect on energy intake with very low-certainty
evidence (Table 2).
We excluded one study from the meta-analysis as it was considered
to have unclear or high risk for all risk of bias domains (Djuric 2002).
This study reported energy intake after 12 months and included
three groups: the weight watchers group (2106 kcal, standard devi-
ation (SD) 673, 13 participants), the individualised group (1833 kcal,
SD 358, 9 participants), and the comprehensive intervention group
(1899 kcal, SD 424, 8 participants) compared to the control group
(2246 kcal, SD 660, 10 participants).
One study collected data from the intervention group and not from
the control group, showing a reduction in energy intake when base-
line was compared with measurements at 12 weeks of -207.3 kcal
(SD 31.5) (Sheppard 2016). Two studies reported no difference in
energy intake but did not provide any data (Reeves 2017; Scott
2013).
Fruit and vegetable intake
Fruit servings per day
Fifteen studies reported on fruit and vegetable intake (Bloom
2008; Demark-Wahnefried 2006; Demark-Wahnefried 2007; Green-
lee 2013; Greenlee 2015; Gruenigen 2012; Harrigan 2016; Hawkes
2013; Kanera 2017; Morey 2009; Park 2016; Pierce 2007; Reeves
2017; Yun 2017; Zick 2017).
Data suitable for meta-analysis on fruit servings per day were pro-
vided in three studies (Greenlee 2015; Gruenigen 2012; Pierce 2007).
• It is uncertain if dietary intervention compared to control has
any effect on fruit servings (MD 0.10 servings, 95% CI -0.82 to
1.02; 67 participants; heterogeneity not applicable; very low-
certainty evidence) in one study at three months (Gruenigen
2012). We downgraded the quality of evidence by one level due
to risk of bias, by one level for imprecision, and by one level for
inability to assess consistency as there was only one study.
• Dietary intervention compared to control may slightly improve
fruit servings (MD 0.62 servings, 95% CI 0.08 to 1.16; 3157 partici-
pants; I2 = 54%; low-certainty evidence) in two studies reporting
fruit portions at six months (Gruenigen 2012; Pierce 2007). We
downgraded the quality of evidence by one level due to risk of
bias and by one level due to inconsistency between studies as
there was only one study.
• Dietary intervention compared to control may have little or no
effect in improving fruit servings (MD 0.47 servings, 95% CI -0.13
to 1.07; 3205 participants; I2 = 56%; low-certainty evidence) in
three studies at 12 months (Analysis 2.5; Figure 4; Greenlee 2015;
Gruenigen 2012; Pierce 2007). We downgraded the quality of ev-
idence by one level due to risk of bias and by one level due to
inconsistency between studies.
Figure 4.    Forest plot of comparison: 2 Dietary
changes, outcome: 2.12 Mean fruit and vegetable serv-
ings (per day).
Subgroup analysis on different cancer sites and on population dif-
ferences was undertaken to explore the high heterogeneity ob-
served in fruit servings.
Three studies were considered for cancer site differences.
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• It is uncertain if dietary intervention has any effect on fruit intake
in uterine cancer survivors at six months and at 12 months with
very low-certainty evidence (Gruenigen 2012).
• In breast cancer survivors, dietary intervention compared to
control probably slightly improves fruit servings with moder-
ate-certainty evidence at six months, and evidence at 12 months
shows that dietary intervention probably has little or no effect
on fruit intake (Table 2; Greenlee 2015; Pierce 2007), with mod-
erate-certainty evidence.
High heterogeneity at 12 months was explored on the basis of pop-
ulation differences.
• In a Hispanic population, we are uncertain whether dietary in-
tervention has any effect on fruit servings with very low-certain-
ty evidence.
• In a mixed population (85% white), dietary intervention com-
pared to control probably slightly improves fruit servings with
moderate-certainty evidence (Table 2).
Vegetable servings per day
• We are uncertain if dietary intervention compared to control
has any effect on adjusted mean vegetable servings in Hispan-
ic women with breast cancer at three months (MD 0.60, 95% CI
-0.23 to 1.43; 67 participants; very low-certainty evidence), at six
months (MD 0.80 servings, 95% CI -0.03 to 1.63; 61 participants;
very low-certainty evidence), and at 12 months (MD 1.10 serv-
ings, 95% CI 0.35 to 1.85; 58 participants; very low-certainty evi-
dence; Analysis 2.9) in one study (Greenlee 2015). We downgrad-
ed the quality of evidence by one level due to risk of bias, by one
level for imprecision, and by one level for inability to assess con-
sistency as there was only one study.
• We are uncertain if dietary intervention compared to control has
any effect on vegetable servings in women with uterine cancer
at three months (MD 1.20 servings, 95% CI 0.00 to 2.40; 67 par-
ticipants; very low-certainty evidence) and at six months and 12
months (six-month MD 0.80 servings, 95% CI -0.37 to 1.97; 69 par-
ticipants; very low-certainty evidence; 12-month MD 0.30 serv-
ings, 95% CI -0.85 to 1.45; 59 participants; heterogeneity not ap-
plicable; very low-certainty evidence; Analysis 2.10) in one study
(Gruenigen 2012). We downgraded the quality of evidence by
one level due to risk of bias, by one level for imprecision, and by
one level due to inability to assess consistency across studies as
there was only one study.
• We are uncertain if dietary intervention compared to control in-
creases vegetable servings in women with breast cancer at three
months (MD 3.70 servings, 95% CI 2.64 to 4.76; 30 participants;
very low-certainty evidence; Analysis 2.11) in one study (Zick
2017). We downgraded the quality of evidence by one level due
to risk of bias, by one level due to imprecision, and by one level
due to inability to assess consistency across studies as there was
only one study.
• Dietary intervention compared to control probably increases
vegetable servings in women with breast cancer at six months
(MD 4.50 servings, 95% CI 4.49 to 4.51; 3088 participants; mod-
erate-certainty evidence) and at 12 months (MD 3.90 servings,
95% CI 3.89 to 3.91; 3088 participants; moderate-certainty evi-
dence; Analysis 2.11) in one study (Pierce 2007). We downgrad-
ed the quality of evidence by one level due to inability to assess
consistency across studies as there was only one study.
Fruit and vegetable servings per day
• We are uncertain if dietary intervention compared to control has
any effect on fruit and vegetable servings in women with uter-
ine cancer at three months (MD 1.20 servings, 95% CI -0.24 to
2.64; 67 participants; very low-certainty evidence; Analysis 2.12)
in one study (Gruenigen 2012). We downgraded the quality of ev-
idence by one level due to risk of bias and by one level due to
inability to assess consistency across studies as there was only
one study, and by one level for imprecision.
• Dietary intervention compared to control may have little if any
effect on fruit and vegetable servings in women with uterine
cancer or breast cancer, and in a mixture of participants with
breast or prostate cancer at six months (MD 0.45 servings, 95%
CI -0.04 to 0.94; 276 participants; I2 = 0%; low-certainty evidence;
Analysis 2.12) in three studies (Demark-Wahnefried 2006; Green-
lee 2013; Gruenigen 2012). We downgraded the quality of evi-
dence by one level due to risk of bias and by one level due to in-
directness.
• Dietary intervention compared to control probably slightly in-
creases fruit and vegetable servings in women with uterine
cancer or breast cancer and in a mixture of participants at 12
months (MD 0.41 servings, 95% CI 0.10 to 0.71; 834 participants;
I2 = 0%; moderate-certainty evidence; Analysis 2.12;Figure 4)
in five studies (Demark-Wahnefried 2006; Demark-Wahnefried
2007; Greenlee 2013; Greenlee 2015; Gruenigen 2012). We down-
graded the quality of evidence by one level due to indirectness.
Adjusted mean fruit and vegetable intake in women with breast
cancer was reported in one study at three months and at six
months, and we are uncertain if there is any effect of dietary inter-
vention with very low-certainty evidence (Table 2; Greenlee 2015).
One study reported adjusted between-group differences in mean
change for fruit servings (410 participants) at six months as 0.2 (95%
CI -0.0 to 0.4), and at 12 months as 0.0 (95% CI -0.2 to 0.3) (Hawkes
2013); for vegetable servings (410 participants), the adjusted be-
tween-group difference in mean change at six months was 0.4 (95%
CI 0.2 to 0.7), and at 12 months was 0.2 (95% CI -0.1 to 0.5). Morey
2009 reported daily servings of fruits and vegetables in the manu-
script as MD 1.11 (95% CI 0.76 to 1.47).
Seven studies did not provide data suitable for inclusion in the
meta-analysis, and one study did not report any data (Reeves 2017).
One study did not report the number of servings but reported the
percentage of participants who increased consumption of fruits
and vegetables to more than five portions a day; 32% of partici-
pants ate more than five servings of fruits and vegetables in the con-
trol group compared to 31% (total 386) in the intervention group
(Bloom 2008). One study reported fruit and vegetable portions in
three arms of a trial as change from baseline at six months (in-
person intervention mean 1.2, SD 3.1, 33 vs telephone calls mean
1.1, SD 2.9, 34 vs control mean -0.3, SD 1.9, 33). For both inter-
vention arms, results showed a difference when compared to the
control arm (P = 0.017) (Harrigan 2016). One study reported fruit
and vegetable intake at baseline, but subsequent data were pre-
sented in graphs at four months and at seven months (Park 2016).
One study reported fruits and vegetables, stating there were differ-
ences between groups (P = 0.819 at three months and P = 0.413 at
12 months), and reported no other data (Yun 2017). One study re-
ported vegetable consumption in grams per day at six months (in-
tervention mean 146.6, SD 56.0, 184 participants vs control mean
124.9, SD 60.8, 219 participants) and at 12 months (intervention
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mean 95.3, SD 44.7, 166 participants vs control mean 81.4, SD 44.1,
210 participants) (Kanera 2017).
Fibre intake
• We are uncertain if dietary intervention compared to control has
any effect on fibre intake in participants with colon cancer at
three months (MD 6.00 g, 95% CI 0.73 to 11.27; 18 participants;
very low-certainty evidence; Analysis 2.14) in one study (Bourke
2011). We downgraded the quality of evidence by one level due
to risk of bias and by one level for inability to assess consisten-
cy as there was only one study, and by one level for impreci-
sion. This comparison was also conducted at six months (MD
4.79 g, 95% CI -4.72 to 14.29; 3127 participants; I2 = 97%; very
low-certainty evidence) and at 12 months (MD 5.12 g, 95% CI
-0.66 to 10.90; 3127 participants; I2 = 97%; very low-certainty ev-
idence; Analysis 2.14) in women with breast cancer in two stud-
ies (Greenlee 2013; Pierce 2007). We downgraded the quality of
evidence by two levels due to inconsistency across studies and
by one level as the CIs were not narrow.
Because of the high level of inconsistency identified, we under-
took subgroup analysis, as two studies had different aims for di-
etary intervention: one study gave weight-reducing advice and en-
rolled participants with BMI ≥ 25 kg/m2 (Greenlee 2013), and the
other study aimed to encourage healthy eating for the intervention
(Pierce 2007). We are uncertain from one study at six months and
at 12 months whether dietary intervention for weight reduction has
any effect on fibre intake with very low-certainty evidence (Green-
lee 2013). In another study of women with breast cancer, partic-
ipants were encouraged to eat a healthy diet; at six months and
at 12 months, dietary intervention compared to control probably
increased fibre intake with moderate-certainty evidence (Table 2;
Pierce 2007).
Two studies looked at change scores (Harrigan 2016; Hawkes 2013).
One of these studies reported fibre intake as grams per 1000 kcal
(in-person mean 5.6, SD 4.1, 33 participants, telephone mean 3.9,
SD 5.3, 34 participants, control mean 1.3, SD 4.2, 33 participants)
and performed between-group comparisons with both interven-
tion arms versus control (P < 0.017) (Harrigan 2016). In another
study, change in fibre was expressed as grams per day adjusted
for baseline values and reported at six months (intervention 0.3 g,
standard error (SE) 0.6 vs control 1.0 g, SE 0.5; 410 participants) and
at 12 months (intervention -0.2 g, SE 0.6 vs control 0.7 g, SE 0.6;
410 participants) (Hawkes 2013). One study reported differences
between intervention and baseline at three months in grams per
day (intervention 19.2, SD 12.2 vs control 13.4, SD 5.4; 22 partici-
pants); data were not available for the control arm at three months
(Sheppard 2016).
Diet Quality Index
Four studies used the Diet Quality Index score (Demark-Wahne-
fried 2006; Demark-Wahnefried 2007; Demark-Wahnefried 2014;
Kim 2011).
• We are uncertain if dietary intervention improves Diet Quality
Index at three months (MD 0.90, 95% CI 0.29 to 1.52; 45 partici-
pants; very low-certainty evidence; Analysis 2.18) in one study
(Kim 2011). We downgraded the quality of evidence by one lev-
el due to imprecision, and by two levels due to risk of selection
bias and lack of blinding.
• Dietary intervention compared to control may improve Diet
Quality Index at six months (MD 5.20, 95% CI 1.04 to 9.36; 182
participants; low-certainty evidence; Analysis 2.17; Figure 5) in
one study (Demark-Wahnefried 2006). We downgraded the qual-
ity of evidence by one level due to no allocation concealment
described and by one level due to inability to assess consistency
as there was only one study.
Figure 5.    Forest plot of comparison: 2 Dietary
changes, outcome: 2.18 Diet Quality Index .
• Dietary intervention compared to control probably may im-
prove Diet Quality Index at 12 months (MD 3.46, 95% CI 1.54 to
5.38; 747 participants; I2 = 12%; moderate-certainty evidence;
Analysis 2.17; Figure 5) in three studies (Demark-Wahnefried
2006; Demark-Wahnefried 2007; Demark-Wahnefried 2014). We
downgraded the quality of evidence by one level due to risk of
bias.
Changes in anthropometric measurements
Fifteen studies measured one or more outcomes for changes in
anthropometric (physical) measures (Bourke 2011; Demark-Wah-
nefried 2006; Demark-Wahnefried 2007; Demark-Wahnefried 2014;
Djuric 2002; Greenlee 2013; Gruenigen 2012; Harrigan 2016; Hawkes
2013; Mefferd 2007; Morey 2009; Pierce 2007; Scott 2013; Sheppard
2016; Swisher 2015). GRADE ratings for changes in anthropometry
are shown in Summary of findings for the main comparison.
Body weight
• Dietary intervention compared to control may have little if any
effect on body weight at three months (MD -3.52 kg, 95% CI -7.34
to 0.29; 247 participants; I2 = 0%; low-certainty evidence; Analy-
sis 3.1) in six studies (Bourke 2011; Greenlee 2013; Gruenigen
2012; Mefferd 2007; Sheppard 2016; Swisher 2015). We down-
graded the quality of evidence by one level due to risk of bias
and by one level for imprecision.
• Dietary intervention compared to control probably has little if
any effect on body weight at six months (MD -2.84 kg, 95% CI
-6.95 to 1.28; 190 participants; I2 = 0%; moderate-certainty evi-
dence; Analysis 3.1) in three studies (Greenlee 2013; Gruenigen
2012; Scott 2013). We downgraded the quality of evidence by
one level for imprecision.
• Dietary intervention compared to control has little if any ef-
fect on body weight at 12 months (MD -0.80 kg, 95% CI -2.01 to
0.41; 3287 participants; I2 = 0%; high-certainty evidence; Analy-
sis 3.1) in five studies that reported body weight (Demark-Wah-
nefried 2014; Greenlee 2013; Greenlee 2015; Gruenigen 2012;
Pierce 2007).
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Adjusted weight was reported in Hispanic women with breast can-
cer at six months in one study (Greenlee 2015), and we are uncer-
tain if dietary intervention compared to control has any effect on
weight with very low-certainty evidence (Table 3).
One study reported weight change at six months (Reeves 2017),
showing that dietary intervention may slightly decrease body
weight with low-certainty evidence, and another study showed that
dietary intervention may have little if any effect on body weight
change at 12 months with low-certainty evidence (Table 3; Morey
2009).
One study reported weight change in three arms after six months
(in-person -5.6, 95% CI -7.1 to -4.1 vs telephone -4.8, 95% CI -6.5 to
-3.1 vs control -1.7, 95% CI -3.2 to -0.3) (Harrigan 2016). Djuric 2002
measured weight in kilograms, and figures in four arms without ac-
tual weights for each group and numbers for each arm at each time
point were not documented clearly, so they were not included in
the analysis.
One study reported weight loss at three months and at six months
(Befort 2016). At three months, data showed there is probably lit-
tle if any effect of dietary intervention on weight loss, but at six
months there is probably a slight decrease in weight in the inter-
vention group compared to the control group with moderate-cer-
tainty evidence (Table 3).
Body mass index
Data expressed as means and standard deviations
• Dietary intervention compared to control may slightly decrease
BMI at three months (MD -1.80 kg/m2, 95% CI -2.95 to -0.65; 247
participants; I2 = 0%; low-certainty evidence, Analysis 3.5; Figure
6) in six studies (Bourke 2011; Mefferd 2007; Scott 2013; Shep-
pard 2016; Swisher 2015; Zick 2017). We downgraded the quality
of evidence by one level due to CI not being very narrow and due
to risk of bias.
Figure 6.   Forest plot of comparison: 3 Changes in an-
thropometry, outcome: 3.5 Mean body mass index (kg/
m2).
• We are uncertain if dietary intervention compared to control
had any effect on BMI at six months (MD -0.70 kg/m2, 95% CI
-2.26 to 0.86; 168 participants; heterogeneity not applicable;
very low-certainty evidence; Analysis 3.5; Figure 6) in one study
(Demark-Wahnefried 2006). We downgraded the quality of evi-
dence by two levels due to risk of bias and by one level due to
inability to assess consistency as there was only one study.
• Dietary intervention compared to control probably slightly de-
creased BMI at 12 months (MD -0.79 kg/m2, 95% CI -1.50 to
-0.07; 777 participants; I2 = 0%; moderate-certainty evidence;
Analysis 3.5; Figure 6) in four studies (Demark-Wahnefried 2006;
Demark-Wahnefried 2007; Demark-Wahnefried 2014; Greenlee
2015). We downgraded the quality of evidence by one level due
to risk of bias.
One study reported BMI as a mean difference at six months; data
showed low-certainty evidence and there may be a slight decrease
in BMI in the intervention group compared to the control group
(Hawkes 2013).
Two studies reported mean differences at 12 months, showing that
dietary intervention probably slightly decreases BMI with moder-
ate-certainty evidence (Table 3; Hawkes 2013; Morey 2009). One
study reported on adjusted mean BMI at six months, and we are un-
certain if there is any effect of intervention on BMI with very low-
certainty evidence (Table 3; Greenlee 2015).
Body composition
Lean body tissue
We are uncertain whether dietary intervention has any effect on
lean body mass at three months (MD -0.30, 95% CI -2.41 to 1.81; 76
participants; very low-certainty evidence; Analysis 3.8) in one study
(Mefferd 2007). We downgraded the quality of evidence by two lev-
els due to risk of bias for sequence generation and blinding, by one
level due to imprecision, and by one level due to inability to assess
consistency as there was only one study.
Body fat
• Dietary intervention compared to control may decrease per-
centage of body fat at three months (MD -4.97%, 95% CI -7.47 to
-2.48; 99 participants; I2 = 0%; low-certainty evidence; Analysis
3.9) in two studies (Mefferd 2007; Swisher 2015). We downgrad-
ed the quality of evidence by one level due to risk of bias assess-
ment and by one level due to imprecision.
• We are uncertain if dietary intervention has any effect on per-
centage of body fat at six months (MD -0.01%, 95% CI -0.05 to
0.03; 39 participants; very low-certainty evidence; Analysis 3.10)
in one study (Greenlee 2013). We downgraded the quality of ev-
idence by one level due to risk of bias assessment and by two
levels due to small sample size and imprecision.
One study reported percentage of body fat in 100 participants ex-
pressed as least squares means from a linear model, and the in-per-
son dietary intervention for six-month change was -3.3 (95% CI -4.4
to -2.1; 33 participants) versus telephone intervention -2.4 (95% CI
-3.7 to -1.2; 34 participants) versus control -1.7 (95% CI -2.8 to -0.5;
33 participants) (Harrigan 2016). One study reported on body fat,
stating there was no difference between groups; data were not giv-
en (Scott 2013).
Waist-to-hip ratio
• Dietary intervention compared to control may have little if any
effect on waist-to-hip ratio at three months (MD -0.03, 95% CI
-0.06 to 0.01; 181 participants; I2 = 63%; low-certainty evidence;
Analysis 3.11) in five studies (Bourke 2011; Greenlee 2013; Mef-
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ferd 2007; Sheppard 2016; Swisher 2015). We downgraded the
quality of evidence by one level due to risk of bias assessment
and by one level due to inconsistency.
• Dietary intervention compared to control may have little if any
effect on waist-to-hip ratio at six months (MD -0.02, 95% CI -0.05
to 0.01; 118 participants; I2 = 0%; low-certainty evidence; Analy-
sis 3.11) in two studies (Greenlee 2013; Scott 2013). We down-
graded the quality of evidence by one level for imprecision due
to small sample sizes and by one level for indirectness.
• Dietary intervention compared to control may have little if any
effect on waist-to-hip ratio at 12 months (MD -0.01, 95% CI -0.04
to 0.02; 106 participants; heterogeneity I2 = 0%; low-certainty ev-
idence; Analysis 3.11) in two studies (Greenlee 2013; Greenlee
2015). We downgraded the quality of evidence by one level due
to imprecision because of small sample size and by one level for
indirectness because studies recruited only Hispanic women.
We undertook subgroup analysis to explore heterogeneity in the
waist-to-hip ratio in different cancer sites at three months. In one
study on colon cancer survivors, we are uncertain whether dietary
intervention had any effect on waist-to-hip ratio with very low-cer-
tainty evidence (Bourke 2011). Studies on breast cancer survivors
showed that dietary intervention may have little if any effect on
waist-to-hip ratio with low-certainty evidence (Table 3; Greenlee
2013; Mefferd 2007; Sheppard 2016; Swisher 2015). We downgrad-
ed the quality of evidence by one level due to risk of bias and by one
level due to indirectness.
Waist circumference
Four studies reported waist circumference in means with SDs (De-
mark-Wahnefried 2014; Greenlee 2015; Gruenigen 2012; Mefferd
2007).
• We are uncertain whether dietary intervention decreases waist
circumference at three months (MD -4.00 cm, 95% CI -12.53 to
4.53; 143 participants; I2 = 66%; very low-certainty evidence;
Analysis 3.17) in two studies (Gruenigen 2012; Mefferd 2007). We
downgraded the quality of evidence by two levels due to risk of
bias assessment and by one level due to inconsistency.
• Dietary intervention compared to control may have little if any
effect on waist circumference at six months (MD -0.33 cm, 95%
CI -4.79 to 4.14; 109 participants; I2 = 0%; low-certainty evidence;
Analysis 3.17) in two studies (Demark-Wahnefried 2014; Grueni-
gen 2012). We downgraded the quality of evidence by two levels
due to wide CI.
• Dietary intervention compared to control may have little if any
effect on waist circumference at 12 months (MD -3.36 cm, 95% CI
-7.55 to 0.82; 148 participants; I2 = 17%; low-certainty evidence;
Analysis 3.17) in three studies (Demark-Wahnefried 2014; Green-
lee 2015; Gruenigen 2012). We downgraded the quality of evi-
dence by two levels due to wide CI.
Two studies reported changes in waist circumference (Green-
lee 2013; Reeves 2017). One study reported on changes at three
months, and we are uncertain if dietary intervention has any effect
on waist circumference with very low-certainty evidence (Green-
lee 2013). Two studies reported on changes at six months, show-
ing that dietary intervention may slightly decrease waist circum-
ference with low-certainty evidence (Greenlee 2013; Reeves 2017).
One study reported on changes at 12 months, and we are uncertain
if dietary intervention has any effect on waist circumference with
very low-certainty evidence (Table 3; Greenlee 2013).
One study reported on change in waist circumference in three arms
after six months (in-person -7.5, 95% CI -9.7 to -5.3 vs telephone
-7.2, 95% CI -9.6 to -4.8 vs control -2.6, 95% CI -4.7 to -0.5) (Harrigan
2016).
One study reported an adjusted change in waist circumference at
six months, and we are uncertain if dietary intervention had any ef-
fect on waist circumference with very low-certainty evidence (Ta-
ble 3; Greenlee 2015).
One study reported an adjusted mean difference in waist circum-
ference (-3.32 cm, 95% CI -1.53 to -5.11 cm; P < 0.001) (Scott 2013).
Hip circumference
Five studies reported on hip circumference (Greenlee 2013; Green-
lee 2015; Harrigan 2016; Mefferd 2007; Reeves 2017).
Two studies reported data as means and SDs (Greenlee 2015; Mef-
ferd 2007).
• We are uncertain if dietary intervention compared to control has
any effect on hip circumference (three months MD -5.40 cm, 95%
CI -10.06 to -0.74; 76 participants; six months MD -3.20 cm, 95%
CI -10.96 to 4.56; 50 participants; 12 months MD -4.00 cm, 95%
CI -11.43 to 3.43; 49 participants; very low-certainty evidence;
Analysis 3.16). We downgraded the quality of evidence at each
time point by one level due to risk of bias assessment, by two
levels due to wide CI, and by one level due to inability to assess
consistency due to one study.
Two studies reported hip circumference as change scores (Green-
lee 2013; Reeves 2017). One study reported on changes at three
months, and we are uncertain if dietary intervention has any ef-
fect on hip circumference change score with very low-certainty ev-
idence (Greenlee 2013). Two studies reported on changes at six
months, and we are uncertain if there is any effect on hip circum-
ference change score with very low-certainty evidence (Greenlee
2013; Reeves 2017). One of these studies reported also on 12-month
change, and we are uncertain if dietary intervention has any effect
on hip circumference change score (Table 3; Greenlee 2013).
One study reported change in hip circumference in three arms after
six months (in-person -6.9 cm, 95% CI -8.5 to -5.2 vs telephone -6.1
cm, 95% CI -8.0 to -4.3 vs control -3.1 cm, 95% CI -4.7 to -1.5) (Har-
rigan 2016).
Patient outcomes, including quality of life (QoL)
Eleven studies measured quality of life (Bourke 2011; Demark-Wah-
nefried 2006; Demark-Wahnefried 2007; Demark-Wahnefried 2014;
Hawkes 2013; Kim 2011; Mefferd 2007; Morey 2009; Reeves 2017;
Scott 2013; Swisher 2015). GRADE ratings for QoL are shown in Ta-
ble 4.
FACT-G QoL
• We are uncertain if dietary intervention compared to control has
any effect on FACT-G score at six months (MD -2.50, 95% CI -5.80
to 0.80; 168 participants; very low-certainty evidence; Analysis
4.1) in one study (Demark-Wahnefried 2006). We downgraded
the quality of evidence by two levels due to risk of bias assess-
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ment and by one level for inability to assess consistency across
studies. This comparison was also done at 12 months (MD -0.52,
95% CI -2.31 to 1.26; 685 participants; I2 = 0%; very low-certainty
evidence; Analysis 4.1) in two studies (Demark-Wahnefried 2006;
Demark-Wahnefried 2007). We downgraded the quality of evi-
dence by two levels due to risk of bias and by one level as CI was
not very narrow.
FACT-B QoL
• We are uncertain if dietary intervention compared to control
has any effect on FACT-B score at three months (MD 15.60, 95%
CI -4.96 to 36.16; 23 participants; heterogeneity not applicable;
very low-certainty evidence) in one study (Swisher 2015). We
downgraded the quality of evidence by one level due to risk of
bias, by one level due to inability to assess consistency across
studies as only one study, and by one level due to imprecision.
This comparison was also performed at six months (MD 4.90,
95% CI -0.80 to 10.60; 90 participants; very low-certainty evi-
dence) in one study (Scott 2013). We downgraded the quality of
evidence by one level due to risk of bias, by one level due to in-
ability to assess consistency across studies as only one study,
and by one level due to imprecision (Analysis 4.3).
FACT-C QoL
• We are uncertain if dietary intervention compared to control af-
fects FACT-C score at three months (MD 14.00, 95% CI 2.87 to
25.13; 18 participants; very low-certainty evidence; Analysis 4.2)
in one study (Bourke 2011). We downgraded the quality of evi-
dence by one level due to risk of bias, by one level due to inability
to assess consistency across studies as there was only one study,
and by one level due to imprecision.
SF-36 QoL mean change physical domain
• We are uncertain if dietary intervention compared to control has
any effect on SF-36 physical score at six months (MD -0.15, 95%
CI -1.59 to 1.28; 500 participants; I2 = 0%; very low-certainty evi-
dence; Analysis 4.5) in two studies (Hawkes 2013; Reeves 2017).
We downgraded the quality of evidence by one level as CIs were
not narrow and by two levels for risk of bias assessment.
• Dietary intervention compared to control may slightly improve
SF-36 physical score at 12 months (MD 1.91, 95% CI 0.45 to 3.37;
1091 participants; I2 = 0%; low-certainty evidence; Analysis 4.5)
in three studies (Demark-Wahnefried 2014; Hawkes 2013; Morey
2009). We downgraded the quality of evidence by two levels due
to risk of bias assessment.
One study reported on the SF-36 QoL physical domain with means
and SDs, and we are uncertain if dietary intervention has any ef-
fect on SF-36 physical score with very low-certainty evidence at six
months and at 12 months (Table 5; Demark-Wahnefried 2006).
SF-36 QoL mental health domain mean change
• Dietary intervention compared to control may have little if any
effect on mean change in SF-36 mental health score at six
months (MD 0.70, 95% CI -0.96 to 2.36; 410 participants; low-cer-
tainty evidence; Analysis 4.6) in one study (Hawkes 2013). We
downgraded the quality of evidence by one level due to risk of
bias assessment and by one level due to inability to assess con-
sistency across studies as there was only one study.
• We are uncertain if dietary intervention compared to control has
any effect on mean change in SF-36 mental health score at 12
months (MD -0.11, 95% CI -3.29 to 3.08; 1091 participants; I2 =
79%; very low-certainty evidence; Analysis 4.6) in three stud-
ies (Demark-Wahnefried 2014; Hawkes 2013; Morey 2009). We
downgraded the quality of evidence by two levels due to risk of
bias assessment and by one level for inconsistency across stud-
ies.
We undertook subgroup analysis to investigate high heterogeneity
at 12 months by investigating data for different cancer sites. In par-
ticipants with breast cancer, we are uncertain if dietary interven-
tion has any effect on mean change in SF-36 mental health score
with very low-certainty evidence in one study (Demark-Wahnefried
2014).
In colorectal cancer patients, dietary intervention may have little or
no effect on SF-36 mental health score with low-certainty evidence
in one study (Hawkes 2013).
In a mixed group of breast, prostate, and colorectal cancer sur-
vivors, dietary intervention may slightly improve mean change in
SF-36 mental health score with low-certainty evidence in one study
(Table 4; Morey 2009).
Cancer-related fatigue
• We are uncertain if dietary intervention compared to control
has any effect on cancer-related fatigue at six months (MD 1.40,
95% CI -0.26 to 3.06; 410 participants; very low-certainty evi-
dence) and at 12 months (MD 1.00, 95% CI -0.81 to 2.81; 410 par-
ticipants; heterogeneity not applicable; very low-certainty evi-
dence; Analysis 4.8) in one study (Hawkes 2013). We downgrad-
ed the quality of evidence by two levels due to risk of bias as-
sessment and by one level due to inability to assess consistency
across studies as only one study is included.
Global QoL
• We are uncertain if dietary intervention compared to control
has any effect on Global QoL at three months (MD 4.71, 95% CI
2.22 to 7.21; 220 participants; I2 = 15%; very low-certainty ev-
idence; Analysis 4.9) in two studies (Kim 2011; Yun 2017). We
downgraded the quality of evidence by two levels due to risk of
bias and by one level due to wide confidence intervals. We al-
so performed this comparison at six months in one study (MD
33.97, 95% CI 28.97 to 38.97; 80 participants; very low-certainty
evidence) (Ghavami 2017), and at 12 months in another study
(MD 4.80, 95% CI -0.79 to 10.39; 174 participants; very low-cer-
tainty evidence; Analysis 4.9) (Yun 2017). We downgraded the
quality of evidence by two levels due to risk of bias assessment,
imprecision, and inability to assess consistency due to only one
study per outcome.
Biochemical measures
GRADE assessment is shown in Table 6.
• We are uncertain if dietary intervention has any effect on to-
tal cholesterol level at three months (MD -18.20 mg/dL, 95%
CI -38.27 to 1.87; 76 participants; heterogeneity not applicable;
very low-certainty evidence) or at six months (MD 5.94 mg/dL,
95% CI 2.45 to 9.43; 83 participants, very low-certainty evidence;
Analysis 5.1), or on triglycerides at three months (MD -40.60 mg/
dL, 95% CI -76.80 to -4.40; 76 participants; very low-certainty ev-
idence; Analysis 5.2) in one study (Mefferd 2007). We downgrad-
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ed the quality of evidence due to risk of bias assessment, impre-
cision, and inability to assess consistency across studies.
Adverse events
• This outcome was not reported with dietary interventions.
D I S C U S S I O N
Summary of main results
This review includes 25 studies involving 7259 participants; we
compared dietary intervention versus usual care or control and in-
cluded no other comparisons. Most participants were women with
breast cancer; we found a small amount of research on colorectal,
prostate, and gynaecological cancer survivors. The evidence was
very mixed overall for reported outcomes (mortality, dietary intake,
anthropometry, quality of life, and biochemistry). See Summary
of findings for the main comparison. The main findings are sum-
marised below.
E7ect of dietary intervention on mortality and morbidity
Low-certainty evidence assessed after 7.3 years suggested little if
any benefit of dietary intervention for survival or secondary malig-
nancy. Other comorbidities were not recorded.
E7ect of dietary intervention on dietary intake
Evidence assessed for dietary intervention after 12 months showed
little or no effect on energy intake (moderate-certainty evidence).
When fruit and vegetable servings were combined, dietary intake
was probably increased with dietary intervention (moderate-cer-
tainty evidence), although for dietary fibre, the results were mixed.
Evidence showed a probably positive effect of dietary intervention
on Diet Quality Index (moderate-certainty evidence).
E7ect of dietary intervention on anthropometry
Evidence assessed after 12 months showed little or no effect of
dietary intervention on body weight (high-certainty evidence). Ev-
idence showed a probably slight decrease in body mass index
after 12 months of dietary intervention (moderate-certainty evi-
dence). Evidence suggested little or no effect of dietary interven-
tion on waist-to-hip ratio after 12-months (low-certainty evidence).
We found no evidence on measurements of body composition.
E7ect of dietary intervention on quality of life aMer 12 months
We are uncertain about effects on Functional Assessment of Can-
cer Therapy (FACT), Short Form (SF)-36, cancer-related fatigue, and
global quality of life measures after 12 months of dietary interven-
tion based on the evidence found (very low-certainty evidence).
E7ect of dietary intervention on biochemistry
We are uncertain if dietary intervention has any effect on total cho-
lesterol or triglycerides (very low-certainty evidence).
Overall completeness and applicability of evidence
For this review, we searched only for studies including people liv-
ing beyond cancer. We therefore excluded all studies that recruit-
ed participants at the start of their treatment programme or at any
point in the care pathway when they were receiving treatment. We
excluded from this review studies including people receiving hor-
mone treatment who still had a malignant tumour.
Evidence of effectiveness for most outcomes evaluated is incom-
plete, particularly for mortality, morbidity, some nutrients, body
composition measurements, and quality of life (QoL) measures re-
lated to patient-reported outcomes. In addition, evidence was of-
ten incompletely reported with missing standard deviations of the
mean and reported differences in weights and measurements that
varied from grams to number of servings and number of people
consuming recommended amounts of food or nutrient. When we
encountered missing data, we contacted some study authors to re-
quest further data, and only one study author provided data; how-
ever we did not incorporate these data into the review. This made
it difficult to perform meta-analyses for these outcomes, and when
we did perform meta-analyses, we included multiple analyses to
present results reported in different formats. In some instances,
heterogeneity was high, so we performed subgroup analyses to ex-
plore these based on ‘a priori’ criteria including different cancer
types and varying nutritional status.
When data were included but not in a form suitable for meta-analy-
sis, we tried to report these data in a narrative format when possi-
ble; however, we did not grade this evidence.
In terms of specific outcomes, we found evidence on the primary
outcome mortality, which showed little if any difference between
groups, although there may be limitations in the time frame the ev-
idence was reported, as it may have not been sufficient for dietary
interventions to influence overall survival. Morbidity as a surrogate
marker was not reported by any of the studies identified for this
review, apart from secondary malignancies. Dietary interventions
were found to have little effect on energy levels, and several studies
reported this with a moderate level of certainty after 12 months. For
fruit and vegetable intake, dietary intervention probably had some
positive effects. We found evidence showing that diet quality was
probably improved with dietary intervention, although results for
dietary fibre were mixed. We found limited evidence for some can-
cer sites and noted differences on subgroup analyses conducted to
examine sites of cancer and nutritional status.
Researchers reported anthropometry using different measure-
ments, some self-reported. For body mass index, we found suf-
ficient evidence to ascertain the effects of dietary interventions.
Studies reporting body composition for fat and muscle as out-
comes were lacking, so the evidence base is incomplete.
For QoL measurements, included studies reported a variety of mea-
surements, which meant there was no compelling evidence by
which to determine overall effect. We found no evidence on pa-
tient-reported outcomes.
The evidence found was primarily based on women with breast
cancer, so these results have limited generalisability to people with
cancer at different sites.
Quality of the evidence
Most evidence is generally of low or very low-certainty as assessed
by GRADE (Higgins 2011), with most studies not evaluating effects
of dietary interventions on key review outcomes, particularly the
primary outcomes of mortality and morbidity (Table 7). Nonethe-
less, a few included studies did stand out, as they provided mod-
erate-certainty evidence on dietary intake and anthropometry (Ta-
ble 8; Table 9). These studies included people with breast cancer
and mixed cancer groups. Evidence was often undermined by un-
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clear study methods or by study design limitations and small sam-
ple sizes, which led to downgrading of the evidence due to impre-
cision of estimates. Outcomes were often measured via self-report
tools and findings were poorly controlled in terms of definitions
and judgements, particularly for some dietary assessment meth-
ods. Studies included were frequently downgraded for risk of bias
due to absence of blinding for subjective outcomes. In addition,
compliance with dietary interventions was seldom reported or as-
sessed by objective tools. Adequate reporting of compliance with
interventions is particularly problematic for dietary intervention
studies. Furthermore, blinding of participants and professionals to
dietary interventions is difficult when the intervention is based on
food.
Evidence rated as moderate-certainty evidence was obtained pri-
marily from women with breast cancer who were included in large
studies conducted in the USA. Other evidence of low to moder-
ate-certainty was obtained from Australia among participants with
colorectal cancer, and from the USA among participants with mixed
cancer types.
A small number of studies reported on secondary outcomes of
quality of life and biochemical measures; thus evidence on changes
that may be attributed to dietary intervention is weak (Table 4; Ta-
ble 6).
Potential biases in the review process
Evidence has been presented as outcomes, as the different dietary
interventions provided were difficult to categorise into any mean-
ingful comparisons and trial authors reported multiple variations in
methods used to provide dietary intervention. Some interventions
were provided by telephone, others face-to-face or by mail, and
others were web-based. Different healthcare professionals pro-
vided information to participants including dietitians, healthcare
workers, and trained coaches. The dietary intervention in some in-
stances incorporated behavioural change theory, and in other in-
stances did not involve behavioural change theory. Some includ-
ed studies used a variety of modes to provide dietary interventions
during the same study.
Our definition of cancer survivorship may have led to potential bi-
ases in the approach to this review. Consequently, we may have
favoured inclusion of studies on women with breast cancer and ex-
cluded studies on men with prostate cancer who have ongoing ma-
lignancies, which can be managed with biological agents and hor-
mone therapies. The inclusion of a large proportion of studies on
breast cancer has led to a bias in the review towards women. We
are therefore uncertain if some of the evidence presented relates to
men who have survived cancer. The definition of cancer survivors
excluded studies that provided dietary interventions before cancer
treatment, but those interventions could have been based on the
same recommendations for survivorship.
Search methods
We did not handsearch all related journals and conference pro-
ceedings; we looked only at abstracts from the American Institute
of Cancer Research that were available online. This may have led to
our missing some abstracts. This decision was made at the protocol
stage because to search all nutrition journals by hand would have
been time-consuming and would have been very resource-inten-
sive. We searched a number of databases and attempted to track
down all reports of the same studies. However, due to the large
number of reports identified and the volume of research reported
in this area, some studies and reports may have been missed, even
though efforts to follow the methods outlined in the protocol were
extensive.
Study selection
We included only randomised controlled trials (RCTs), and we in-
cluded only studies that reported a comparison between dietary
intervention and usual care or written materials. We did not include
studies that compared dietary interventions or different diets in
people who had survived cancer. This limits our findings on com-
parison of dietary interventions to people who have survived can-
cer.
Data extraction and analysis
When studies reported outcomes for multiple time points, we tried
to report the time points at three, six, and 12 months, and for
mortality at the last time point reported. When data were missing
and we could calculate from the reports, we did so, and we used
Cochrane tools to assist in some calculations. However, if data were
not available and were not retrieved by contacting authors, we re-
ported findings in a narrative format. We used the random-effects
model for all meta-analyses, irrespective of statistical heterogene-
ity, as at the protocol stage, we anticipated that clinical hetero-
geneity with respect to study populations and interventions would
be high across all included studies. All subgroup analyses that were
performed were pre-specified in the protocol. Subgroup analyses
were performed by cancer site and nutritional status. We did not
grade the certainty of evidence for narrative results.
Agreements and disagreements with other studies or
reviews
A number of other reviews have presented evidence on dietary in-
terventions in people who have survived cancer (Demark-Wahne-
fried, 2015; Goode 2015; Pierce 2009a; Reeves 2014; Roberts, 2017;
Stacey, 2015). One review evaluated data from dietary intervention
studies in people who had survived cancer based on mode of provi-
sion for the intervention, which could be telephone conversations,
digital interaction, or face-to-face meetings (Goode 2015).
In this review, most study participants received information via the
telephone, which concurs with the findings presented. The conclu-
sions suggest that included evidence supports broad reach modal-
ities, particularly the telephone, to provide lifestyle interventions
(Goode 2015). The favourable opinions regarding broad reach ap-
proaches compared to face-to-face and group sessions are not di-
rectly supported by the data reported in our review, as we have
presented data based on outcomes. It is difficult to classify dietary
interventions, as a large proportion of trials are multi-modal in
approach, and interventions were delivered with different levels
of follow-up and by a range of personnel (Table 1). In addition,
some of the dietary interventions that we identified had behaviour-
al change strategies incorporated while others did not (Table 1).
Suggestions are made on how to gather more data on long-term
outcomes and for cancer types other than breast cancer in combi-
nation with health economic data (Goode 2015). A review of digi-
tal health provided contradictory conclusions challenging the con-
cept that broad-ranging dietary interventions are effective by sug-
gesting that a review of digital health interventions revealed mixed
results from a narrative synthesis of any effects on diet (Roberts,
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2017). Added to this debate are the findings from a review of the-
ory-based nutritional behaviour change interventions for cancer
survivors, which reported that including a behaviour change strat-
egy led to improvement in at least one aspect of dietary intake,
although no consensus was reached regarding mode of provision
of the intervention from the evidence reviewed in these studies
(Stacey, 2015).
Mortality and morbidity
One review discussed in length differences among studies includ-
ing participants with breast cancer that have had a long enough
time frame to evaluate overall survival and comorbidities (Pierce
2009a). We did not find any effect on our primary outcome mea-
sures, which included mortality and secondary malignancies, from
one very large included study providing low-certainty evidence
(Pierce 2007). However, another large RCT, again including par-
ticipants with breast cancer, demonstrated differences between
groups favouring the intervention (Chlebowski, 2006). We excluded
this trial from our review as participants were recruited while they
were still potentially receiving active therapy within 365 days after
surgery for breast cancer. This study showed that for participants
who did not relapse, the hazard ratio (HR) for an event in the di-
etary intervention group compared to the control group was 0.76
(95% confidence interval (CI) 0.60 to 0.98), for recurrence-free sur-
vival was 0.71 (95% CI 0.53 to 0.94), and for disease-free survival was
0.81 (95% CI 0.65 to 099). However for overall survival, the HR was
0.98 (95% CI 0.65 to 1.21) (Chlebowski, 2006).
Differences in results from the two large studies in breast cancer
cohorts could be due to the different samples recruited; one study
recruited women between the ages of 48 and 79 years (Chlebowski,
2006), and the study included in this review recruited participants
from 18 to 70 years of age (Pierce 2007). In Pierce 2009a, it is pointed
out in the discussion that there was a difference between trials in
time after diagnosis when participants were recruited, as well as
in disease severity. Participants in Chlebowski, 2006 were likely to
be younger and more highly educated, and were less likely to be
obese.
It can be concluded that there may be overall benefit for survival
when dietary interventions are provided to subgroups of people
with breast cancer (Pierce 2009a). However, there is a paucity of ev-
idence on these primary outcomes in other cancer cohorts.
Dietary intake
Another review concurred with our findings, highlighting beneficial
effects on diet quality from dietary interventions in cancer survivor-
ship (Demark-Wahnefried, 2015).
Anthropometry
A narrative review of the evidence from intervention trials con-
curs with the findings of this review, demonstrating benefits of di-
etary intervention for weight loss and supporting our results in re-
lation to body mass index for people who have survived cancer af-
ter 12 months of intervention (Demark-Wahnefried, 2015). We re-
ported on evidence from women with breast cancer including four
studies that showed a slight reduction in body mass index (mod-
erate-certainty evidence). However, not all of these studies had di-
etary interventions that were aimed at weight reduction. Data from
meta-analysis on mean weight measured between groups in kilo-
grams showed no differences among five studies after 12 months,
although it has to be acknowledged that mean weight is not an ide-
al outcome to show differences between groups because it does
not take into account changes as a proportion of overall body size.
A further review of weight loss in women with breast cancer showed
positive effects of dietary interventions on weight loss but also re-
ported benefit in decreasing waist-to-hip ratios (Reeves 2014). We
found mixed results for waist-to-hip ratios across cancer sites. Di-
etary interventions showed some benefit with variable effect sizes
in women with breast cancer, but not in women with uterine can-
cer.
Quality of life
It was highlighted by another review that improvements in QoL re-
sulted from dietary interventions (Demark-Wahnefried, 2015). We
found mixed results depending on the measurement tool and the
QoL domain used. Benefits were seen in physical domains for a
mixed group of cancer survivors, but not consistently in mental
health domains, and mixed results on global QoL were noted over
time.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Moderate-certainty evidence shows that dietary interventions can
modify food and nutrient intakes and can positively affect some an-
thropometric measurements, particularly for women after breast
cancer. Outcomes that showed evidence of some probable im-
provement were intake of fruits and vegetables and diet quality.
Energy intake was not shown to be affected by dietary interven-
tions. Body mass index was probably slightly reduced with dietary
interventions. Lack of evidence from one included study suggests
that dietary interventions improve overall mortality, and we found
no evidence on the effects of dietary interventions on morbidities.
Short-term changes in dietary intake and in anthropometric mea-
surements were not always shown to be sustained over a longer pe-
riod.
In relation to quality of life (QoL), we are uncertain about study re-
sults.
Included studies described some positive benefits of dietary inter-
vention for cancer survivors, although inconsistencies between in-
cluded studies suggest that people may benefit differently from di-
etary interventions in terms of alterations in dietary intake and an-
thropometry, depending on type of cancer, nutritional status, and
regular eating habits.
Different personnel administered the dietary interventions, but di-
etitians did so in most studies. It is important to note that training
and appropriate understanding are required when dietary inter-
ventions are provided to people who have survived cancer. Some
studies described in detail the behaviour change strategies used,
and it is important to note that as modifications to dietary intake
represent a behaviour change, it is essential to incorporate these
behaviours into dietary interventions used in practice.
Implications for research
Implications for future research include the following.
We identified 26 ongoing studies that are relevant to this review,
including 11 studies on breast cancer, three on colorectal cancer,
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three on gynaecological cancer, and nine on mixed cancer types, in-
dicating that this area is developing rapidly. Studies are now being
undertaken to examine previously neglected cancer sites. In addi-
tion, long-term follow-up data on participants already randomised
into cohorts are being reported, adding to the evidence base as
studies mature.
Evidence in some areas is incomplete or lacking, and further re-
search is required, including evaluation of dietary interventions for
participants with cancer at sites other than the breast. These tu-
mour sites could include colorectal or endometrial cancer, where
a link has been established between occurrences and either di-
etary intake or obesity, making these important areas for future
research. Moreover, a number of large ongoing studies recruiting
participants with colorectal cancer will add substantially to the ev-
idence.
In relation to measurement of outcomes, we found a lack of data
on body composition when routinely available imaging was used
to evaluate changes in body composition. Use of mobile or digi-
tal applications to deliver interventions was limited, and this may
well be an approach that will facilitate delivery of dietary interven-
tions in the future. Developing outcomes that make use of digital
technologies and routine imaging in assessment of dietary inter-
ventions would add to future research. No studies in this review in-
cluded comorbidities as an outcome measure, and this is a huge
reason why modifying dietary intake studies that include comor-
bidities as an outcome would enhance findings in future research.
We identified some high-quality studies, although not all trials fol-
lowed CONSORT guidelines and could be improved in relation to
quality and standards of reporting. There were only a few studies
that attempted to blind assessors; this would be a feasible way to
decrease risk of bias in future research.
This review is focused on survivors who were enrolled into studies
after all treatments were completed, so it would be interesting to
undertake further review of dietary interventions in patients who
are living with cancer, particularly in light of the advancement of
biological agents and hormone therapies used in prostate, breast,
and gynaecological cancers. The optimal time to administer dietary
interventions for healthy eating within cancer pathways for all can-
cer sites is a topic that remains controversial, as different studies in-
cluded participants at different time points after their cancer treat-
ment. Determining the optimal time to deliver dietary interventions
is therefore worthy of further research.
Studies investigating dietary interventions and changes in anthro-
pometrics need long-term follow-up to identify differences in clin-
ical outcomes including mortality and morbidity. This is often dif-
ficult due to the resource implications of conducting studies with
long-term follow-up. The use of surrogate markers as early indica-
tors for tumour recurrence may offer an advantage in studies where
cancer recurrence is an important outcome in the evaluation of di-
etary interventions.
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Participants Number randomised: 172
721 screened, 505 excluded; 216 attended study orientation visit, 6 excluded; 210 entered weight loss
intervention, 38 excluded; 87 assigned to group phone counselling; 85 assigned to newsletter; 76 as-
sessed at month 18 in the phone counselling group; 78 assessed at month 18 in the newsletter group;
85 included in the primary analysis in the phone counselling group; 83 included in primary analysis in
the newsletter group
Inclusion: post-menopausal breast cancer survivors. Residing in rural areas. BMI 27 to 45 kg/m2. Age 75
years or younger. Diagnosis of stage 0 to IIIc disease within the last 10 years. Completion of treatment at
least 3 months before study entry. Clearance from oncologist given
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Exclusion: pending joint replacement; serious cardiac or pulmonary condition; insulin-dependent dia-
betes; history of bariatric surgery; current substance abuse; major depression; binge eating disorder
Gender: female
Age, mean: 58 (SD 8.1) years
Type of cancer: breast
Therapy previously received for cancer: anti-hormone 55.8%; surgery, lumpectomy 61.0%; surgery,
mastectomy 48.8%; chemo 67.4%; radiation 72.1%
Cancer stage: stage 0: 8.1%, stage I: 44.2%, stage II: 33.7%, stage III: 14.0%
Ethnicity: Caucasian 99.4%
Baseline physical activity: NR
Education: high school 21.5%, some college 41.9%, bachelors degree 20.9%, masters/doctorate 15.7%
Interventions Comparison: lifestyle bi-weekly group phone-based counselling vs mailed newsletters
Intervention: phase 1: 25-week 60-minute conference call sessions conducted by a registered dietitian
or psychologist, delivered to groups of 12 to 15 women at a time; phase 2: 26 bi-weekly conference call
sessions with the same counsellor
Control: phase 1: as above; phase 2: 9 newsletters
Outcomes Weight change from 6 to 18 months: weighed in light clothing in a fasting state using calibrated scales
Program and participant costs and incremental cost-effectiveness ratios: counsellor tracked time -
participant time spent in sessions, self-monitoring, and reading materials
Duration of follow-up: 18 months
Notes Funding: NIH/NCI R01CA155014
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Study statistician generated the randomisation
Allocation concealment
(selection bias)
Low risk Randomisation was blinded from both participants and research staG until the





Low risk Two-phase study with diet and physical activity states blinded for phase 1 was
undertaken, but as it was a diet and exercise intervention, it is difficult to see
how this was applied logistically. However, outcome is not likely to be influ-





Unclear risk No subjective outcomes
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk Outcome is not likely to be influenced by lack of complete blinding
Befort 2016  (Continued)
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Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes








Unclear risk No subjective outcomes
Selective reporting (re-
porting bias)
Low risk All primary outcomes reported








Participants Number randomised: 404
940 women were screened, and 194 were ineligible, mainly due to cancer recurrence or new cancer.
From 746 who were eligible, 27 could not be scheduled for interview, 315 refused, and 260 were inter-
ested in participating but could not commit to the requirements of the study
Inclusion: women who had been cancer-free for 5 years after diagnosis of breast cancer; who were 50
years of age or younger at diagnosis and agreed to participate in a minimum of 2 monthly workshops
and 2 interviews
Exclusion: NR
Age, years: 23 to 39: 13%; 40 to 44: 29%; 45 to 50: 58%
Gender: female
Type of cancer: breast
Therapy previously received for cancer: chemotherapy only 21%, radiation only 21%, chemo and ra-
dio 34%, tamoxifen 39%
Cancer stage: in situ 18%, local 54%, regional 26%, remote 1%
Ethnicity: Euro-American 76%, African American 5%, Latina 7%, Asian 10%, Other 2%
Baseline physical activity: 77% of control group and 71% of intervention group exercised on 2 or more
days per week for at least 30 minutes
Education: 61% were college graduates; 80% were employed at least part time
Interventions Comparison: workshops vs delayed intervention
Bloom 2008 
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Intervention: a series of three 6-hour-long workshops were conducted on Saturdays at 1-month in-
tervals. Through a variety of activities and presentations, each workshop addressed 4 cross-cutting
themes, including targeting unmet informational needs, promoting exercise and nutrition, improving
communication skills, and providing and receiving emotional support. Workshops were delivered by
trained health professionals, including a medical oncologist who specialised in breast cancer, a phar-
macist, 2 attorneys, a gynaecologist, an exercise physiologist, a representative of the women’s healthy
eating and living (WHEL) study, and a fitness instructor
Control: women in the control group (delayed intervention) were invited to attend a 1-day educational
workshop following completion of the post-test assessment
Outcomes Dietary changes: fruits and vegetables questionnaire and fat screeners questionnaire (Block, 1986 and
1990)
Quality of life: changes in knowledge score and changes in communication
No. of healthy eating changes made: survey on how many fruits and vegetables consumed each day,
and how often non-fat and low-fat foods were consumed
Duration of follow-up: 6 months
Notes Funding: NIH, NCI R01-CA 078951
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)










High risk No blinding; outcome is likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Unclear risk No objective outcomes appropriate for this review
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement is likely to be in-








Low risk 4% loss to follow-up, leaving a sample of 387/404. ITT was used
Bloom 2008  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement









Participants Number randomised: 18
180 participants were identified through nurse-led follow-up clinics; 29 responded as interested, 11
were screened out due to ineligibility, 9 were randomised to intervention, 9 were randomised to con-
trol, 1 was lost to follow-up
Inclusion: histologically confirmed colon cancer, which had been resected 6 to 24 months previously
Exclusion: existing participation in regular physical activity; Karnofsky rating < 80; unstable angina; un-
controlled hypertension; recent myocardial infarction or a pacemaker
Age, years (SD): 52 to 80 (69)
Intervention arm: 67.9 (5.7)
Control arm: 70.3 (8.7)
Gender:
Intervention: 5 male, 4 female
Control: 7 male, 2 female
Ethnicity: NR
Type of cancer: colon
Therapy previously received for cancer: surgery: n = 17, chemotherapy: n = 6, palliative care: n = 1
Cancer stage: NR
Baseline physical activity: chair sit-to-stand reps
Intervention arm: 10 median (range 8 to 16)
Control arm: 10 median (range 7 to 16)
Education: NR
Interventions Comparison: supervised and home-based exercise with dietary advice vs cancer follow-up service
Intervention: 12-week lifestyle intervention made up of supervised and home-based exercise sessions
and dietary advice. Exercise sessions took place within a dedicated exercise suite at Sheffield Hallam
University and were supervised by an experienced exercise physiologist. During the first 6 weeks, par-
ticipants attended 2 group-based supervised exercise sessions per week. During the final 6 weeks, par-
ticipants attended the university facility once a week and were asked to perform 2 home-based exer-
Bourke 2011 
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cise sessions a week. Participants were also provided with a nutrition advice info pack on a fortnightly
basis throughout the intervention and engaged in healthy eating seminars in a group format
Control: holistic nurse-led colorectal cancer follow-up service
Outcomes Dietary changes: 3-day diaries kept by the participant to self-report food intake
Changes in weight/anthropometry: weight, height, BMI, and hip-to-waist ratio measured by exercise
physiologist
Quality of life: FACT-C used to assess disease-specific QoL
Duration of follow-up: 12 weeks
Notes Funding: eNIHR Cardiovascular Biomedical Research Unit
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Patients were randomised by an independent researcher via code numbers us-
ing nQuery statistical software
Allocation concealment
(selection bias)
Low risk Randomisation was undertaken by a senior academic who was not directly in-
volved in recruitment or assessment of patients. The randomisation sequence
was not disclosed to the researcher responsible for day-to-day running of the










High risk No blinding; outcome is likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk Assessor of outcomes was blinded to group allocation
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement was patient self-








Low risk Only 1 person dropped out due to stroke (6% attrition). ITT was used
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
Other bias Unclear risk Insufficient information
Bourke 2011  (Continued)
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Participants Number randomised: 182
3290 identified, 2431 cases with complete physician and contact data, 2037 approved for contact, 688
consented to participate, 506 ineligible, 182 enrolled into study and completed telephone interview,
93 randomised to control arm, 89 randomised to intervention arm, 168 completed 6-month follow-up
telephone interview, subset of 33 completed performance tests and anthropometrics, 160 completed
12-month follow-up phone call, subset of 31 consisted of 22 dropouts, included in ITT
Inclusion criteria and exclusion criteria: patients were excluded if conditions precluded unsuper-
vised exercise (uncontrolled congestive heart failure or angina, recent myocardial infarction, or breath-
ing difficulties requiring oxygen use or hospitalisation; use of a mobility aid other than a cane; plans
to have hip or knee replacement) or a high fruit and vegetable diet (kidney failure or chronic warfarin
use); had progressive malignant disease or additional primary tumours; were unable to participate
fully in telephone counselling or in mailed material interventions (severe hearing or speaking impair-
ment, inability to speak/write English, or mental incompetence); reported fewer than 2 physical func-
tion deficits (unlikely to experience change in physical function); were already routinely exercising or
adhering to a low-fat, high-fruit and vegetable diet
Age: intervention: 71.5 mean (SD 4.4), control: 71.9 mean (SD 5.6) years
Gender:
Female: intervention: n = 51 (57.3%), control: n = 53 (57.0%)
Male: intervention: n = 38 (42.7%), control: n = 40 (43%)
Ethnicity:
White: intervention: n = 73 (82.0%), control: n = 77 (82.8%)
African American: intervention: n = 13 (14.6%), control: n = 14 (15.0%)
Other/Unknown: intervention: n = 3 (3.4%), control: n = 2 (2.2%)
Type of cancer: breast or prostate
Therapy previously received for cancer: NR
Cancer stage: NR
Baseline physical activity: NR
Education: NR
Interventions Comparison: diet and exercise counselling and tailored materials vs general health counselling
Intervention: telephone counselling and tailored print materials aimed at increasing exercise and im-
proving overall diet
Control: general health counselling and materials
Outcomes Physical function: SF-36
Diet: Diet Quality Index (DQI) from 3-day dietary recalls
Demark-Wahnefried 2006 
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Weight and height: self-reported
QoL: functional assessment of cancer therapy breast and prostate quality of life instrument
Duration of follow-up: 12-months
Notes Funding: supported by Grants No. AG11268 and CA106919 from the National Institutes of Health, the
Mary Duke Biddle Foundation, Grant No. NR07795 (E.C.C.), and the Susan G. Komen Foundation
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Eligible participants were block randomly assigned to the study
Allocation concealment
(selection bias)










High risk No blinding; outcome was patient self-reported and therefore is likely to be in-
fluenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
High risk No blinding of outcome assessment; outcome measurement was patient self-
reported and therefore is likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement was patient self-








High risk 22% lost to follow-up, leaving a sample of 160/182. ITT was used
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported




Methods Design: randomised, single-blinded, parallel-group, attention-control active treatment-controlled
phase II clinical trial
Country: USA
Demark-Wahnefried 2007 
Dietary interventions for adult cancer survivors (Review)









Cochrane Database of Systematic Reviews
Accrual dates: July 2002 to October 2005
Trial Reg: NR
Participants Number randomised: 543
Out of 2155, 543 were eligible (1612 excluded), 271 were randomised to the intervention arm, and 272
were randomised to the control arm
At 1-year follow-up, 519 were included in the analysis: 18 in the intervention arm were lost to follow-up,
and 6 in the control arm were lost to follow-up. 271 in the intervention arm and 272 in the control arm
were included in 1-year follow-up ITT analysis
At 2-year follow-up, 489 were included in the analysis: from 1-year to 2-year follow-up, an additional 30
were lost to death, illness, no longer wanting to participate, and unable to be contacted
Inclusion: early-stage (in situ, localised, or regional) breast and prostate cancer, identified within 9
months of diagnosis
Exclusion: conditions precluding unsupervised exercise (i.e. uncontrolled congestive heart failure or
angina, recent myocardial infarction, or breathing difficulties requiring oxygen use or hospitalisation;
walker or wheelchair use; plans to have hip or knee replacement); conditions precluding a high fruit
and vegetable diet (kidney failure or chronic warfarin use); progressive cancer or additional primary tu-
mour; non-English speakers/writers
Age: range 22 to 85, 57 mean (SD 10.8) years
Gender: 44% male, 56% female from all who responded; 29% of respondents were ineligible
Type of cancer: breast and prostate
Therapy previously received for cancer: 44% radiation therapy including brachytherapy, 27%
chemotherapy, 85% surgery
Cancer stage:
Breast: 8% stage 0, 29% stage I, 17% stage II, 3% stage III
Prostate: 17% stage 0, 23% stage II, 3% unknown
Ethnicity: 83% white; 13% black; 4% other
Baseline physical activity: minutes of activity per week
Intervention: 53.4 mean (SD 112.7)
Control: 44.6 mean (SD 89.1)
Education: 12% < high school graduate, 30% some college or associate experience, 58% college gradu-
ate/post graduate
Interventions Comparison: telephone counselling and tailored print materials on diet and exercise vs general health
counselling
Intervention: participants received sequentially tailored mailed materials, in 2 behavioural domains.
These were consistent with the transtheoretical model, and health messages were customised to the
participant’s stage of readiness to promote behaviour change
Control: participants received standardised mailed materials on improving cancer survivors’ diet and
exercise behaviours. The intervention was delivered over 10 months and involved personalised mailed
printed materials promoting fruit and vegetable consumption followed by 7 newsletters at 6-weekly in-
tervals
Demark-Wahnefried 2007  (Continued)
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Outcomes Dietary changes: telephone interviews using diet history questionnaire (Diet Quality Index score, to-
tal percentage of calories from fat, total percentage of calories from saturated fat, number of daily serv-
ings of fruits and vegetables)
Changes in BMI: telephone interview using self-reported data (kg/m2). Measured heights and weights
performed on a 23% subsample using wall mounted stadiometer and calibrated platform scales
(weight expressed as BMI; kg/m2)
QoL: telephone interview using Functional Assessment of Cancer Therapy - General (FACT-G) score
Biochemical measures: phlebotomy performed on a 23% subsample after a 4-hour fast. Analysis of HDL
cholesterol (mg/dL), C-reactive protein, insulin, IL-6, and alpha-carotene
No. of healthy eating changes made: telephone interview
No. of lifestyle behaviour changes made: telephone interview
Changes in level of physical activity: telephone interview using 7-day physical activity recall (minutes
per week)
No. of adverse events: toll-free number provided for participants to ring and record events at any
time. Events categorised by a committee blinded to random assignment status as serious (life-threat-
ening, permanently debilitating, or requiring hospitalisation overnight) or non-serious (all other
events)
Participants' opinion on helpfulness of the intervention: telephone interview using 5-point Likert
scale from completely to not at all helpful (no direction stated – assume 1 is completely helpful)
Duration of follow-up: 24 months
Notes Funding: National Institutes of Health, American Institute of Cancer Research, Susan G. Komen Foun-
dation
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random assignment lists were generated by a project statistician using soft-
ware of the Cancer and Leukaemia Group B
Allocation concealment
(selection bias)
Low risk Implemented in a blinded fashion at an office that was physically removed










High risk No blinding; outcome was patient self-reported and therefore is likely to be in-
fluenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Unclear risk No objective outcomes appropriate for this review
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement was patient self-
reported and therefore is likely to be influenced by lack of blinding
Demark-Wahnefried 2007  (Continued)
Dietary interventions for adult cancer survivors (Review)

















Low risk Attrition was low - 4.4% at 1 year and 10% at 2 years. ITT was used in the final
analysis, inputting no change in behaviour across time for dropouts
Selective reporting (re-
porting bias)
Low risk All outcomes reported




Methods Design: 2-centred, single-blinded, parallel-group
Country: USA
Accrual dates: October 2007 to October 2009
Trial Reg: NCT00630591
Participants Overweight or obese post-menopausal survivors of breast cancer and their overweight or obese adult
daughters from USA
Number randomised: 68 dyads
2517 eligible breast cancer survivors identified, 2306 gained permission to mail out a study invitation,
2244 living cases had a contactable/usable address, 139 responded and had eligible daughters – fur-
ther invitation sent, 85 dyads met inclusion criteria and were still interested – sent full study consent,
70 dyads provided consent, 18 dyads in control arm, 25 dyads in individually tailored arm, 25 dyads in
team tailored arm, 59 dyads completed 6-month follow-up, 63 dyads completed 12-month follow-up
Inclusion and Exclusion: women diagnosed with AJCC stage 0 to III breast cancer who had complet-
ed primary treatment but were within 5 years of diagnosis with no evidence of progressive disease or
second primary tumours, and who had a biological daughter and were aged > 21 years. Both mother
and daughter had to meet the following criteria: BMI 25 to 39.9 kg/m2. No pre-existing medical condi-
tions that would preclude adherence to the intervention. Ability to speak and write English. Communi-
ty dwelling in the USA, Puerto Rico, or Guam. Not currently exercising for at least 150 minutes. Not en-
rolled in any other weight loss programmes
Gender: female
Age: mothers: 61.3 mean (SD 7.4) years
Ethnicity: non-Hispanic white: n = 100 (74%), Hispanic white: n = 10 (7%), African American: n = 24
(18%), Asian: n = 2 (1%)
Type of cancer: breast
Cancer stage: stage 0: n = 12 (18%), stage I: n = 29 (43%), stage II: n = 21 (31%), stage III: n = 3 (4%), miss-
ing: n = 3 (4%)
Baseline physical activity: Mothers in: control arm = 31.9 min/week, individual arm = 39.8 min/week,
team arm = 32.4 min/week
Education: Mothers: less than high school: n = 1 (1.5%), high school graduate: n = 18 (26.9), some col-
lege: n = 25 (37.3%), college graduate: n = 23 (34.3%)
Demark-Wahnefried 2014 
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Interventions Comparison: tailored diet and exercise delivered individually vs tailored diet and exercise that empha-
sised the mother-daughter bond vs standard diet and exercise materials
Intervention: mother-daughter dyads were randomly assigned to (1) a tailored diet and exercise inter-
vention that was delivered in parallel and individually to mothers and daughters (intervention arm); (2)
a tailored diet and exercise intervention that emphasised the mother-daughter bond in a team-based
approach (TEAM arm); or (3) an attention control arm that received standardised diet and exercise ma-
terials (control arm)
Control: received a copy of the National Cancer Institute brochure, “Facing Forward,” and the Ameri-
can Institute for Cancer Research publication, “Facts on Weight Management and Cancer,” which were
included in a personalised binder
Outcomes Dietary changes: 2-part telephone interview to gather dietary data using the interactive Nutrition Data
System revised software (NCC food and nutrient database system v.2006, Minneapolis)
Changes in weight/anthropometry: physical measures of height, weight, BMI, and waist circumfer-
ence
Quality of life: 2-part telephone interview using the SF-36
No. of healthy eating changes made: 2-part telephone interview to gather data on total energy in-
take; energy from fats, sugars, and alcohol; fruit and vegetable, whole grain, dairy, meat, sodium, and
sat fat intake to derive a Healthy Eating Index Score
Duration of follow-up: 12 months
Notes Funding: National Institutes of Health
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Dyads were randomly assigned by an oG-site statistician to 1 of the 3 arms,
within strata defined based on the race of the mother (white/non-white)
Allocation concealment
(selection bias)
Low risk Dyads were randomly assigned by an oG-site statistician to 1 of the 3 arms,





Low risk Single-blind trial; however, no further detail is given. Outcome is not likely to





High risk Single-blind trial; however, no further detail is given. Outcome was patient
self-reported and therefore is likely to be influenced by lack of complete blind-
ing
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk Single-blind trial; however, no further detail is given. Outcome is not likely to
be influenced by lack of complete blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk Single-blind trial; however, no further detail is given. Outcome measurement




Low risk 10% were lost to follow-up, with very similar dropout between arms
Demark-Wahnefried 2014  (Continued)
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Low risk 10% were lost to follow-up, with very similar dropout between arms
Selective reporting (re-
porting bias)
Low risk All primary outcomes reported




Methods Design: randomised pilot study to test an individualised approach towards weight loss in obese




Participants Number randomised: 48
13 in control arm, 10 in weight watchers arm, 13 in individualised arm, 11 in comprehensive arm, 9
dropped out over the first 12 months
Inclusion and Exclusion: ages 18 to 70 years. Stage I or II breast cancer that had been diagnosed within
the past 4 years. Free of any recurrence as confirmed by a physician. Chemotherapy or radiation thera-
py had to be completed at least 3 months previously with the exception of tamoxifen
Age: range 36 to 70 years
Gender: female
Type of cancer: breast
Therapy previously received for cancer: chemotherapy: n = 30 (63%), on tamoxifen at recruitment: n
= 30 (63%)
Cancer stage: stage I or II
Baseline physical activity: NR
Ethnicity: white: n = 35 (73%), African American: n = 12 (25%)
Education: college graduate: n = 30 (63%), employed at recruitment: n = 42 (88%)
Interventions Comparison: participants were randomly assigned to 1 of 4 groups: control, weight watchers (WW), in-
dividualised counselling, or a combination of WW and Individualised counselling
Intervention: WW arm: women were encouraged to attend WW meetings but received no other dietary
or exercise advice
Individualised arm: contacts by the dietitian were scheduled weekly for the first 3 months, biweek-
ly for months 3 to 6, and monthly thereafter. All individual contacts were made by telephone appoint-
ment. A monthly group meeting was also arranged, which women were encouraged to attend. In addi-
tion, all women received a monthly packet of written information on various weight loss topics
The counselling approach used the theoretical framework of Bandura's social-cognitive theory
Djuric 2002 
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Comprehensive arm: participants received individualised counselling and were also asked to attend
weekly WW meetings
One dietitian provided the counselling sessions. The dietitian had over 10 years of experience in weight
loss counselling in clinical settings. Meetings were organised via weight watchers groups, which are
well known internationally and follow their own standards and training
Control: participants received the National Cancer Institute's “Action Guide to Healthy Eating” and
“Food Guide Pyramid” pamphlets, but they received no other dietary or exercise advice. They met with
a dietitian at baseline and at 3, 6, and 12 months for outcome assessments. Controls were allowed to
follow a weight reduction diet on their own if desired
Outcomes Dietary changes: 3-day food records were completed at baseline and at 3, 6, and 12 months. Food
records were kept on forms that enumerated foods eaten, time of day, and amount eaten. A registered
dietitian taught the women how to keep food diaries and how to estimate portion sizes. The records
were reviewed together with the dietitian and the participant at each of the 4 data collection points.
Nutrient calculations were performed using the Minnesota Nutrition Data System Research software
Changes in weight/anthropometry: at baseline and at 3, 6, 9, and 12 months, women were weighed in
clothing but without shoes using a professional beam scale, and percentage of body fat was measured
using tetra-polar bioelectrical impedance. Height was measured at baseline only
Biochemical measure: information taken from Jen 2004 – at baseline and at 3, 6, and 12 months, fast-
ing blood samples were obtained. Blood samples were centrifuged, and plasma was stored at -70 de-
grees centigrade until analyses were conducted for glucose, triglycerides, cholesterol, insulin, and lep-
tin
Duration of follow-up: 30 months
Notes Funding: Grant RO3 CA89761 from NIH; the weight watchers group, Farmington Hills, Michigan; and the
Ford Motor Company fund
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomly assigned. Insufficient information about the sequence generation
process to permit judgement
Allocation concealment
(selection bias)










High risk No blinding; outcome was patient self-reported and therefore is likely to be in-
fluenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk No blinding; outcome is not likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement was patient self-
reported and therefore is likely to be influenced by lack of blinding
Djuric 2002  (Continued)
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Low risk Attrition rate was low
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement




Methods Design: randomised controlled trial
Country: Iran
Accrual dates: 2012 to 2015
Trial Reg: NR
Participants Number: 80
No other details about eligibility and recruitment
Inclusion: women with BMI > 25 and classified as disease stage I to III; must have completed breast
cancer primary treatment (surgery, chemotherapy, radiotherapy) at least 3 months ago, and not more
than 18 months ago; on Nolvadex (tamoxifen) and other endocrine treatments but not hormone re-
placement therapy (HRT). Must be willing and able to attend supervised exercise sessions at least 3
times per week for a period of 24 weeks, with the intention of achieving an 80% minimum compliance
target for attendance. Must be adults (18 years and above); must be able to read and write in Persian.
Must receive a certificate from a cardiologist to participate in exercise sessions
Exclusion: metastatic breast cancer; inoperable or active loco-regional disease. Following alterna-
tive/complementary diets or taking high-dose antioxidant supplement. Physical/psychiatric impair-
ment that would seriously impair physical mobility. Severe nausea, anorexia, or other disease affect-
ing health (e.g. arthritis, multiple sclerosis). Use of HRT or oral contraceptives within the past 4 months
(HRT is not commonly prescribed in women who are recovering from breast cancer treatment). En-
gaged in exercise at the beginning of study (2 or more times per week for at least 30 minutes per ses-
sion during the previous 3 months). Unable for other reasons to continue to participate in research
Gender: female
Age: mean 48.99 (SD 9.42) years
Ethnicity: Asian
Type of cancer: breast
Therapy previously received for cancer: chemotherapy with tamoxifen or radiation therapy
Cancer stage: stage I, II, or III
Baseline physical activity: NR
Education: primary school n = 19; secondary school n = 7; high school n = 40; greater than high school n
= 14
Ghavami 2017 
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Interventions Comparison: lifestyle intervention vs usual care
Intervention: 12-week individualised intervention promoting prescribed exercise and a balanced diet
through stage-matched telephone counselling and a workbook. Moderate exercise 3 to 5 days per week
and individual healthy eating advice and written information
Control: usual care with no specific details
Outcomes Quality of life: EORCT QLQ-C30 30-item questionnaire
Duration of follow-up: 12 months
Notes Funding: NR
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Used a random numbers table
Allocation concealment
(selection bias)










High risk Participants and personnel not blinded
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Unclear risk No objective outcomes
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes








Low risk No patients lost to follow-up
Selective reporting (re-
porting bias)
Unclear risk Study protocol not available; unclear if there was selective reporting
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Participants Number randomised: 42
112 agreed to be screened, 70 not enrolled, 22 randomised to intervention (1 dropout), 20 randomised
to control (3 dropouts), 38 retained for full 12 months
Inclusion: age 21 to 70 years; self-identified as Hispanic or of African descent (African American or
Caribbean). Diagnosis of stage 0 to IIIa breast cancer. Completed surgery, chemotherapy, and radiation
therapy at least 6 months before. No evidence of recurrent or metastatic disease. BMI > 25 kg/m2. Se-
dentary (defined as physically active to the point of sweating < 20 minutes per week). Not actively en-
gaged in a weight loss programme. Non-smoker. Haemoglobin A1c < 8%; blood pressure < 140/90. Low-
density lipoprotein cholesterol < 150 mg/dL. Both pre-menopausal and post-menopausal women were
included in this pilot study to explore the feasibility aspect of the study in both populations
Exclusion: smokers because investigators held it was more important to engage these women in a
smoking cessation programme than a weight loss programme. Uncontrolled diabetes, hypertension,
and hypercholesterolaemia as a precaution to avoid exacerbation of underlying cardiac and/or meta-
bolic conditions in an intervention that was in the early testing phase
Age: intervention: mean 52.6 (SD 8.0); control: mean 48.6 (SD 9.6) years
Gender: female
Type of cancer: breast
Treatment previously received for cancer (%):
Intervention: 19.1 mastectomy, 81.0 lumpectomy, 76.2 lymph node dissection, 86.4 radiation, 81.8
chemotherapy, 18.2 tamoxifen, 45.5 aromatase
Control: 45.0 mastectomy, 65.0 lumpectomy, 60.0 lymph node dissection, 65.0 radiation, 75.0
chemotherapy, 50.0 tamoxifen, 40.0 aromatase
Cancer stage (%): intervention: 50.0 stage I, 27.3 stage II, 13.6 stage III. Control: 35.0 stage I, 40.0 stage
II, 15.0 stage III
Ethnicity:
Intervention: 22.7% African descent, 77.2% Hispanic descent
Control: 20.0% African descent, 80.0% Hispanic descent
Baseline physical activity:
Occupational index: intervention: 2.6 mean (SD 0.5), control: 2.8 mean (SD 0.5)
Active living Index: intervention: 2.5 mean (SD 0.7), control : 2.8 mean (SD 0.5)
Sports and exercise index: intervention: 1.5 mean (SD 0.2), control: 1.5 mean (SD 0.3)
Physical fitness VO2 max (mL/kg/min): intervention: 17.9 mean (SD 3.1), control: 19 mean (SD 4.0)
Education (%): less than high school: intervention 36.4, control 25; high school or GED: intervention
18.2, control 55; some college: intervention 13.6, control 10; college or higher: intervention 31.8, con-
trol 10
Interventions Comparison: 6-month Curves weight loss programme vs wait-list control
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Intervention: participants received 6 months of the Curves weight loss programme, followed by 6
months of observation, during which they could engage in any diet and physical activity of their choice
Control: in the wait-list control arm, participants were observed for 6 months, during which they were
asked not to change their physical activity or diet, followed by 6 months of the Curves programme. To
allow women randomised into the immediate intervention arm to initiate participation in the nutrition
courses as part of a group, randomisation occurred at 5 different time points throughout the course of
the study
Outcomes Anthropometric measures: weight and height were measured using a calibrated electronic scale (SR
Instruments, Tonowanda, NY) and stadiometer (Genentech Accustat, San Francisco, CA). Waist and hip
circumferences were measured by trained study staG using a Gulick II tape measure (Country Technolo-
gy, Gays Mills, WI)
DEXA and body composition: body composition was measured by DEXA using the Hologic QDR 4500
densitometer (Hologic, Waltham, MA). Baseline and 6-month measurements used the same densitome-
ter, software, and scan speed
Serum metabolic marker analyses: serum samples were analysed in batches after all samples were
collected
Cholesterol (total, high-density lipoprotein, indirect low-density lipoprotein), triglycerides, glu-
cose, and hsCRP: measured via an Integra 400 Plus automated chemistry analyser (Roche Diagnos-
tics, Indianapolis, IN). Radioimmunoassays were used to measure insulin (Siemens, Deerfield, IL), total
ghrelin (LINCO Research, St. Charles, MO), and adiponectin (Millipore, Billerica, MA)
Diet: dietary intake was assessed using the Spanish version of the Block Questionnaire, with text in
both Spanish and English on each page (28). The original 110-item Block Questionnaire was developed
using NHANES dietary recall data, which include representation of African Americans. The Spanish ver-
sion of the Block Questionnaire includes additional food items typical of diets among Hispanics
Duration of follow-up: 12 months
Notes Funding: this research was supported by Gateway for Cancer Research (H.G.), Women At Risk (H.G), the
Susan G. Komen Foundation (D.L.H.), and Grant Number UL1 RR024156 from the National Center for
Research Resources, a component of the National Institutes of Health (NIH) and NIH Roadmap for Med-
ical Research
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomised via randomly permuted blocks
Allocation concealment
(selection bias)











High risk No blinding; outcome was patient self-reported and therefore is likely to be in-
fluenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Low risk No blinding of outcome assessment; outcome measurement is not likely to be
influenced by lack of blinding
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Objective outcomes
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement was patient self-








Low risk Attrition was 9% and dropout from each group was similar. ITT was used
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement




Methods Design: randomised controlled trial
Country: USA
Accrual dates: January 2011 to March 2012
Trial Reg: NCT01414062
Participants Number randomised: 70
405 identified, 156 did not meet inclusion criteria, 142 refused, 37 unable to contact, 34 allocated to
intervention, 36 allocated to control, 4 lost to intervention follow-up, 5 lost to control follow-up, 30
analysed in intervention at 6 months, 31 analysed in control at 6 months
Inclusion: Spanish-speaking women. History of stage 0 to III breast cancer. At least 3 months post treat-
ment. No evidence of metastatic disease. Age 21 years or older. Hispanic descent and fluent Spanish.
No uncontrolled diabetes mellitus. No uncontrolled comorbidities. Non-smoker. Mean intake of < 5
servings of fruits and vegetables per day. Access to a functional phone or cell phone. Not currently ac-
tive in a dietary change programme
Gender: female
Age: intervention: mean 55.1 (SD 9.1), control: mean 58.0 (SD 10.1) years
Type of cancer: breast
Therapy received for cancer:
Intervention: mastectomy 44.1%, radiation 70.6%, chemo 44.1%, anti-hormonal 73.5%
Control: mastectomy 44.4%, radiation 55.6%, chemo 52.8%, anti-hormonal 72.2%
Cancer stage:
Intervention: ductal carcinoma in situ 35.3%, I 32.4%, II 14.7%, III 11.8%, locally advanced 5.9%
Control: ductal carcinoma in situ 22.2%, I 44.4%, II 25.0%, III 2.8%, locally advanced 2.8%
Ethnicity:
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Intervention: black 20.6%, white 41.2%, Native American 5.9%, mixed 14.7%
Control: black 30.6%, white 38.9%, Native American 0.0%, mixed 16.7%
Baseline physical activity: 519 mean (SD 584) minutes per week
Education:
Intervention: less than high school 35.5%, high school 32.4%, some college 14.7%, college degree or
higher 14.7%
Control: less than high school 33.3%, high school 19.4%, some college 41.7%, college degree or higher
5.6%
Interventions Comparison: 9 sessions of culturally based education focusing on nutrition, cooking, and food shop-
ping vs written dietary recommendations
Intervention: 9-session nutritional intervention programme over 12 weeks
Control: 22-page Spanish-language healthy eating for breast cancer survivors
Outcomes Biochemical measures: fasting blood
Body composition: anthropometric measures
Dietary intake: three 24-hour recalls, interviewer-administered diet questionnaire, telephone call
every month to assess diet
Duration of follow-up: 12 months
Notes Funding: National Cancer Institute R21CA152903
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation sequence was generated by the study biostatistician
Allocation concealment
(selection bias)










High risk Participants and personnel not blinded
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk No blinding; outcome is not likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding; outcome was patient self-reported and therefore is likely to be in-
fluenced by lack of blinding
Greenlee 2015  (Continued)
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Low risk All primary outcomes reported








Participants Number randomised: 75
398 letters sent to patients from the tumour registry, 114 patients responded to the letter (28.6%),
17 were unable to commit to the longitudinal study, and 22 were not interested/unknown reason, 75
(18.9%) were eligible and consented, 41 were assigned to the intervention and 34 to the control. Adher-
ence to the intervention was 84.1%, with 100% assessed at 3 months, 100% at 6 months, and 85.4% at
12 months. In the control group, 76.5% were assessed at 3 months, 82.4% at 6 months, and 70.6% at 12
months. Attrition in the overall trail was 21.3%
Inclusion: women with histologically confirmed stage I or II EC. Had undergone surgery consisting of
total abdominal hysterectomy, bilateral salpingo-oophorectomy, with no evidence of disease. Diag-
nosed in the previous 3 years. Body mass index ≥ 25 (overweight/obese). Performance status 0 to 2.
Medical clearance from primary care physician. Approval to contact from treating gynaecological on-
cologist
Exclusion: individuals unable to read the consent form. Severe depression, dementia, or cognitive
deficit. Unavailable for longitudinal follow-up assessments. Pre-existing medical condition that was a
barrier to unsupervised walking
Gender: female
Age: intervention: 57.0 mean (SD 8.6) years, control: 58.9 mean (SD 10.9) years
Ethnicity:
Intervention: 87.8% Caucasian, 9.8% African American, 2.4% Other
Control: 94.1% Caucasian, 2.9% African American, 2.9% Other
Type of cancer: uterine cancer
Therapy previously received for cancer: 39.0% in intervention group and 35.3% in control group had
received prior radiation therapy
Cancer stage: I and II
Education:
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Intervention: 14.6% < high school, 9.8% 12th grade, 36.6% some college, 39.0% college graduate or
higher
Control: 11.8% < high school, 23.5% 12th grade, 23.5% some college, 41.2% college graduate or higher
Interventions Comparison: lifestyle intervention (SUCCEED) group that received nutrition, exercise, and behavioural
modification counselling vs usual care (UC) group
Intervention: 16 group sessions were conducted (10 weekly followed by 6 biweekly) in the SUCCEED
group. Physician face-to-face counselling occurred at 3, 6, and 12 months. Additional support was pro-
vided from the dietitian in the form of newsletters, emails, and telephone calls
Control: patients randomised to the usual care group received an information brochure ("Healthy Eat-
ing and Physical Activity Across Your Lifespan," "Better Health and You")
Outcomes Changes in weight/anthropometry: weight change at 12 months measured via scales
Dietary changes: energy and fruit and vegetable intake measured by 2 (1 weekday, 1 weekend day) 24-
hour recalls
Anthropometrics: measured by a registered dietitian with 24-hour recalls carried out by trained inter-
viewers
Duration of follow-up: 12 months
Notes Funding: American Cancer Society
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation was stratified using block sizes of 6 or 8
Allocation concealment
(selection bias)










High risk No blinding; outcome was patient self-reported and therefore is likely to be in-
fluenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk No blinding; outcome is not likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement is likely to be in-




High risk Attrition was high at 21% and was uneven across groups - 35/41 85% interven-
tion and 24/34 71% control
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High risk Attrition was high at 21% and was uneven across groups - 35/41 85% interven-
tion and 24/34 71% control
Selective reporting (re-
porting bias)
Unclear risk All primary outcomes reported, but not all secondary outcomes




Methods Design: randomised controlled trial: 3 arms
Country: USA
Accrual dates: June 2011 to December 2012
Trial Reg: NR
Participants Number randomised: 100
825 screened via telephone, 429 ineligible, 296 not interested, 33 in-person counselling, 34 telephone
counselling, 33 usual care
Inclusion: breast cancer survivors with BMI > 25 kg/m2, diagnosed in the 5 years before enrolment with
stage 0 to 3 breast cancer, had completed chemotherapy and/or radiation therapy at least 3 months
before enrolment. Physically able to exercise, agree to be randomly assigned, give informed consent to
participate in all study activities. Had to be accessible by phone and English literate
Exclusion: women who were pregnant or intending to become pregnant in the next year, recent stroke
or myocardial infarction, severe uncontrolled mental illness
Gender: all female
Age: 59.0 mean (SD 7.5) years
Type of cancer: breast
Adjuvant treatment after surgery: none: n = 15 (15%), radiation only: n = 36 (36%), chemotherapy on-
ly: n = 22 (22%), radiation and chemotherapy: n = 54 (54%)
Cancer stage: 0: n = 15 (15%), 1: n = 51 (51%), 2: n = 24 (24%), 3: n = 7 (7%), unknown: 3 (3%)
Ethnicity: non-Hispanic white: n = 91 (91%)
Baseline physical activity: moderate to vigorous-intensity physical activity (minutes/week): 99 mean
(SD 127)
Education: high school degree: n = 8 (8%), some college: n = 26 (26%), college degree: n = 29 (29%),
graduate degree: n = 37 (37%)
Interventions Comparison: in-person counselling vs telephone weight loss counselling vs usual care
Intervention: weight loss intervention adapted from the diabetes prevention programme. Both in-per-
son and telephone counselling groups received the same lifestyle intervention
Control: usual care group received the American Institute for Cancer Research nutrition and physical
activity brochures and were referred to the Yale Cancer Centre Survivorship clinic. ITT was used
Outcomes Diet: 120-item food frequency questionnaire
Harrigan 2016 
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Height: stadiometer (nearest 0.1 cm)
Weight: measured while wearing light indoor clothing, without shoes (nearest 0.1 kg)
Waist: measurement taken at smallest waist circumference (nearest 0.1 cm)
Body fat: dual-energy x-ray absorptiometry scans (DEXA) performed to assess body fat with a Hologic
4500 scanner
Serum biomarkers: fasting (> 12 hours) blood draw was performed. Serum samples were stored at -80
degrees C until assayed
Duration of follow-up: 6 months
Notes Funding: American Institute of Cancer Research
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)















Unclear risk Subjective outcomes not reported
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk Study staG blinded to randomisation and lab technicians blinded to treatment
assignment
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes








Unclear risk Subjective outcomes not reported
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
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Methods Design: 2-armed prospective randomised controlled trial
Country: Australia
Accrual dates: October 2008 to June 2009
Trial Reg: ACTRN 2608000399392
Participants Number randomised: 410
1141 colorectal cancer survivors assessed for eligibility, 57 excluded, 124 no response from doctor, 78
doctor refusal, 205 allocated to intervention, 171 completed 6-month follow-up, 34 lost to follow-up,
159 completed 12-month follow-up, 12 lost to follow-up, 205 allocated to usual care, 176 completed 6-
month follow-up, 29 lost to follow-up, 163 completed 12-month follow-up, 13 lost to follow-up
Inclusion and Exclusion: persons age ≥ 18 years residing in Queensland. Histologically confirmed diag-
nosis of primary CRC (i.e. C18-C20, C218) within the previous 12 months. Queensland Cancer Registry
notification from 1 October 2008, to 30 June 2009. Ability to understand and provide written informed
consent in English. No metastatic disease (confirmed during screening interview). No medical condi-
tion limiting adherence to an unsupervised PA programme (as confirmed by their referring physician).
A telephone. ≥ 1 poor health behaviour consistent with Australian recommendations (i.e. exercise < 150
minutes per week, < 2 servings of fruit or < 5 servings of vegetables per day, or overweight (BMI > 25 kg/
m2))
Gender:
Intervention: male 106, female 99
Control: male 115, female 90
Age:
Intervention: mean 64.9 (SD 10.8) years
Control: mean 67.8 (SD 9.2) years
Type of cancer: colorectal
Therapy previously received for cancer:
Intervention: surgery 95.6%, chemo 41.5%, other therapy 11.7%
Control: surgery 96.6%, chemo 39.5%, other therapy 14.2%
Cancer stage:
Intervention: A 17.6%, B 31.7%, C 22.0%, D 28.8%
Control: A 19.0%, B 25.9%, C 23.4%, D 31.7%
Baseline physical activity: NR
Education: completed high school: intervention: 89.8%, control: 91.7%
Interventions Comparison: 6-Month telephone-delivered health coaching (HC) intervention commencing within 12
months of CRC diagnosis vs usual care (UC)
Intervention: 11 telephone-delivered HC sessions, a participant handbook, regular motivational post-
card prompts, a pedometer, and the quarterly study newsletter sent to UC participants. The interven-
tion was based on Acceptance Commitment Therapy (ACT). ACT interventions have been successful-
ly used to enhance HRQoL and to promote positive health behaviours for various health conditions in-
cluding chronic pain, diabetes, epilepsy, smoking, and obesity or weight management
Control: UC participants received 4 freely available educational brochures produced by Cancer Coun-
cil Australia on understanding CRC and cutting cancer risk, diet, and physical activity. Participants also
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received a quarterly study newsletter to enhance participant retention and were contacted for all fol-
low-up assessments
Outcomes HRQoL: Short Form–36
Cancer-related fatigue: 13-item Functional Assessment of Chronic Illness Therapy Fatigue Scale
Weight management: BMI (kg/m2) using self-reported height and weight measurements
Dietary intake: Cancer Council Victoria Food Frequency Questionnaire
(Dietary intake was quantified for total and saturated fats (percent of kJ intake), fibre (grams per day),
fruits and vegetables (servings per day)
(Cancer Council Victoria Food Frequency Questionnaire shows acceptability reliability and validity
compared with 7-day weighted food records and has been successfully used via telephone among can-
cer survivors)
Duration of follow-up: 12 months
Notes Funding: supported by the Australian Government through Cancer Australia
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants were randomly assigned to HC (n = 205) or UC (n = 205) at a ratio
of 1 to 1 via a computer-generated random number sequence
Allocation concealment
(selection bias)
Low risk Allocation sequence was generated by Can-Change computer application de-
velopers and was concealed from project investigators and from the project










High risk Participants were not blinded; outcome was patient self-reported and there-
fore is likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
High risk Participants were not blinded; outcome measurement was patient self-report-
ed and therefore is likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk Participants were not blinded; outcome measurement was patient self-report-




High risk At 12 months, retention was 77.6% for the intervention group and 79.5% for




High risk At 12 months, retention was 77.6% for the intervention group and 79.5% for
the control group (P = 0.47). Similar dropout between groups. ITT was used
Hawkes 2013  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk All primary outcomes reported, but not all secondary outcomes




Methods Design: randomised controlled trial
Country: Netherlands
Accrual dates: November 2013 to June 2014
Trial Reg: Dutch Trial Register NTR3375
Participants Number randomised: 518
1303 eligible, 785 no participation (decline before consent 100, not meeting inclusion criteria 5, com-
puter literacy 10, unknown 670), 231 allocation to control group (no consent 7, not meeting inclusion
criteria 2, baseline incomplete 13), 221 follow-up for 6 months (lost 10), 212 follow-up for 12 months
(lost 19), 231 allocation to intervention group (no consent 6, not meeting inclusion criteria 15, baseline
incomplete 13), 188 follow-up for 6 months (lost 43), 169 follow-up for 12 months (lost 62)
Inclusion: 18 years of age or older. Previously diagnosed with cancer. Successful completion of the
main treatment period. Up to 1 year ago. Receive aftercare (e.g. preventive hormonal therapy) or med-
ical check-ups. No cancer during last medical check-up. All types of cancer. No groups were excluded
(on condition that the main treatment period was successfully completed). Ability to speak and read
the Dutch language. Access to the web and minimal Internet experience (monthly access)
Exclusion: serious medical, psychiatric, or cognitive disease that would interfere with participation
Gender: female: intervention: n = 183 (79.2 %), control: n = 186 (80.5%)
Age:
Intervention: mean 55.6 (SD 11.5) years
Control: mean 56.2 (SD 11.3) years
Ethnicity: NR
Type of cancer: various (breast cancer: intervention = 70%, control = 71%)
Therapy previously received for cancer:
Surgery, chemotherapy, radiation: intervention: n = 86 (37.2%), control: n = 108 (46.8%)
Surgery, chemotherapy: intervention: n = 61 (26.4%), control = 48 (20.8%)
Surgery, radiation: intervention: n = 46 (19.9%), control: n = 30 (13.0%)
Other: intervention: n = 38 (16.5%), control: n = 45 (19.5%)
Cancer stage: NR
Baseline physical activity:
Weekly days > 30 minutes PA; intervention 4.9 mean (SD 1.9); control 4.6 mean (SD 2.0)
Light PA minutes p/w: intervention 1521.5 mean (SD 897.9); control 1430.2 mean (SD 897.7)
Moderate PA minutes p/w: intervention 595.9 mean (SD 620.5); control 526.5 mean (SD 546.5)
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Vigorous PA minutes p/w: intervention 231.0 mean (SD 323.9); control 238.0 mean (SD 426.0)
Education:
Low: intervention n = 76 (32.9%); control n = 97 (42.0%)
Medium: intervention n = 76 (32.9%); control n = 70 (30.3%)
High: intervention n = 79 (34.2%); control n = 64 (27.7%)
Interventions Comparison: online intervention questionnaire vs wait-list control
Intervention: cancer survivors in the experimental group who enter the online portal receive gener-
al information on dealing with distress, obtaining social support, self-managing disease, and optimis-
ing healthy lifestyles. They are free to fill out a questionnaire on personal needs, which will lead them
to tailored advice about the mentioned topics. Also information about possible other helpful interven-
tions and social workers is provided. Cancer survivors in the experimental group are free to enter the
online portal as often as they want to
Wait-list control: provided with access to online intervention after the last measurement
Outcomes Physical activity: Self-reported Questionnaire to Assess Health Enhancing Physical Activity – SQUASH
Vegetable consumption: Dutch Standard questionnaire on Food Consumption
Duration of follow-up: 12 months
Notes Funding: KWF Kankerbestrijding, Netherlands Laboratory for Lifelong Learning (NELLL)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomised allocation (ratio of 1:1) was automatically performed by means of
a digital randomiser after centralised registration of participants
Allocation concealment
(selection bias)
Low risk Randomised allocation (ratio of 1:1) was automatically performed by means of










High risk Participants and personnel not blinded.
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Unclear risk No objective outcome measures
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes




Unclear risk No objective outcome measures
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Unclear risk Primary outcomes: physical activity and fruit and vegetable consumption re-
ported
Primary outcome of well-being not reported








Participants Number randomised: 45
951 participants identified from centre; 188 agreed to participate; 143 were excluded due to not meet-
ing inclusion criteria, failing to complete screening tests, refusing to participate, or still receiving treat-
ment; 23 randomised to intervention; 22 randomised to control; 5 lost to follow-up in intervention arm;
4 lost to follow-up in control arm
Inclusion: women aged 20 years or older with stage 0 to III breast cancer. Primary treatment complet-
ed. Unmet behaviour goals or a poor diet as measured by the Diet Quality Index
Exclusion: progressive disease. Additional primary tumours. Currently being treated for cancer. Con-
dition that precludes unsupervised exercise or could interfere with fruit and vegetable diet. Any of the
following contraindications for exercise: serum platelets lower than 100,000/mm3. Serum haemoglobin
lower than 10 g/dL, body temp 37.8 or higher. White blood cell count 11,000/mm3 or higher
Gender: female
Age:
Intervention: 44.6 mean (SD 9.9) years
Control: 47.1 mean (SD 7.3) years
Type of cancer: breast
Therapy previously received for cancer (n): mastectomy 6, breast-conserving surgery 39, radiation
therapy 35, chemotherapy 37, hormone therapy 36
Cancer stage (n): stage 0: 5, stage I: 19, stage II: 15, stage III: 6
Ethnicity: NR
Baseline physical activity: NR
Education(n): high school or less: 29, completed university: 16
Interventions Comparison: simultaneous stage-matched exercise and diet intervention vs control
Intervention: stage-matched telephone counselling complemented with a workbook, individualised
prescription for regular exercise, balanced diet programme based on guidelines for survivors (Doyle
Kim 2011 
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2006) and guidelines of the Korean Nutrition Society. Prescription of exercise and diet was delivered
weekly by 2 specially trained nurses during 30-minute telephone counselling session
Control: details not stated
Outcomes Dietary changes: assessed by 3-day dietary recall and the Diet Quality Index tool for the Korean popu-
lation
Quality of life: European Organisation for Research and Treatment of Cancer quality of life question-
naire was used to measure functional status and global QoL
Behaviour change towards consumption of a healthy diet: participants were assessed on their
readiness to change based on TTM stages of change
Duration of follow-up: 12 weeks
Notes Funding: National Cancer Centre grant
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random numbers table, although there is the possibility of selection bias due
to the low level of enrolment
Allocation concealment
(selection bias)










High risk No blinding; outcome was patient self-reported and therefore is likely to be in-
fluenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Unclear risk No objective outcomes appropriate for this review
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement was patient self-








Low risk Attrition was 20%,but was similar in both groups, with 5 dropouts in the inter-
vention arm and 4 in the control arm. Analyses were performed on an ITT basis
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement
Other bias Unclear risk Insufficient information to permit judgement
Kim 2011  (Continued)
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Methods Design: randomised controlled trial
Country: USA
Accrual dates: 2002 (4-month period)
Trial Reg: NR
Participants Number randomised: 85
736 sent a letter, 296 responded, 211 were excluded (most did not meet the overweight criteria, and
other common reasons included not interested, did not have invasive breast cancer, and were in anoth-
er nutrition study), 56 randomised to Intervention, 49 randomised to control, 9 dropout from interven-
tion, 76 included in analysis (29 control and 47 intervention)
Inclusion: breast cancer survivors who met the following inclusion criteria: 18 years of age and older;
diagnosed with stage I to IIIA breast cancer within the previous 14 years; completed initial treatments
(i.e. surgery, adjuvant chemotherapy, radiation therapy); initial BMI > 25.0 kg/m2 and a minimum of 15
kg over ideal weight as defined by Metropolitan Life Insurance tables (1983); willingness and ability to
attend group meetings and to maintain contact with investigators for 12 months; ability to provide di-
etary and exercise data by telephone at prescribed intervals
Exclusion: inability to participate in physical activity because of severe disability (e.g. severe arthritic
condition). Vulnerable individuals, such as pregnant women, were also excluded
Gender: female
Age: mean 56.3 (SD 8.2) years; range 34 to 72 years
Ethnicity: non-Hispanic white n = 71 (93%), Hispanic n = 2 (3%), African American n = 1 (1%), Pacific Is-
lander n = 1 (1%), Other n = 1 (1%)
Type of cancer: breast
Therapy previously received for cancer: NR
Cancer stage: Ia: n = 35 (46%), 1b: n = 3 (4%), Iia: n = 26 (34%), IIb: n = 10 (13%), IIIa: n = 2 (3%), tamox-
ifen use: n = 37 (54%)
Baseline physical activity: moderate + vigorous physical activity at baseline (hours/week)
Control: mean 4.0 (SD 3.4)
Intervention: mean 3.2 (SD 2.0)
Education:
High school n = 6 (8%), some college n = 21 (28%), college graduate n = 40 (53%), postgraduate n = 9
(12%)
Interventions Comparison: weekly 6-week intervention with cognitive-behavioural therapy for obesity vs wait-list
control
Intervention: once weekly, 16-week intervention or wait-list control
The intervention incorporated elements of CBT for obesity, addressing a reduction in energy intake,
as well as exercise, with the goal of an average of 1 hour a day of moderate to vigorous activity. Body
weight, total and regional body fat (by dual energy X-ray absorptiometry), waist and hip circumference,
and blood lipids were assessed at baseline and after 16 weeks of intervention
Control: wait-list group
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Outcomes Physical measures for body composition: anthropometry, scan, blood lipids
Duration of follow-up: 16 weeks
Notes Funding: NIH grants CA90413 and CA101489
Risk of bias
















High risk No blinding; outcome was patient self-reported and therefore is likely to be in-
fluenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk No blinding; outcome is not likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement is not likely to be




High risk Attrition was 11%, but dropout rates between groups - 61% control and 16%




High risk Attrition was 11%, but dropout rates between groups - 61% control and 16%
intervention - were unequal. ITT was not used
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement




Methods Design: randomised controlled trial
Country: USA
Accrual dates: July 2017 to May 2007
Trial Reg: NCT00303875
Morey 2009 
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Participants Number randomised: 641
67,161 individuals were identified, 47,146 were excluded (duplicates, deceased, missing contact de-
tails), Study letters of invitation were mailed to 20,015 individuals, 2156 expressed interest and were
sent an eligibility questionnaire, 1208 responses were received, 567 individuals were ineligible
Intervention (n = 319) or delayed intervention control group (n = 322)
Inclusion: breast, prostate, and colorectal cancer. Diagnosed at least 5 years ago. Aged 65 years or old-
er. No evidence of progressive disease or second cancer
Exclusion: physician denied permission to contact patient. Institutionalised individuals. BMI < 25 or
> 40. Severe hearing or speaking impairment. Non-English speaking or writing. Contraindications to
unsupervised exercise (angina, myocardial infarction < 6 months, congestive heart failure, chronic ob-
structive pulmonary disease, plan to have a hip or knee replacement, walker or wheelchair use, recent
stroke with hemiparesis). Already performing more than 150 minutes of moderate to vigorous exercise
per week
Age:
Intervention: mean 73.0 (SD 5.0) years
Control: mean 73.1 (SD 5.1) years
Gender:
Male: intervention: n = 147 (46.1%)
Control: n = 145 (45.0%)
Ethnicity: white: intervention: n = 284 (89.0%), control: n = 285 (88.5%)
Type of cancer:
Breast: intervention: n = 143 (44.8%), control: n = 146 (45.3%)
Prostate: intervention: n = 131 (41.1%), control: n = 130 (40.4%)
Colorectal: intervention: n = 45 (14.1%), control: n = 46 (14.3%)
Therapy previously received for cancer: none stated
Cancer staging: NR
Baseline physical activity: NR
Education: some college education: intervention: n = 201 (63.0%), control: n = 94 (60.2%)
Interventions Comparison: 12-month diet and exercise intervention delivered via telephone counselling and tailored
mailed materials vs delayed intervention control
Intervention: personally tailored workbook and series of quarterly newsletters, along with a pro-
gramme of telephone counselling and automated prompts (i.e. 15 sessions and 8 prompts over the 12-
month period)
Control: delayed intervention, wait-list control
Outcomes Dietary intake: data were averaged from 2 unannounced 24-hour recalls, using the interactive Nutri-
tion Data System for Research software, version 2006 (Nutrition Coordinating Center, Minneapolis, Min-
nesota)
Self-reported height and weight: collected for estimation of BMI and weight loss
Duration of follow-up: 12 months
Morey 2009  (Continued)
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Notes Funding: supported by National Institutes of Health grants CA106919 and P30AG028716, and grant
E3386R from Veterans Affairs Research and Development
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomisation method by race, cancer type, and sex with even distribu-
tion into an intervention or delayed intervention control group
Allocation concealment
(selection bias)










High risk No blinding; outcome was patient self-reported and therefore is likely to be in-
fluenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
High risk No blinding of outcome assessment; outcome measurement was patient self-
reported and therefore is likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement was patient self-




Low risk Attrition even across groups. 88 dropouts with reasons (14% lost to follow-up),




Low risk Attrition even across groups. 88 dropouts with reasons (14% lost to follow-up),
but all participants included in the final analysis
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement




Methods Design: randomised controlled trial
Country: Berlin
Accrual dates: September 2011 to October 2013
Trial Reg: NCT01819324
Participants Number randomised: 173
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Invitation letter 1397, ClinicalTrials.gov 16, main hospital 866, returned to sender 124, received 177 (ex-
cluded 4, not eligible 3, did not complete required materials 1), TTMI 57, follow-up for 4 months 40 (lost
17), follow-up for 7 months 43 (3 came back), SLM 58, follow-up for 4 months 43 (lost 15), follow-up for
7 months 41 (lost 2), control 58, follow-up for 4 months 50 (lost 8), follow-up for 7 months 47 (lost 3)
Inclusion: first diagnosed with breast cancer in the past 1.5 years. Stage 0 to 2 breast cancer. No prior
adjuvant treatment for another cancer. Can read and write English. Not participating in other health
behaviour research right now
Exclusion: apparently serious mental disturbance, male breast cancer survivors
Gender: female
Age: TTMI mean 55.73 (SD 10.91); SLM mean 57.74 (SD 10.7); UC mean 55.72 (SD 10.92) years
Ethnicity:
White: TTMI n = 54 (94.7%); SLM n = 56 (96.6%); UC n = 53 (93.0%)
African American: TTMI n = 1 (1.8%); SLM n = 1 (1.7%); UC n = 2 (3.5%)
Hispanics: TTMI n = 1 (1.8%); SLM n = 0; UC n = 1 (1.8%)
Other: TTMI n = 1 (1.8%); SLM n = 1 (1.7%); UC n = 1 (1.8%)
Type of cancer: breast
Therapy previously received for cancer:
Current cancer treatment
No: TTMI n = 35 (64.8%); SLM n = 38 (70.4%); UC n = 33 (58.9%)
Yes: TTMI n = 19 (35.2%); SLM n = 16 (29.6%); UC n = 23 (41.1%)
Cancer stage: NR
Baseline physical activity: exercise time (minutes): NR
Education:
Less than high school: TTMI n = 0; SLM n = 1 (1.7%); UC n = 0
High school/GED 6: TTMI n = 7 (10.5%); SLM (12.1%); UC n = 8 (14.0%)
Some college: TTMI n = 11 (19.3%); SLM n = 9 (15.5%); UC n = 8 (14.0%)
2-year college degree (Associate's): TTMI n = 7 (12.3%); SLM n = 4 (6.9%); UC n = 5 (8.8%)
4-year college degree (BA/BS): TTMI n = 17 (29.8%); SLM n = 23 (39.7%); UC n = 20 (35.1%)
Graduate degree (MA, PhD): TTMI n = 16 (28.1%); SLM n = 13 (22.4%); UC n = 12 (21.0%)
Professional degree (MD, JD): TTMI n = 0; SLM n = 1 (1.7%); UC n = 4 (7.0%)
Interventions Comparison: mail-based teachable moment materials vs mail-based standard lifestyle management
vs usual care
Experimental: targeting the teachable moment: receiving targeting the teachable moment interven-
tion materials (focused on health behaviours and issues specific to breast cancer survivors) every other
week for 4 months
Active comparator: standardised lifestyle management: receiving standardised lifestyle management
materials (focused mostly on health behaviours) every other week for 4 months
No intervention: usual care: receiving SLM materials at the end of 7 months
Park 2016  (Continued)
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Outcomes Primary outcome measures:
Changes in eating habits measured by the National Cancer Institute Quick Food Scan
Diet habits (amount of fat and fruit/vegetable uptake)
Changes in physical activity measured by the Paffenbarger physical activity questionnaire
Frequency and amount of time for physical exercise
Secondary outcome measures:
Changes in coping strategies measured by the Brief COPE
Coping strategies (e.g. problem-focused coping, emotional approach coping)
Changes in self-efficacy measured by the general self-efficacy questionnaire
General sense of perceived self-efficacy
Changes in social support measured by the Interpersonal Support Evaluation List (ISEL)
Social support
Changes in life meaning measured by the Meaning in Life Questionnaire (MLQ)
Presence of meaning and search for meaning
Duration of follow-up: 7 months
Notes Funding: National Cancer Institute
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants completed baseline questionnaires (T1) and then were random-
ly assigned (using a blocked design to ensure equal numbers of participants in
each group) to 1 of 3 groups
Allocation concealment
(selection bias)
Unclear risk Participants completed baseline questionnaires (T1) and then were random-
ly assigned (using a blocked design to ensure equal numbers of participants in










High risk Participants and personnel not blinded
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Unclear risk No objective outcome measures
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk Patient self-report
Park 2016  (Continued)
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High risk Dropout from intervention groups: targeting the teachable moment 25% and
standard lifestyle management 30% vs 19% control
Selective reporting (re-
porting bias)
Unclear risk Protocol could not be located; insufficient information to make a judgement




Methods Design: multi-institutional randomised controlled trial
Country: USA
Accrual dates: 1995 to 2000 (month not specified)
Trial Reg: NCT00003787
Participants Number randomised: 3107
7572 breast cancer patients screened; 4463 excluded due to not meeting inclusion criteria, declining to
participate, or unable to commit to study; 1546 randomised to intervention; 1561 randomised to con-
trol. In the intervention group, 16 were lost to follow-up and 2 withdrew. In the control group, 8 were
lost to follow-up and 19 withdrew. 1537 included in intervention group primary analysis, 1551 included
in control group primary analysis
Inclusion: diagnosis of a primary operable invasive breast carcinoma categorised by American Joint
Committee on Cancer (edition IV) criteria. Stage I (≥ 1 cm), stage II, or stage IIIA within the past 4 years.
Age at diagnosis between 18 and 70 years. Treatment with axillary dissection and total mastectomy or
lumpectomy followed by primary breast radiation. No current or planned chemotherapy. No evidence
of recurrent disease or new breast cancer since completion of initial local treatment. No other cancer in
the past 10 years
Exclusion: objective evidence of recurrent disease; current enrolment in another dietary clinical tri-
al. Diagnosis with a comorbidity requiring a specific diet or using a medication that contraindicated
a high-fibre diet. Pregnancy. Receiving oestrogen replacement therapy, including vaginal oestrogen
creams. Cirrhosis. Other primary or recurrent invasive cancer within the last 10 years (other than non-
melanoma skin cancer or carcinoma of the cervix in situ). Unable to commit to the intervention sched-
ule. Life-threatening disease or medical condition, other than breast cancer, that would interfere with
participation in an 8-year diet study. Any previous diagnosis of invasive breast carcinoma
Age:
Intervention: mean 53.3 (SD 8.9) years
Control: mean 53.0 (SD 9.0) years
Gender: female
Type of cancer: breast
Therapy previously received for cancer:
Intervention: mastectomy 52.8%, breast-sparing surgery 47.2%, radiation 61%, adjuvant chemotherapy
71.2%, ever anti-oestrogen use 19.5%
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Control: mastectomy 51.6%, breast-sparing surgery 48.4%, radiation 62%, adjuvant chemotherapy
68.6%, ever anti-oestrogen use 65.3%
Cancer stage:
Intervention: I 15.6%, II 40.3%, III 35.9%, unspecified 8.3%
Control: I 15.8%, II 40%, III 35.9%, unspecified 8.3%
Ethnicity:
Intervention: white 85%, African American 4%, Hispanic 5.7%, Asian American 3%, mixed/other 2.3%
Control: white 85.6%, African American 3.7%, Hispanic 5%, Asian American 3.2%, mixed/other 2.5%
Baseline physical activity: NR
Education: NR
Interventions Comparison: intensive counselling to adopt a dietary pattern high in fruits, vegetables, and fibre and
low in fat vs advice to follow the 5-a-day diet
Intervention: telephone counselling, supplemented with 12 cooking classes in the first year and
monthly newsletters throughout the study
Control: women randomised to the comparison group were provided with print materials (from the US
Department of Agriculture and the National Cancer Institute) describing a diet with a recommended
daily intake of 5 servings of vegetables and fruits, more than 20 g of fibre, and less than 30% total ener-
gy intake from fat
Outcomes Overall survival: National Death Index was searched using social security number, name, and date of
birth
Incidence of secondary malignancy/comorbidities: during telephone interview, clinical staG queried
participants regarding the occurrence of any new or existing medical diagnoses. Any report of breast
cancer event or death triggered a confirmation interview and collection of medical records and/or
death certificate
Dietary changes: assessed by sets of 4 prescheduled 24-hour dietary recalls conducted by telephone
on random days over a 3-week period, stratified for weekend vs weekday. Recalls were scheduled at
baseline and at 1 year, 4 years, and 6 years and on 50% random samples at 6, 24, and 36 months
Changes in weight and blood analysis: clinic visits conducted at baseline, 1 year, 2 or 3 years (ran-
domly determined), 4 years, and 6 years included measured weight and venepuncture. Separated
blood samples were stored in cryovials in −80°C freezers for later analysis
Duration of follow-up: 6 years
Notes Funding: study was initiated with support from the Walton Family Foundation and was continued with
funding from National Cancer Institute grant CA 69375. Some data were collected from general clinical
research centres (National Institutes of Health grants M01-RR00079 and M01-RR00827)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants were randomly assigned to intervention or comparison group via
a random permuted-block design stratified by tumour stage, age, and clinical
site
Pierce 2007  (Continued)
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Allocation concealment
(selection bias)
Low risk Allocation of participants was conducted by the clinical site coordinator run-
ning the study’s randomisation computer programme, which automatically










High risk No blinding; outcome is likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk No blinding; outcome is not likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement is likely to be in-




Low risk Minimal dropout with 1% lost to follow-up overall and similar numbers drop-




Low risk Minimal dropout with 1% lost to follow-up overall and similar numbers drop-
ping out of the intervention and control groups. ITT was used
Selective reporting (re-
porting bias)
Low risk All primary outcomes reported




Methods Design: 2-armed randomised controlled trial
Country: Australia
Accrual dates: July 2009 to June 2010
Trial reg: NR
Consent: written informed consent was obtained
Participants Number randomised: 90
927 identified, 743 obtained oncologist consent and were sent a letter, 248 consented to contact, 45
randomised to the intervention, 45 randomised to usual care, 5 lost to follow-up in the intervention
arm, 11 lost to follow-up in the usual care arm, 45 analysed in each group
Inclusion: women survivors after a diagnosis of stage I to III breast cancer. Age 18 to 75 years. Diagnosis
of breast cancer approximately 9 to 18 months before. Completed primary cancer treatment. BMI 25 to
40 kg/m2. Resided within 50 km of the state capital Brisbane. English speaking
Reeves 2017 
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Exclusion: diagnosis of ductal carcinoma in situ or distant metastatic disease. Previous diagnosis of in-
vasive breast cancer. Any other cancer in the past 5 years. Contraindications to participation in an un-
supervised exercise or weight loss programme. Self-reported mental health condition that would inter-
fere with study participation. Using or planning to use weight loss medications. Previously had or plan-
ning to have bariatric surgery. Not contactable for the duration of the study
Gender: female
Age: mean 55.3 (SD 8.7) years
Ethnicity: Caucasian 96.7%
Type of cancer: breast
Therapy received for cancer: surgery only 3.3%; surgery and chemo 14.4%; surgery and radiotherapy
28.9%; surgery, chemo, and radiotherapy 53.3%; trastuzumab 13.3%; endocrine treatment 73.3%
Cancer stage: stage I 48.9%, stage II 33.3%, stage III 17.8%
Baseline physical activity: NR
Education: high school or less 32.2%, trade/technical 30.0%, university or higher 37.8%
Interventions Comparison: telephone diet and physical activity intervention vs usual care
Intervention: weight loss intervention of diet and physical activity. Intervention included posted mate-
rials and up to 16 calls from a dietitian over a 6-month period
Control: mailed brief feedback after assessments; after 6-month assessment, provided with the inter-
vention workbook and a diary
Outcomes Changes in weight/anthropometry: objectively measured during the in-person assessment
Dietary changes: self-reported dietary intake by two 24-hour dietary recall telephone interviews as-
sessed at baseline and at 6 months. Dietary intake included vegetables, energy, energy density, carbo-
hydrates, total fat, and saturated fat
Healthy eating changes: dietary strategies recorded included portion control, dietary self-monitoring,
and reducing fat intake
Quality of life: assessed by SF-36; fatigue was measured on the 13-item FACIT; fatigue and body image
were assessed by body image and relationship scale
Duration of follow-up: data collected at baseline and at 6 months
Notes Funding: early career researcher grant from the University of Queensland, project grant funding from
the National Health and Medical Research Council and Queensland Health Core Infrastructure Funding
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation sequence and group allocation were generated by a staG
member not involved with the study using a computer-generated random
number sequence, with block sizes of 6
Allocation concealment
(selection bias)
Low risk Randomisation sequence and group allocation were generated by a staG
member not involved with the study using a computer-generated random




Low risk No blinding; outcome is not likely to be influenced by lack of blinding
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High risk Participants and personnel not blinded
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk Suggested outcome assessors blinded to patient groups, but not enough de-
tail provided. However, outcome is not likely to be influenced by lack of blind-
ing
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding; outcome was patient self-reported and therefore is likely to be in-













Unclear risk Insufficient information to permit judgement








Participants Number randomised: 90
523 sent recruitment letter, 371 did not respond to letter, 86 enquiries from other sources, 238 total
number of enquiries, 60 excluded, 64 refused to participate, 14 could not contact, 10 declined after fa-
miliarisation, 47 allocated to intervention group, 43 allocated to control, 6 lost to follow-up interven-
tion, 5 lost to follow-up control, 41 completed 6-month intervention assessments, 38 completed 6-
month control assessments
Inclusion: overweight women with BMI 25 kg/m2. Completed surgery, chemotherapy, and radiothera-
py for early-stage breast cancer (stage I to III) 3 to 18 months previously. Receiving adjuvant endocrine
treatments and yet to complete a 1-year course of adjuvant trastuzumab. Subject to acceptable cardiac
function determined by a multi-gated acquisition (MUGA) scan and consultant approval
Exclusion: concomitant HRT or oral contraceptives; metastatic or active loco-regional disease. Phys-
ical or psychiatric impairment limiting physical mobility. Severe nausea, anorexia, or other condition
precluding participation in exercise. Following alternative/complementary diets. Taking high-dose an-
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Intervention: 55.6 mean (SD 10.2) years
Control: 55.9 mean (SD 8.9) years
Type of cancer: breast
Therapy previously received for cancer:
Mastectomy: intervention: n = 28 (60%), control: n = 9 (21%)
Breast-conserving surgery: intervention: n = 19, control: (40%) n = 34 (79%)
Chemotherapy: intervention: n = 27 (57%), control: n = 23 (54%)
Radiotherapy: intervention: n = 40 (85%), control: n = 35 (81%)
Tamoxifen: intervention: n = 23 (49%), control: n = 22 (51%)
Aromatase inhibitor: intervention: n = 14 (30%), control: n = 11 (26%)
Trastuzumab: intervention: n = 4 (9%), control: n = 6 (14%)
Lymphedema: intervention: n = 10 (21%), control: n = 15 (35%)
Cancer stage: all early stage, I to III
Ethnicity: white: intervention: n = 46 (98%), control: n = 42 (98%)
Baseline physical activity:
Resting heart rate, beats/min at baseline: intervention: 78 mean (SD 12), Control: 74 mean (SD 11)
Education (SES):
Secondary and A levels: intervention: n = 18 (38%), control: n = 12 (28%)
Degree: intervention: n = 8 (17%), control: n = 8 (19%)
Vocational qualifications: intervention n = 6 (13%), control: n = 2 (5%)
Interventions Comparison: exercise and hypocaloric healthy eating programme vs control
Intervention: 24-week lifestyle intervention with 3 weekly supervised exercise sessions and an individ-
ually tailored hypocaloric healthy eating programme. Each participant also received one-to-one indi-
vidualised dietary advice and written information (‘‘Weight Loss on a Plate,’’ Scottish Dietetic Associa-
tion). Additional weekly small-group nutrition education seminars included topics such as dietary fat
intake, hydration, achieving a healthy balanced diet, and alcohol consumption
Control: a healthy eating booklet, "Eat Well" (Food Standards Agency, UK), which also included brief
advice on keeping active
Outcomes Weight: measured by a standard technique
BMI: measured by a standard technique
Waist circumference: measured by a standard technique
Waist- to-hip ratio: measured by a standard technique
% body fat: measured using bioelectrical impedance
QoL: measured using the Functional Assessment of Cancer Therapy - General (FACT-G), including the
breast subscale (FACT-B)
Dietary intake: measured using 3-day diet diaries, which were analysed for total energy and macronu-
trient intake (NetWisp 3: Tinuviel Software Systems, Cheshire, UK)
Scott 2013  (Continued)
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Duration of follow-up: 6 months
Notes Funding: American Institute for Cancer Research (Grant number 05A008-REV)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Patients were randomly allocated (1:1 ratio) to 1 of 2 groups: (1) lifestyle inter-
vention group, or (2) control group. Randomisation was performed by an inde-
pendent researcher at the Clinical Trials Research Unit, University of Leeds
Allocation concealment
(selection bias)











High risk No blinding; outcome is likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk No blinding; outcome is not likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement is likely to be in-




Low risk Attrition 12%. Missing outcome data balanced in numbers across invention




Low risk Attrition 12%. Missing outcome data balanced in numbers across invention
and control groups. ITT with missing data inputted
Selective reporting (re-
porting bias)
Low risk All outcomes reported




Methods Design: 2-arm randomised controlled trial
Country: USA
Accrual dates: December 2010 to January 2012
Trial Reg: NR
Participants Number randomised: 31
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106 screened, 37 ineligible, 69 eligible, 50 consent, 19 declined participation, 19 not randomised, 15 in-
tervention, 16 control, 12 completed, 1 withdrew, 3 lost to follow-up, 10 completed, 5 withdrew
Inclusion: self-identified as African American. Overweight or obese (BMI ≥ 25 kg/m2 and ≤ 40 kg/m2. Se-
dentary (exercises less than 60 min/week for previous 6 months). Early-stage/localised breast cancer
6 months. 5 years post active treatment. Ability to read and speak English. Ability to provide informed
consent
Exclusion: history of other cancers (except basal or squamous cell carcinoma). Recurrence of breast
cancer. Current enrolment in another physical activity or dietary clinical trial or commercial pro-
grammes like Weight Watchers. Inability to commit to the intervention schedule. Telephone inaccessi-
bility. Pre-existing conditions that preclude adherence to an unsupervised exercise programme. Failure
to provide medical clearance. Morbidly obese (BMI ≥ 40 kg/m2)
Gender: female
Age: mean 54.7 (SD 9.8) years
Type of cancer: breast
Therapy previously received for cancer: NR
Cancer staging: early stage/localised
Ethnicity: African American
Baseline physical activity:
Control (minutes/week (mean ± SD)): vigorous 37.5 ± 71.4, moderate 53.6 ± 60.9, walking 100.0 ± 87.6,
total 205.0 ± 196.9
Metabolic equivalents (MET) (minutes/week (mean ± SD)): vigorous 300 ± 570.9, moderate 214.5 ±
243.5, walking 313.5 ± 283.9, total 688.5 ± 794.2
Intervention: (minutes/week (mean ± SD)): vigorous 37.5 ± 84.5, moderate 62.5 ± 129.8, walking 140.7 ±
229.0, total 291.7 ± 387.0
Metabolic equivalents (MET) (minutes/week (mean ± SD)): vigorous 300 ± 675.8, moderate 250.0 ±
519.2, walking 464.4 ± 755.7, total 291.7 ± 387.0
Education: NR
Interventions Comparison: Stepping STONE intervention (physical activity and diet intervention) vs control (general
health info for cancer survivors)
Intervention: 12-week Stepping STONE intervention based on theory of planned behaviour and so-
cial-cognitive theory. Participants met once every 2 weeks for 90-minute group session – 30 minutes
physical activity and 60 minutes educational session. On weeks not meeting, individual telephone
coaching sessions with a trained survivor coach for 15 minutes
Control: general health information for cancer survivors – facing forward life after cancer treatment.
Offered intervention at completion of the study
Outcomes Weight, waist, and hip circumference: physical measurement
Food intake: participants recorded food intake for 4 days
Duration of follow-up: 12 weeks
Notes Funding: National Cancer Institute R21CA149996, Biostatistics and Bioinformatics Shared Resource
and Tissue Culture Shared Resource NCI grant P30CA51008
Risk of bias
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)














Unclear risk Not reported. No subjective outcomes appropriate for this review
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk No blinding; outcome is not likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes








Unclear risk Not reported. No subjective outcomes appropriate for this review
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to permit judgement








Participants Number randomised: 23 (13 intervention, 10 control).
66 survivors invited to participate, 28 enrolled
Inclusion: stage I, II, or III invasive breast cancer. > 3 months after completion of active treatment.
Body mass index (BMI) > 25 kg/m2. Confirmed ER/PR/HER2 neu-negative status (per pathology report);
younger than 80 years of age
Swisher 2015 
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Exclusion: significant cardiac disease, renal failure; significant symptomatic lymphoedema. Physical or
psychological comorbidities that would prohibit exercise testing or participation. Diagnosis of diabetes
mellitus. Active smoking status
Gender: female
Age:
Intervention: mean 53.8, range: 43 to 65 years
Control: mean 53.6, range: 36 to 71 years
Ethnicity: NR
Type of cancer: breast
Therapy previously received for cancer:
Surgery: intervention (13): lumpectomy 13, mastectomy 5, radiation (Y/N) 13/5, chemotherapy (Y/N)
17/1
Control (10): lumpectomy 6, mastectomy 4, radiation (Y/N) 7/1, chemotherapy (Y/N) 7/1
Cancer stage: I, II, or III (no further detail provided).
Baseline physical activity: exercise time (minutes): intervention: 12.4, control: 13.8
Education: NR
Interventions Comparison: moderate exercise and diet counselling vs usual care
Intervention: get fit for the fight programme. Programme consisted of supervised, moderate-inten-
sity aerobic exercise 3 times per week at the exercise facility and 2 unsupervised sessions per week at
home. Dietary counselling consisted of 2 individual sessions with the study dietitian - a specialist in nu-
trition for cancer patients. Participants completed a 3-day diet record during baseline testing before
meeting individually with the dietitian
Control: written materials about healthy eating for cancer survivors and suggestions on ways to
achieve regular physical activity. Not instructed to avoid diet change or exercise
Outcomes Weight loss (body mass, BMI, % fat): BMI was calculated from height and weight measurements with-
out shoes and in light clothing
Waist and hip circumferences: measured via a spring-loaded tape measure
Body fat percentage: calculated from skin fold measurement at 7 body sites according to American
College of Sports Medicine standards
Quality of life: Function After Cancer Therapy - Breast (FACT-B)
Duration of follow-up: 12 weeks
Notes Funding: institutional research grant from the American Cancer Society
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation was determined a priori by the study statistician, and group
assignments were placed in opaque envelopes
Allocation concealment
(selection bias)
Low risk Randomisation was determined a priori by the study statistician, and group
assignments were placed in opaque envelopes
Swisher 2015  (Continued)
Dietary interventions for adult cancer survivors (Review)



















High risk No blinding; outcome is likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk No blinding; outcome is not likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes
High risk No blinding of outcome assessment; outcome measurement is likely to be in-




High risk Uneven dropout between groups - 0% control and 18% intervention. ITT was




High risk Uneven dropout between groups - 0% control and 18% intervention. ITT was
used with some data but not all
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported




Methods Design: randomised controlled trial
Country: South Korea
Accrual dates: April 2012 to August 2013
Trial Reg: NCT01527409
Participants Number randomised: 248
546 eligible patients, 298 excluded; Leach Program group: 115 (69.3%) participants completed the 12-
month course at 3 months, and 117 (70.5%) at 6 to 12 months; UC group, 60 (73.2%) participants com-
pleted the course at 3 months and 57 (71.3%) at 12 months
Inclusion: ≥ 20 years old. Platelet count ≥ 100,000/mm3. Serum haemoglobin ≥ 10 g/dL. Not already
met 2 or more behavioural goals aimed for in the study. Energy expenditure achieved by at least mod-
erate exercise for at least 150 minutes/week. Intake of ≥ 5 servings of fruits and vegetables per day. To-
tal score > 72 points in the Post Traumatic Growth Inventory
Exclusion: currently receiving cancer treatment. Progressive malignant disease or recurrent, metasta-
sised, or additional primary cancer. Condition that might compromise adherence to an unsupervised
exercise programme (e.g. uncontrolled congestive heart failure or angina, recent myocardial infarc-
tion, breathing difficulties requiring oxygen use or hospitalisation, inability to walk without a walker or
wheelchair, planning to receive hip or knee replacement surgery). Condition that could interfere with
ingestion of a diet high in vegetables and fruits (e.g. kidney failure, need for chronic warfarin). Serious
Yun 2017 
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psychological disorder (e.g. bipolar disease, schizophrenia, eating disorder). Infection (body tempera-
ture ≥ 37.2°C or WBC ≥11,000 mm3). Visual or motor dysfunction. Pregnant
Gender: male 42 (20.39), female 164 (79.61)
Age: mean 50.68 (SD 9.43) years
Type of cancer: stomach (n = 51), lung (n = 5), breast (n = 123), colorectal (n = 11), gynaecological (n =
9), other (n = 1)
Therapy previously received for cancer:
Missing - 10, surgery - 195 (99.49), radiotherapy- 100 (51.02), chemotherapy - 119 (60.71), hormonal
therapy - 51 (43.59)
Cancer stage: stage 0 - 5 (2.51), stage 1 - 100 (52.67), stage 2 - 66 (33.17), stage 3 - 20 (10.05), stage 4 - 2
(1.01), other (5/6) - 6 (3.02)
Ethnicity: Korean
Education: high school graduate or less 105 (51.47), college graduate 99 (48.53)
Interventions Comparison: LEACH (physical activity, diet, and distress) programme vs usual care
Intervention: 1-hour health education workshop (physical activity, dietary habits, and distress man-
agement) and 3-hour leadership workshop (Seven Habits of Highly Effective People With Cancer). Next,
the Intervention group was also offered individual coaching by telephone for a 24-week period
Control: encouraged to continue their usual care and given a health education booklet on physical ac-
tivity, dietary habits, and distress management
Outcomes Physical activity: measured in METs (kcal/kg/week)
Diet: a validated questionnaire on fruit and vegetable intake
Post-traumatic growth: measured using the 21-item Post-Traumatic Growth Inventory
Duration of follow-up: outcomes were measured at 0, 3, 6, and 12 months, but data from the 6-month
period were not included in the analysis due to lack of participants
Notes Funding: national cancer centre, national R&D programme for cancer control, ministry of health and
welfare, Republic of Korea
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)















High risk Participants and personnel not blinded
Yun 2017  (Continued)
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Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Unclear risk No objective outcome measures
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes












Unclear risk Protocol could not be located; insufficient information to make a judgement




Methods Design: pilot randomised clinical trial
Country: USA
Accrual dates: January 2014 to April 2015
Trial Reg: NCT01902745
Participants Breast cancer survivors, completed treatment with reported persistent fatigue
Number randomised: 30
50 assessed for eligibility, 20 excluded, 15 allocated to fatigue reduction diet (FRD), 15 allocated to gen-
eral health curriculum (GHC), 30 completed treatment and were included in the analysis
Inclusion: 18 years of age or older. BMI between 18.5 and 35 kg/m2. Diagnosis of local regional breast
cancer (stage 0 to IIIa). Completed all cancer treatments except for hormonal therapy and herceptin.
At least 1 year previously, reported persistent fatigue starting on or after cancer diagnosis. Score > 4 on
the brief fatigue inventory. Low fruit and vegetable intake (fewer than 5.5 servings per day)
Exclusion: diagnosis pf untreated anaemia. Hypothyroid or hyperthyroid and supplemented with
omega 3 fatty acids. On a medically prescribed diet. Pregnant. Wanting to become pregnant or lactat-




FRD: mean 64.4 (SD 10.0) years
GHC: mean 60.4 (SD 9.35) years
Type of cancer: breast
Cancer stage:
Zick 2017 
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FRD: stage 0: 7%, stage 1: 27%, stage 2: 47%, stage 3: 13%, unknown: 7%
GHC: stage 0: 33%, stage 1: 20%, stage 2: 27%, stage 3: 13%, unknown: 0%
Therapy received for cancer:
FRD: surgery 100%, chemo 73%, radiation 86%, hormone 12%




Baseline physical activity: NR
Education: NR
Interventions Comparison: fatigue reduction diet vs general health curriculum
Intervention: individualised counselling using the theoretical framework of Bandura's social-cognitive
theory, delivered via 6 brief 15-minute telephone counselling calls by a registered dietitian and based
on dietary intake
Control: individualised counselling using the theoretical framework of Bandura's social-cognitive the-
ory, delivered via 6 brief 15-minute telephone counselling calls by a study staG member and based on
general health (with no dietary info)
Outcomes Severity and impact of fatigue: 9-item Brief Fatigue Inventory
Sleep quality: 19-item PSQI
Dietary intakes: 7-day food diaries and 24-hour recalls
Adherence to dietary goal: daily food checklists and serum fatty acids
Duration of follow-up: 3 months
Notes Funding: supported by grants from the James Stuart and Barbara Padnos Research Funds for Cancer
Research and the NIH CTSA
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation code was computer-generated in blocks of size 6 by the study
biostatistician. Study personnel who had no contact with participants or study




Low risk Upon randomisation, the next number in the sequence was chosen, and the









High risk Participants and personnel not blinded
Zick 2017  (Continued)
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Subjective outcomes
Blinding of outcome as-
sessment (detection bias) 
Objective outcomes
Low risk No blinding; outcome is not likely to be influenced by lack of blinding
Blinding of outcome as-
sessment (detection bias) 
Subjective outcomes













Unclear risk Protocol could not be located; insufficient information to permit a judgement
Other bias Unclear risk Insufficient information to make a judgement
Zick 2017  (Continued)
ACT: Acceptance Commitment Therapy.
BMI: body mass index.
CBT: cognitive-behavioural therapy.
CRC: colorectal cancer.
DEXA: dual-energy X-ray absorptiometry.
DQI: Diet Quality Index.
EC: endometrial cancer.
EORCT QLQ-C30: 30-item questionnaire of the European Organisation for Research and Treatment.
FACIT: Functional Assessment of Chronic Illness Therapy.
FACT-B: Functional Assessment of Cancer Therapy - Breast.
FACT-C: Functional Assessment of Cancer Therapy - Colorectal.
FACT-G: Functional Assessment of Cancer Therapy - General.
FRD: fatigue reduction diet.
GHC: general health curriculum
HDL: high-density lipoprotein.
HRQoL: health-related quality of life.




NHANES: National Health and Nutrition Examination Survey.
NR: not reported.
PA: physical activity.
PSQI: Pittsburgh Sleep Quality Index.
QoL: quality of life.
R&D: research and development.
SD: standard deviation.
SES: supplementary education services.
SF-36: Short Form-36.
SLM: standard lifestyle method.
TTMI: Targeting the Teachable Moment Intervention.
UC: usual care.
WHEL: Women's Healthy Eating and Living study.
WW: Weight Watchers.
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Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Abrams 2014 Editorial article
Anderson 2014 Participants are not cancer survivors
Arends 2014 Single food group only (fruit and vegetable) used in the intervention: this is not sufficient to repre-
sent healthy eating
Arnold 2015 Intervention uses supplementation
Boddie 2010 Intervention uses supplementation
Bourke 2014 Not an RCT
Brewer 2015 Not an RCT
Campbell 2009 Single food group only (fruit and vegetable) used in the intervention: this is not sufficient to repre-
sent healthy eating
Capozzi 2012 Protocol article with no follow-up publications
Chlebowski 2008 As in paper by Reddy 2005 (WINS trial): participants were not survivors but were early-stage breast
cancer patients. In addition, some participants were receiving chemotherapy at recruitment
Chlebowski 2013 Review article
Chlebowski 2015 (WINS Trial) Participants were not survivors but were early-stage breast cancer patients. In addi-
tion, some participants were receiving chemotherapy at recruitment
De Waele 2015 Intervention took place at time of treatment
del Rocio Berglund 2012 (FASEB abstract 626.6) Intervention uses supplementation
del Rocio Berglund 2012a (FASEB abstract 1024.2) Intervention uses supplementation
Delvin 2014 Participants were not human
Demark-Wahnefried 2008 Intervention took place before and during participants' chemotherapy treatment
Dennis Parker 2014 Not an RCT
Djuric 2010 Participants were still receiving chemotherapy when randomised to the intervention
Emond 2010 Intervention was not dietary
Ferdowsian 2007 Review article
Flynn 2010 Intervention uses olive oil - enriched or low-fat diet
Frensham 2014 Intervention was not dietary, and trial was quasi-randomised
Fukui 2014 Intervention was acupuncture - not dietary
Garrett 2013 Not an RCT
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Study Reason for exclusion
George 2015 Not an RCT
Giallauria 2014 Intervention was not dietary
Goodwin 2019 On active treatment
Hagemann 2019 Study design
Haggerty 2014 Intervention was focused on comparison of 2 technologies
Hershman Intervention was not dietary
Ho 2013 Protocol article with no follow-up publications
Hung 2013 Participants received stem cell transplantation
James 2011 Protocol article with no follow-up publications
James 2015 Data for cancer survivors could not be extracted
Ko 2010 Uses the same data from the NC SRIDES study (Campbell 2009), which was excluded because the
intervention used only a single food group, which is not representative of healthy eating
Koner 2012 Not an RCT
Koutoukidis 2019 Study design
Kwiatkowski 2017 Dietray intervention was not clearly specified
Lee 2014 Intervention was not dietary
Lee 2018 2 × 2 factorial randomised controlled trial, where results are collapsed so the comparison of inter-
est (dietary intervention vs control) is not presented in the manuscript
Li 2008 Intervention uses supplementation
Ligibel 2019 Review
Lynch 2014 Outcomes were focused on sedentary behaviour - not on nutritional status/dietary intake
McCarroll 2014 Intervention uses supplementation
McDonald 2014 Protocol article with no follow-up publications
Moriya 2014 Intervention uses immune-enhancing diet
Nelson 2008 Review article
O'Neill 2010 Recruited participants were receiving androgen deprivation therapy for treatment of prostate can-
cer
Park 2019 Design
Pasanisi 2009 Not sure if trial is randomised. Not enough details on participants, methods, or outcomes
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Study Reason for exclusion
Paxton 2012 Intervention uses supplementation
Pellegrini 2014 Review article
Rack 2010 Review article and protocol with no follow-up publications.
Reddy 2005 (WINS Trial) Participants were not survivors but were early-stage breast cancer patients. In addi-
tion, some participants were receiving chemotherapy at recruitment
Rock 2015 Intervention was not dietary
Sedlacek 2011 Not an RCT
Song 2015 Not an RCT
Stacey 2017 Results reported only data for the intervention group at 12 months - not for the control group
Stricker 2013 Participants were quasi-randomised
Thiebaut 2006 Editorial article
Thomas 2009 Not an RCT; conducted for development of a tool only
Thompson 2012 Not an RCT
Thomson 2014 Not an RCT
Tyagi 2005 Intervention was not dietary
Urowitz 2012 Not an RCT
Van Der Werf 2015 Protocol only
Villasenor 2014 Outcomes focused on inflammation - not on nutritional status/dietary intake
Vona-Davis 2015 Primarily intervention was exercise-based. Dietary intervention included only advice on reduction
of calorie intake
Xing 2014 Review article
RCT: randomised controlled trial.
 
Characteristics of studies awaiting assessment [ordered by study ID]
 




Participants Number randomised: 60
Brown 2018 
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Inclusion: body mass index (BMI) > 25.0 kg/m2; completion of all surgery, chemotherapy, and/or
radiation at least 1 month before study enrolment (concurrent treatment with adjuvant hormon-
al or biologic therapies was acceptable); ECOG performance status of 0 (fully active without re-
striction) or 1 (restricted in physically strenuous activity, but ambulatory); and ability to walk 2 city
blocks and to speak and read English
Exclusion: other serious medical conditions such as unstable cardiovascular disease or digestive
disorders that would preclude participation in a physical activity and dietary intervention
Gender: female n = 58, male n = 3
Age: 52 ± 9 years
Type of cancer:
Breast: intervention 24 (80%), control 22 (73%)
Gynecological: intervention 0 (0%), control 4 (13%)
Hematological: intervention 2 (7%), control 2 (7%)
Genitourinary: intervention 1 (3%), control 1 (3%)
Gastrointestinal: intervention 1 (3%), control 1 (3%)
Sarcoma: intervention 2 (7%), control 0 (0%)
Therapy previously received for cancer:
Chemotherapy: intervention 19 (63%), control 21 (70%)
Radiation: intervention 22 (73%), control 18 (60%)
Hormone: intervention 20 (67%), control 22 (73%)
Cancer stage: NR
Ethnicity:
White:intervention 26 (87%), control 26 (87%)
Black: intervention 2 (7%), control 1 (3%)
Other: intervention 2 (7%), control 3 (10%)
Education:
High school or less: intervention 1 (3%), control 4 (13%)
Some college: intervention 5 (17%), control 5 (17%)
College degree or more: intervention 24 (80%), control 21 (70%)
Interventions Comparison: weight loss intervention vs wait-list control
Intervention: weight loss intervention participated in a 15-week, in-person, group-based pro-
gramme that was led by a health coach with a background in nutrition and an exercise physiolo-
gist. Behavioural content of the programme described herein was modelled after the Lifestyle In-
tervention in Adjuvant Treatment of Early Breast Cancer (LISA) study
Control: wait-list control
Outcomes Primary aim of the study was to evaluate the efficacy of the intervention in lowering body mass. Se-
condary aims of the study were to evaluate effects of the intervention on body composition, physi-
cal fitness, and concentrations of serum biomarkers linked to cancer risk and prognosis




Methods Design: pilot randomised controlled trial
Parekh 2018 
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Participants Number randomised: 59
Inclusion: 18+ years of age; diagnosed with breast cancer; speak, read, and understand English flu-
ently; completed prescribed treatment (surgery, chemotherapy, and/or radiation therapy) within
the previous 6 months at the Perlmutter Cancer Center. Willing to attend all scheduled data collec-
tion visits, to complete questionnaires, and to attend educational sessions
Exclusion: pregnant women and women with a poor prognosis (survival < 6 months per oncolo-
gist)
Gender: female
Age: mean 57.7 years
Type of cancer: breast
Therapy previously received for cancer: NR
Cancer stage: NR
Ethnicity:
Asian: intervention 1 (3.6), control 2 (6.5)
Black or African American: intervention 8 (28.6), control 5 (16.1)
White: intervention 19 (67.9), control 21 (67.7)
American Indian/Alaskan Native: intervention 0, control 2 (6.5)
Other race: intervention 0, control 1 (3.2)
Education:
Did not complete high school: intervention 0, control 0
High school: intervention 2 (7.1), control 0
Some college: intervention 7 (25.0), control 9 (29.0)
Bachelor’s degree: intervention 7 (25.0), control 11 (35.5)
Master’s degree: intervention 11 (39.3), control 11 (35.5)
PhD: intervention 1 (3.6), control 0
Interventions Comparison: 6 nutritional education sessions vs brochure information
Intervention: nutrition literacy training curriculum education on breast cancer and nutrition in the
context of the disease, over a period of 3 months (6 sessions; 12 hours in total)
Control: nutrition information brochures developed by the American Institute for Cancer Research
for cancer survivors
Outcomes Nutrition literacy: assessment instrument for breast cancer patients (NLit-BCa) was administered at
baseline and at completion of the study
Fruit and vegetable intake: estimated using a validated block screener that ranks individuals with
regard to consumption
Parekh 2018  (Continued)
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Height and body weight: measured by standard procedures using a stadiometer; weight was mea-
sured by standard procedures using a digital weighing scale
Health literacy: Newest Vital Sign (NVS) tool was developed by Pfizer Inc. and is a validated method
to assess health literacy




Methods Design: 2-arm randomised controlled trial
Accrual dates: NR
Trial Reg: NR
Participants Number randomised: 153
Inclusion: overweight and obese (BMI ≥ 25 kg/m2), early-stage (0 to III), English-speaking breast
cancer survivors who had completed their treatment 2 or more months before study enrolment
Exclusion: NR
Gender: female
Age: intervention: mean (SD) 55.3 ± 10.3 years; control: mean (SD) 58.4 ± 8.2 years
Type of cancer: breast
Therapy previously received for cancer:
Surgery: intervention 57 (95.0), control 60 (92.3)
Chemotherapy: intervention 37 (61.7), control 45 (69.2)
Radiation: intervention 38 (63.3), control 39 (60.0)
Hormonal therapy: intervention 16 (26.7), control 26 (40.0)
Antibody therapy: intervention 6 (10.0), control 7 (10.8)
Reconstruction: intervention 23 (38.3), control 25 (38.5)
Cancer stage:
Stage 0: intervention 5 (8.3), control 7 (10.8)
Stage 1: intervention 18 (30.0), control 17 (26.2)
Stage 2: intervention 20 (33.3), control 18 (27.7)
Stage 3: intervention 8 (13.3), control 13 (20.0)
Don’t know: intervention 9 (15.0), control 10 (15.4)
Ethnicity:
Anglo: intervention 25 (41.7), control 28 (43.1)
Latino: intervention 31 (51.7), control 33 (50.8)
Other: intervention 4 (6.7), control 4 (6.2)
Zuniga 2019 
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Education:
High school graduate or less: intervention 9 (15.0), control 7 (10.8)
Some college/Assoc degree: intervention 24 (40.0), control 17 (26.2)
College graduate or higher: intervention 27 (45.0), control 41 (63.1)
Interventions Comparison: individualised anti-inflammatory dietary vs standard care
Intervention: individualised anti-inflammatory dietary prescriptions and behaviour change cues
through 6 monthly workshops (culinary demonstrations, recipes, and meal planning), reinforced
by evidence- and theory-based patient navigation, motivational interviewing, and tailored newslet-
ters personalised to individual readiness for change
Control: minimal nutritional information at baseline, monthly American Institute for Cancer Re-
search informational brochures, and 2 telephone calls before assessment appointments
Outcomes Anthropometric data:
Questionnaires for Barriers to Care, social support, depression scale (CES-D), coping self-esteem,
family health history, health Behaviour change, Cancer Worry Scale, FACT-G, FACT-B (Breast Can-
cer Functional Assessment of Cancer Therapy Scale), self-efficacy, IPAQ short (last 7 days), PSS-14




Notes Funding: supported by Susan G. Komen (SAB08-0005); Redes en Accion: The National Latino Can-
cer Research Network (U54CA153511); the Institute for Health Promotion Research at UT Health
San Antonio; and the UT Health San Antonio Mays Cancer Center through the NCI Cancer Center
Support Grant (P30 CA054174)
Zuniga 2019  (Continued)
BMI: body mass index.
CES-D: Center for Epidemiologic Studies Depression Scale.
ECOG: Eastern Cooperative Oncology Group.
FACT-B: Functional Assessment of Cancer Therapy - Breast.
FACT-G: Functional Assessment of Cancer Therapy - General.
IPAQ: International Physical Activity Questionnaire.
NR: not reported.
PSS-14: Perceived Stress Scale.
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Diet and physical activity change or usual care in improving survival in patients with previously
treated stage II, III, or IV ovarian, fallopian tube, or primary peritoneal cancer
Methods Randomised phase III trial
Participants Patients with previously treated stage II, III, or IV ovarian, fallopian tube, or primary peritoneal can-
cer. After treatment, participants will be randomised to either healthy lifestyle counselling or usual
care
Interventions Group 1: (lifestyle intervention) Participants receive a dietary intervention designed to promote
increased levels of plasma carotenoids, to control weight, and to ensure adequacy of micronutri-
ent intake. Participants also undergo a physical activity intervention comprising a moderately low
Alberts 2008 
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aerobic regimen, face-to-face counselling on how to read food labels to estimate grams of fat per
serving, and telephone counselling by a lifestyle intervention counsellor once a week for 4 weeks,
then twice a month for 6 months, monthly for the subsequent 6 months, and then once every oth-
er month for 11 months. Participants complete daily fat gram and step diaries at least 3 times per
week
GROUP 2: (comparison lifestyle) Participants receive a study notebook containing general study-
related information. Participants are not asked to record diet or physical activity but are provided
a single sample diary in their study notebook. Participants receive telephone contact on a sliding
scale similar to the intervention group, but at less frequent intervals (22 vs 33 calls over the course
of the intervention)
After completion of the study, participants are followed every 3 months for 2 years, every 6 months
for 3 years, and then annually thereafter
Outcomes Biomarkers (e.g. total carotenoid), survival, compliance, QoL, bowel function, sleep duration/quali-
ty, anthropometry, dietary intake, telomere length
Biomarkers to be measured at baseline and at 6, 12, and 24 months. After completion of the study,
participants are followed every 3 months for 2 years, every 6 months for 3 years, and then annually
thereafter
Starting date July 2008





Trial name or title The women’s wellness after cancer program: a multi-site, single-blinded, randomised controlled
trial protocol
Methods Single-blinded, multi-centre, randomised controlled trial
Participants Women treated for blood, breast, and gynaecological cancer within 24 months of completion of
chemotherapy (primary or adjuvant) and/or radiotherapy
Interventions Intervention: comprises an evidence-based interactive iBook and journal, web interface, and vir-
tual health consultations by an experienced cancer nurse trained in delivery of the WWACP. The
12-week intervention focuses on evidence-based health education and health promotion after a
cancer diagnosis, incorporating promotion of physical activity, good diet, smoking cessation, and
reduction of alcohol intake, plus strategies for sleep and stress management. The programme is
based on Bandura’s social-cognitive theoretical framework
Control: usual care
Outcomes The primary outcome is health-related quality of life, as measured by the Functional Assessment of
Cancer Therapy - General (FACT-G). Secondary outcomes are menopausal symptoms as assessed
by the Greene Climacteric Scale; physical activity elicited with the Physical Activity Questionnaire
Short Form (IPAQ-SF); sleep measured by the Pittsburgh Sleep Quality Index; habitual dietary in-
take monitored with the Food Frequency Questionnaire (FFQ); alcohol intake and tobacco use
measured by the Australian Health Survey and anthropometric measures including height, weight,
and waist-to-hip ratio. All participants were assessed with these measures at baseline (at the start
of the intervention), at 12 weeks (at completion of the intervention), and at 24 months (to deter-
mine the level of sustained behaviour change)
Anderson 2017 
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Starting date 21/10/2014
Contact information Prof Debra Anderson
School of Nursing and Midwifery
Griffith University / Menzies Health Institute









Trial name or title Promotion of healthy lifestyle and risk modification for cancer survivors and their partners/care-
givers (ENRICH: exercise and nutrition routine improving cancer health)
Methods A wait-list randomised controlled trial
Participants Patients who have been diagnosed with cancer of any type and have completed all active treat-
ment. Participants are either cancer survivors or carers
Interventions The ENRICH intervention provides education and information for participants to set up their own
home-based walking programme with pedometer, their own resistance training programme with
Gymstick (exercise stick with elastic tubing), and healthy diet info provided via 6 face-to-face, 2-
hour sessions, over an 8-week period
The wait-list control group will receive the intervention after the programme has been evaluated
Outcomes Physical activity, self-reported step counts, fruit and vegetable intake, BMI, waist circumference,
social support levels, QoL, mediators of physical activity changes
Outcome measures at baseline and at 8 weeks (endpoint), 20 weeks, and 12 months
Starting date December 2009
Contact information Ms Garielle Asprey
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Trial name or title Effect of the new Norwegian food-based dietary guidelines on chronic diseases in colorectal cancer
Methods Parallel randomised controlled trial
Participants Patients diagnosed with colorectal cancer stage I to III, who have finished cancer treatment and are
50 to 75 years of age. Participants are randomised to an intensive dietary intervention, based on
the new Norwegian food-based dietary guidelines; in addition, focus is placed on foods that have
been shown to inhibit inflammation or oxidative stress
Interventions The intervention will aid participants in undertaking a diet based on the new Norwegian food-
based dietary guidelines. This will include access to clinical nutritionists, free food, food discounts,
cooking courses, cookbook/recipes, study website, and organised physical activity
The control group will receive counselling on physical activity only
Outcomes Biomarkers of comorbid conditions, oxidative stress and inflammation, compliance tested by bio-
markers in blood, physical function, grip strength, physical activity level, dietary pattern
Outcomes measured at baseline and at 6 months and 12 months
Starting date March 2012






Trial name or title Prevention of breast cancer recurrence through weight control, diet, and physical activity interven-
tion (PREDICOP)
Methods Randomised controlled trial
Participants Breast cancer patients with stage I, II, IIIA (or T1-3, N0-N2, M0) at diagnosis, randomised to interven-
tion or control group
Interventions Intervention group: lifestyle intervention combining weight control, diet, and physical activity
Control group: minimal diet intervention and minimal physical activity intervention
Outcomes Time frame: 5 years from recruitment day
Primary outcome measures: time to local and distant recurrence
Secondary outcome measures: overall survival, disease-free survival, quality of life (time frame:
baseline, 1 year, and 3 years)
Other outcome measures: changes in biomarkers (time frame: baseline and 1 year )
Starting date January 2014
Contact information Contact: Antonio Agudo, MD, PhD; +34 932607401; a.agudo@iconcologia.net
Contact: Noemie Travier, MSc; +34 932607401; ntravier@iconcologia.net
Cirauqui 2014 
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Trial name or title Harvesting health programme in improving diet and physical activity level in cancer survivors
Methods Pilot clinical trial with single group assignment
Participants Cancer survivors who have completed cancer treatment within the previous 12 months. Partici-
pants must have a computer, Internet access, and an active email account
Interventions Intervention arm: supportive care (Harvesting Health Programme). Participants undergo a series of
10 educational and training sessions over 1 hour every 2 weeks, comprising education on current
research, evidence-based health guidelines, application techniques, reference materials specific to
extended-stage cancer survivors, and recommendations and personal health goals for survivorship
Outcomes Behaviour change, biomarker levels assessed by values for the health and wellness index, diet,
physical activity, QoL
Outcomes measured from baseline up to 12 months
Starting date October 2014
Contact information Steven Clinton





Trial name or title Internet-based weight loss program for colorectal cancer survivors.
Methods Randomised phase I wait-list trial
Participants Patients who have survived colorectal cancer (stage I to III) and completed treatment up to 10
years ago. Participants must have no current evidence of cancer and must have access to the Inter-
net at home or at work
Interventions Arm I (12-week Internet-based weight loss intervention): patients attend an in-person 60-minute
session with a health educator. The health educator will provide basic weight loss advice according
to established guidelines and advice on diet modification to reduce calorie intake. The health edu-
cator will also recommend gradual increase in physical activity and will help patients set a realistic
target weight to achieve at the end of the 12-week intervention period. The health educator will in-
troduce the participant to the intervention website and will assist in setting up access. Participants
are given a 1-page written summary on how to use the website. Participants are advised to log in to
the website twice a week during the 12-week intervention period
Arm II (wait-list control): patients are instructed to continue their usual dietary and physical activ-
ity routines during a 12-week period. After the waiting period, patients receive the Internet-based
weight loss intervention for 12 weeks as in arm I
Outcomes Patients in both arms complete surveys at baseline and at 12 months to assess sociodemographics,
disease and treatment characteristics, prior Internet experience, depressive symptoms, weight, di-
Coups 2009 
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eting and weight loss experiences, weight loss expectations, physical activity, and dietary outcome
expectancies
Patients in arm II complete an additional follow-up survey at 24 weeks
Starting date December 2009
Contact information Elliot Coups





Trial name or title  




Participants Age 50 years or older; resident of Alabama, Mississippi, North Carolina, or Tennessee in the United
States; diagnosed with multiple myeloma or localised kidney or ovarian cancer; or (localised (in-
cludes in situ) through regional) breast, colorectum, endometrium, or prostate cancer
Interventions Participants will participate in 1 of 3 arms
1. Diet followed by exercise intervention
2. Exercise followed by diet intervention
3. Wait-list control followed by combined diet and exercise intervention
Outcomes Primary outcomes:
Change in dietary quality and intake (patient-reported outcome)
Change in body weight
Change in physical activity and sleep
Physical activity and sleep will be measured objectively via blank screen accelerometers, which are
small devices (1 × 2 inches) that will be worn at the waist during waking hours and switched to a
wrist band during sleep for a 7-day period at each assessment point
Secondary outcomes:
Change in waist circumference
Waist circumference
Change in muscle mass
To assess muscle mass, 3 days before home assessment, participants will take a capsule containing
deuterium-labelled creatine (creatine is a substance commonly found in protein-containing foods,
and deuterium is a naturally occurring element), administration of which is proven as safe with sev-
eral studies conducted in humans across the lifespan from pre-term infants to elders
Demark-Wahnefried 2019 
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Change in physical performance
Participants will complete the Senior Fitness Battery during in-person assessments, which includes
chair stands, 3-metre walk, sit-to-stand, reaching (stretching exercises of the arms and legs), and
the 2-minute step test
Change in physical activity (patient-reported outcome)
Physical activity will be measured via validated questionnaires (e.g. the Godin Leisure Time Exer-
cise Questionnaire)
Change in quality of life (patient-reported outcome)
Participants will complete questionnaires (PROMIS Cancer-Related Item Bank and Short Form-12)
to self-report quality of life
Change in healthcare utilisation (patient-reported outcome)
Participants will complete a healthcare utilisation survey to capture physician and emergency
room visits and hospitalisations
Starting date June 2019






Trial name or title An Internet-based weight loss and exercise intervention for breast cancer survivors (iWEB)
Methods Single-arm intervention of a 24-week weight loss and exercise intervention
Participants Survivors of breast cancer who have completed all treatment 2 to 12 months before study initia-
tion. BMI between 27 and 50 kg/m2 with access to a computer and the Internet
Interventions Patients will participate in weekly online chats about behavioural and diet modifications led by a
qualified facilitator. Participants will also engage in increasing amounts of aerobic activity through-
out the course of the intervention. The intervention will last 6 months, and diet and body measures
will be taken at baseline and at the end
Outcomes Diet measures to work out total calorie and fat intake, anthropometrics (weight, BMI, body fat %),
active energy expenditure, inflammatory biomarkers
Outcomes measured at baseline and at 6 months (intervention endpoint)
Starting date July 2012





Dietary interventions for adult cancer survivors (Review)









Cochrane Database of Systematic Reviews
Trial name or title Virtual weight loss programme in maintaining weight in African American breast cancer survivors
Methods Randomised controlled trial
Participants Breast cancer survivors with previous invasive carcinoma at stage IA to IIIC, randomised to control
or intervention group
Interventions Experimental: group I (SparkPeople programme). Patients receive one 30-minute session with the
research assistant for training on how to use the SparkPeople website, and may request additional
training if needed. Patients are instructed to self-monitor their diet at least weekly using SparkPeo-
ple and physical activity levels daily using the Fitbit monitoring device, which integrates with the
SparkPeople programme. Patients receive weekly motivational reminders to log into the website
for 3 months via email, text, or phone, based on patient preference (active phase). Patients then
enter the maintenance phase for an additional 3 months without reminders
Active comparator: group II (wait-list). Patients receive the weight loss handout and a Fitbit health
monitoring device and proceed with their usual life. After 6 months, patients receive the SparkPeo-
ple treatment as in Group I
Outcomes Time frame: up to 12 months
Primary outcome measures: changes in weight, recruitment, retention rate
Secondary outcome measures: changes in caloric intake, in cardio-metabolic risk factors, in car-
diopulmonary fitness, in physical activity, in quality of life for social-cognitive theory variables
Patient feedback on programme, as measured by semi-structured interview
Starting date May 2015
Contact information Principal Investigator: Jeanne Ferrante, 732-743-3222; Rutgers Cancer Institute of New Jersey, New





Trial name or title STRIDE (Steps Toward Improving Diet and Exercise): an online lifestyle intervention for cancer sur-
vivors living in South Australia
Methods Parallel randomised controlled trial
Participants Women and men with any type of cancer (except skin cancer) treated with curative intent. Not un-
dergoing any active treatment at point of recruitment
Interventions Intervention participants will take part in a 12-week lifestyle programme, during which they will
wear a pedometer and will use an online resource. The main focus of the online resource is a step
log, where participants enter their daily step counts, perceptions of exertion, and feelings daily.
Based on this information, they will be emailed weekly step count goals. The website will also in-
clude a virtual notice board, where community service organisers can advertise events and activi-
ties related to physical activity and healthy eating. Info on healthy eating will be provided based on
the cancer council Australian nutrition guidelines, which supports the recommendations provided
in the Australian Guide to Healthy Eating
Outcomes Adherence measured by logins to the website and follow-up telephone calls every 2 weeks, anthro-
pometry, physical and psychological health data, physical activity, QoL, dietary habits
Frensham 2013 
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Outcomes measured at baseline and at endpoint (12 weeks)
Starting date April 2013
Contact information Miss Lauren Frensham, University of South Australia, GPO Box 2417, Adelaide SA 5001, Australia






Trial name or title Exercise, diet, and counselling in improving weight loss in overweight female breast or colorectal
cancer survivors
Methods 12-month phase II single group assignment trial
Participants Women with a previous diagnosis of stage I, II, or III invasive breast cancer or colorectal cancer with
no evidence of the disease at the time of registration. Participants must have a BMI of 25 kg/m2
or above and must be willing to attend the Curves fitness centre at least 3 times per week for 12
months
Interventions Participants are instructed to practice 30 to 45 minutes of medium-hard exercise 5 to 7 days a week
at a Curves fitness centre or outside Curves for 12 months. Participants receive written materials
on physical activity guidelines and the Curves fitness and weight management plan and are in-
structed to follow a higher carb diet plan, which promotes a 1500-kcal/d diet that is high in fruits
and vegetables consisting of 30% protein, 45% carbohydrates, and 25% fat. In addition, partici-
pants receive the dietary guidelines for cancer survivors, which recommend eating 5 or more serv-
ings of fruit/vegetables per day or a diet that is high in whole grains, low in sat fat, low in sugary
foods, and low in alcohol. Participants receive 14 behavioural counselling sessions by telephone
with the goal of increasing intervention adherence and participant retention. Each session lasts 40
minutes and occurs weekly on weeks 1 to 5 and then every 6 weeks by month 6. Participants also
receive monthly email newsletters with health tips and motivational messages
Outcomes Dietary intake, QoL, anthropometric measures, body fay %, biomarkers
Outcomes measured at baseline and at 6 months and 12 months. Further participant follow-up at
24 and 36 months
Starting date October 2011





Trial name or title  
Methods Design: pilot randomised controlled trial retrospective
Country: Ireland
Groarke 2018 
Dietary interventions for adult cancer survivors (Review)









Cochrane Database of Systematic Reviews
Accrual dates: NR
Trial Reg: ISRCTN18676721
Participants Overweight/obese cancer survivors
Interventions The study is employing a 2 groups (experimental and control) x 3 time points (baseline, 3 months,
6 months) mixed analysis of variance design to investigate the impact of a personalised solution
(wear a Fitbit activity monitor, using a personalised dietary or physical activity intervention that
will employ an educational component along with a shared decision-making and goal-setting mod-
el) vs standard care on primary and secondary health outcomes
Outcomes Primary outcomes:
Average daily step count, measured via Fitbit device continuously for 6 months
BMI and weight
Secondary outcomes:
Sleep quality, measured via Fitbit device continuously for 6 months
The following measures are recorded
Physical fitness, measured using 6-minute walk test - resting HR, BP, SpO2, recovery HR, BP, SpO2
Dietary behaviour, measured using Food Frequency Questionnaire
General health status (MOS SF-36; Ware et al, 2000), fatigue (Mendoza, Wang, Cleeland, et al., 1999),
self-efficacy (Schwarzer & Jerusalem, 2010), exercise self-efficacy (Bandura, 2006), exercise-related
social support (Sallis et al, 1987)
Starting date August 2017





Trial name or title ASCOT: lifestyle study for cancer survivors
Methods Randomised controlled trial, single randomisation only
Participants Patients who received a diagnosis of breast, colorectal, or prostate cancer in 2012/2013, and who
express an interest in taking part in a trial of a lifestyle programme from 7 NHS Trusts across Lon-
don and Essex
Interventions Intervention group: the ‘Healthy Habits for Life’ intervention consists of a self-guided printed book-
let designed to help cancer survivors make healthy lifestyle behaviours habitual. Participants re-
ceive a telephone call from a researcher who will talk participants through the printed booklet, to
check understanding, and to answer any questions and encourage engagement with the material
Usual care group: did not receive any specific advice
Outcomes Time frame: 0, 3, and 6 months
Primary outcome measures: composite health behaviour risk index
Heinrich 2015 
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Secondary outcome measures: alcohol; dietary intake, physical activity, quality of life, sleep, smok-
ing status
Starting date February 2015





Trial name or title Diet and physical activity intervention in CRC survivors
Methods A 12-month phase II feasibility trial
Participants Both males and females with histologically proven colorectal adenocarcinoma and within 1 year of
completion of main cancer treatment
Interventions Participants will be randomised in a 2 x 2 factorial design for 2 targeted behaviours prescribed over
12 months:
Dietary intervention to meet the target of (1) < 5 servings of red/processed meat weekly; < 2 serv-
ings would be processed meat 2.2 servings of refined grains daily
Physical activity intervention with the following targets: (1) general health target - 30 minutes of
moderate to vigorous physical activity (MVPA) 5 days per week (i.e. 10 MET-hours/week); (b) cancer
outcome target - 60 minutes of MVPA 5 days per week (i.e. 18 to 20 MET-hours/week)
Meeting both dietary and physical activity target interventions
No Intervention: usual care - following general lifestyle advice in accordance with the recommen-
dations of the Department of Health in Hong Kong available in the public domain
Primary outcome measure is whether target levels of PA and dietary intake could be met at the end
of the intervention
Outcomes Outcomes were measured at 6, 12, 18, and 24 months:
Physical activity, dietary changes, rates of compliance, determinants of compliance, facilitators
and barriers to intervention, measurement of theoretical constructs underlying physical activity,
dietary interventions
Outcomes measured post intervention only at 12 and 24 months:
Body composition, physical fitness, quality of life
Starting date October 2012





Trial name or title Lifestyle, exercise, and nutrition study 2 (LEAN 2)
Irwin 2014 
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Methods A parallel randomised controlled trial
Participants Those with a diagnosis of breast cancer - American Joint Committee on Cancer (AJCC) stages 0 to
IIIC, with BMI > 25 kg/m2
Completed surgery, chemotherapy, and radiation at least 2 months ago and physically able to exer-
cise
Interventions Intervention arm: intervention will be based on the Diabetes Prevention Program weight loss pro-
gramme, which uses a combination of reduced caloric intake, increased physical activity, and be-
haviour therapy. Content of the weight loss programme will be similar for the in-person and tele-
phone interventions, but the approach will vary (i.e. in-person vs telephone counselling). Partici-
pants will be taught diet, exercise, and behaviour change strategies via the telephone (weekly calls
for month 1, every other week for months 2 and 3, and monthly for months 4 to 6). All lessons and
diet and physical activity logs will be mailed to participants at the beginning of the programme.
Participants will record their daily diet and exercise in the logs
Control arm: usual care/wait-list - at 6 months, participants in the wait-list group may choose to
participate in the 11 sessions either in-person or via telephone or a combination of the two modes
of delivery. They will also be offered the opportunity to return to Yale at 12 months (immediately
after the end of the 6-month counselling sessions) to have weight and DEXA measured
Outcomes BMI, weight, height, body fat percentage, hormones, physical activity, dietary intake
All outcomes are measured at baseline and at 6 months
Starting date April 2014







Trial name or title Weight loss referral for healthier survivorship in obese stage I and II endometrial cancer survivors
or atypical hyperplasia
Methods Pilot clinical trial with single group assignment
Participants Women with a history of stage I or II endometrial cancer or a diagnosis of complex atypical hyper-
plasia and a BMI of at least 30 kg/m2
Interventions Patients are referred to a weight loss specialist for assistance with weight loss, and medical chart
reviews are performed at baseline and every 3 months for 24 months
Outcomes Accrual with intervention defined as number of patients who agree to participate, compliance with
intervention, weight loss, compliance with lifestyle changes, incidence of obesity, progression-free
survival, overall survival, recurrence rate, level of functioning, quality of life, and symptoms
Outcomes are collected at baseline, at 12 months, and at 24 months. Patients are also contacted at
90 days to determine whether they have initiated any weight loss interventions
Starting date January 2015
Jernigan 2015 
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Trial name or title Get healthy after breast cancer - examining the feasibility and acceptability of referring breast can-
cer survivors to the NSW ‘Get Healthy Service’ – a telephone-delivered programme targeting physi-
cal activity, healthy diet, and weight loss
Methods A single-group feasibility study
Participants Females, aged 18 to 75 years, with a first diagnosis of stage I to III breast cancer (unilateral or bilat-
eral). To have completed primary treatment with curative intent (i.e. initial surgery, chemothera-
py, radiation therapy) within the past 12 months (endocrine or targeted therapies may be ongoing).
Scheduled to return to the breast cancer clinic where they were recruited into the study for a fol-
low-up appointment within approximately 6 months of starting the study
Interventions Participants will receive 6 months of telephone counselling from the 'NSW Get Healthy Information
and Coaching Service' (GHS). The GHS is a free telephone counselling programme designed to help
participants increase their physical activity, improve their diet, and achieve and maintain a healthy
weight. Participants receive up to 10 coaching calls, with an average duration of 13 minutes, over
a period of 6 months (up to 6 calls during the first 12 weeks, and up to 4 calls in the remaining 14
weeks). GHS health coaches are all university qualified health professionals, such as psychologists,
nurses, dietitians, exercise physiologists, sports scientists, social workers, and physiotherapists.
They receive further training to ensure they meet the requirements of the GHS
Outcomes GHS uptake and number of calls (from GHS records), women’s satisfaction with the GHS, weight, di-
etary intake, physical activity, quality of life, fatigue, depression, body image, menopausal symp-
toms
Outcomes measured at baseline and at 6 months (endpoint)
Starting date January 2014
Contact information Dr Sheleigh Lawler, The University of Queensland, School of Population Health, Cancer Prevention
Research Centre, Level 4 Public Health Building, Herston Road, HERSTON, QLD, 4006, Australia






Trial name or title Lifestyle change, self-management, and problem-solving in daily life in cancer survivors; an online
portal for change and support
Methods Parallel randomised controlled trial
Participants Patients who were previously diagnosed with cancer and successfully completed the main treat-
ment period, up to 1 year ago
Lechner 2012 
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Interventions Cancer survivors in the experimental group who enter the online portal to receive general infor-
mation on dealing with distress, obtaining social support, self-managing disease, and optimising
healthy lifestyles. They are free to fill out a questionnaire on personal needs, which will lead them
to tailored advice about the mentioned topics. Also information about possible other helpful inter-
ventions and social workers is provided. Cancer survivors in the experimental group are free to en-
ter the online portal as often as they want during 1 year
The wait-list control group will be provided with access to the online intervention after the last
measurement
Outcomes Psychosocial distress, anxiety and depression, quality of life, physical activity, smoking behaviour,
alcohol consumption, dietary behaviour, habit strength, self-management, empowerment, per-
ceived social support, perceived peer support
All outcomes are measured at baseline and at 3, 6, and 12 months
Starting date March 2012





Trial name or title Healthy living after cancer: weight management pilot study
Methods A 16-week crossover randomised controlled trial
Participants History of any malignancy and completed all adjuvant surgery, chemotherapy, and/or radiation at
least 1 month before study enrolment (patients receiving ongoing hormonal or biologic therapy are
eligible to participate). BMI > 25 kg/m2 and ECOG performance status of 0 or 1. Physically able to
exercise and physician consent to start a weight loss programme
Interventions Immediate weight loss programme group: patients will also be provided with exercise and dietary
goals to implement at home. The programme consists of 16 sessions focused on reducing calories
and increasing exercise. Sample goals of the programme include reducing weight by 1 or 2 pounds
per week and increasing exercise to at least 150 minutes of moderate exercise (such as walking) per
week. Weight loss sessions will take place once per week for 16 weeks at Dana-Farber. The partici-
pant will meet with a dietitian and an exercise specialist weekly during the sessions to set diet and
exercise goals for the week. Each session will consist of discussion of a diet and/or exercise topic
for 30 minutes and 30 minutes of group exercise. The participant will also be given a pedometer to
help keep track of his/her exercise, a cookbook with low-calorie recipes, and a journal to keep track
of their exercise and the food eaten each day. The participant will bring the journal to each weight
loss session to review with study staG
Delayed Weight Loss Programme Group - will take part in the weight loss intervention after the 16-
week control period
Outcomes Weight, anthropometrics, QoL, physical activity, body image
Assessment of outcomes will occur at baseline (pre-randomisation), at the end of the 16-week in-
tervention or control period, and at 32 weeks
Starting date October 2013
Contact information Dr Jennifer Ligibel, Dana-Farber Cancer Institute
jligibel@partners.org
Ligibel 2013 
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Trial name or title My lifestyle intervention of food and exercise (MyLIFE)
Methods Parallel randomised controlled trial
Participants Female patients, age 21 to 65 with a history of stage 1, 2, or 3 breast cancer. To have completed pri-
mary treatments (chemotherapy, radiation, and/or surgical treatment) for breast cancer (with or
without maintenance therapy) within the last 3 months to 5 years of providing consent. Be will-
ing/able to attend groups and assessments in Gainesville or Jacksonville. BMI of 27 to 45 kg/m2 and
weight-stable (i.e. not lost/gained ≥ 10 lbs in the preceding 6 months, or since the end of primary
treatment)
Interventions Tailored lifestyle intervention (TLI) - participants randomised to the TLI condition will receive a 3-
month weight management programme tailored to the specific needs of women in remission from
breast cancer
Commercial Weight Loss Programme (CWLP) - participants randomised to the CWLP condition will
receive a 3-month commercial weight loss programme (i.e. Weight Watchers) at no cost
Outcomes Body weight, inflammatory/metabolic disease markers associated with breast cancer recurrence,
HDL cholesterol, blood glucose control, caloric intake, body composition, waist circumference,
sagittal abdominal diameter, physical activity, health-related quality of life, self-efficacy to abstain
from eating, frequency of participants' utilisation of specific weight management strategies, sys-
tolic and diastolic blood pressure
Outcomes measured at baseline, at 3 months, and at 9 months
Starting date June 2012







Trial name or title  




Participants Men or women with a history of breast cancer who have completed treatment ≥ 6 months ago (not
including hormonal therapy, Zometa, or other non-chemotherapy/radiation cancer treatment at
the discretion of the principal investigator)
O'Connor 2018 
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Interventions This trial studies how well exercise and nutritional education work in improving physical function
and quality of life in older breast cancer survivors
GROUP I (ACTIVE TREATMENT): participants complete a home-based aerobic and resistance exer-
cise programme and receive nutrition education for 12 weeks
GROUP II (WAITLIST): participants are placed on a wait-list for 12 weeks and then complete a home-
based aerobic and resistance exercise programme and receive nutrition education for 12 weeks
Outcomes Primary outcomes:
Activity levels for all participants will be collected using the Fitbit applications and a weekly activity
log
Quality of life as assessed by the Self-Geriatric Assessment Measure (GA-Self-Assessment)
Secondary outcomes:
Diet quality as assessed by the ASA24 website
Sleep as assessed by the Pittsburgh Sleep Quality Index (PSQI)
The PSQI measures the quality and pattern of sleep in adults. There are 19 items. Each item is
weighted on a 0 to 3 interval scale
Anxiety and the effect of a home-based aerobic and resistance exercise and nutrition education in-
tervention questionnaire
19-item questionnaire that measures the stages of the self-determination continuum with respect
to motivation to exercise
Centers for Epidemiologic Studies Depression Scale (CESD-R)
Starting date November 2018





Trial name or title A lifestyle intervention for breast cancer survivors
Methods A 4-month parallel randomised controlled trial
Participants Women diagnosed with stage 0 to 2 breast cancer in the past 1.5 years. Must have received no pri-
or adjuvant treatment for another cancer. Can read and write English and not participating in other
health behaviour research upon recruitment
Interventions Participants will be assigned randomly to 1 of 3 groups: (1) newly developed mail-based inter-
vention (Targeting the Teachable Moment Intervention; TTMI), (2) standard lifestyle intervention
(SLM), and (3) usual care. Both TTMI and SLM focus on health behaviours; however TTMI additional-
ly addresses psychosocial issues specific to breast cancer survivors
All participants will complete questionnaires at the time they start the study, at the end of 4
months, and 3 months later for a follow-up
Park 2013 
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If participants are assigned to any of the intervention groups, they will receive materials every oth-
er week for 4 months. If participants are assigned to the usual care group, they will receive the
same materials as the standard lifestyle intervention et the end of the 7 months
Outcomes Eating habits, physical activity, coping strategies, self-efficacy, social support, life meaning
Outcome measures at baseline, 4 months, and 7 months
Starting date April 2011





Trial name or title A randomized controlled trial of diet, physical activity, and breast cancer recurrences - the DIANA-5
study
Methods A multi-centre randomised controlled trial
Participants 2000 breast cancer patients at high risk of recurrence are being randomised to 2 groups. Compli-
ance is being monitored through weight and hormonal-metabolic change. The main analysis will
be done by intention-to-treat
Interventions Of the 2000 patients, 1000 received the WCRF Decalogue for dietary prevention of cancer, and 1000
received an active support (kitchen courses, physical activity classes, and common meals)
Outcomes Body weight and triglycerides
Starting date 2012






Trial name or title Weight management among breast cancer survivors
Methods Single-group intervention trial
Participants Women who had a breast cancer diagnosis (self-reported) 2 or more years ago. Last cancer treat-
ment (including surgery, radiation, or chemotherapy (self-reported)) was 6 or more months ago.
Current ownership of an iOS or an Android-based platform smart phone and home Wi-Fi. Ability to
speak and read in English. Overweight or obese (body mass index ≥ 25)
Interventions Experimental: mHealth Platform, the primary interventions employed in the study are Wi-Fi en-
abled tracking devices, text message communications, and behavioral counselling
The mHealth intervention for cancer survivors devised by the investigators consists of several com-
ponents: (1) a commercially available smart phone app that captures patients' behavioural data
(steps, sleep, weight) using devices (a FitBit and a FitBit scale), (2) text messages to participants to
Quintiliani 2015 
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collect additional data (foods eaten, eating habits), and (3) phone sessions with a non-profession-
ally trained health counsellor about diet and physical activity behaviours
Investigators propose to test feasibility and preliminary outcomes on weight, behaviours, psycho-
logical factors, and participant engagement in the intervention of our mHealth counselling inter-
vention among 20 breast cancer survivors
Outcomes Body weight, steps per day, diet Intake, sleep, engagement with the intervention from baseline, fre-
quency of diet intake tracking
Starting date February 2015







Trial name or title Protein-sparing modified fast intervention for weight loss in obese endometrial cancer survivors
Methods A pilot single-group study
Participants Patients previously diagnosed with endometrial cancer and successfully treated through surgery.
Body mass index (BMI) > 30 kg/m2 and > 8 weeks removed from surgery to treat the endometrial
cancer
Interventions This pilot clinical trial studies protein-sparing modified fast (PSMF) intervention for weight loss in
obese endometrial cancer survivors. The PSMF is a diet that is very low in carbohydrates and calo-
ries and is designed to induce fast, safe weight loss. The diet consists of only lean meats (beef, pork,
poultry, and seafood) in amounts adequate to meet protein requirements based on the individual's
body weight
Experimental: supportive care (PSMF). Participants will take part in a Protein-Sparing Modified Fast
(PSMF) intervention for weight loss. Participants will undergo a dietary intervention high in protein
for 6 weeks, or until they have lost 15% of their body weight. This intervention will be followed by
weight maintenance, during which participants will reintroduce non-starchy vegetables to their di-
et. At this time, participants will also receive informational material and dietary education, which
teaches participants how to read nutrition labels and calculate carbohydrate loads in foods. Partic-
ipants are given the Obesity and Weight-Loss Quality of Life Questionnaire to survey the impact of
the intervention
Outcomes Weight loss, cholesterol and triglycerides, markers of inflammation (C-reactive protein, interleukin
6), glucose, number of dropouts, percentage of positive urinary ketone tests as a marker of dietary
adherence, adverse events, quality of life
After completion of the study, participants are followed up at 2 weeks and at 4 weeks, and then at
2, 3, 4, 5, and 6 months
Starting date May 2014
Contact information Kimberly Resnick, Case Comprehensive Cancer Center, USA
216 844 3954
Resnick 2014 
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AJCC: American Joint Committee on Cancer.
BMI: body mass index.
BP: blood pressure.
CESD-R: Center for Epidemiologic Studies Depression Scale Revised.
CWLP: commercial weight loss programme.
ECOG: Eastern Cooperative Oncology Group.
FACT-G: Functional Assessment of Cancer Therapy - General.
FFQ: Food Frequency Questionnaire.
HDL: high-density lipoprotein.
HR: heart rate.
IPAQ-SF: International Physical Activity Questionnaire Short Form.
MET: metabolic equivalent.
MOS SF-36: Medical Outcomes Study Short Form Health Survey.
MVPA: moderate to vigorous physical activity.
PA: physical activity.
PSMF: protein-sparing modified fast.
PSQI: Pittsburgh Sleep Quality Index.
QoL: quality of life.
SLM: standard lifestyle method.
SpO2: peripheral capillary oxygen saturation.
TLI: tailored lifestyle intervention.
TTMI: Targeting the Teachable Moment intervention.
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Overall survival





Statistical method Effect size
1 Mortality 1   Hazard Ratio (Fixed, 95% CI) 0.98 [0.77, 1.23]
2 Morbidity 1   Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Number of cancer events 1 3107 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.84, 1.15]
 
 
Analysis 1.1.   Comparison 1 Overall survival, Outcome 1 Mortality.




Hazard Ratio Weight Hazard Ratio
  N N (SE) IV, Fixed, 95% CI   IV, Fixed, 95% CI
Pierce 2007 0 0 -0 (0.119) 100% 0.98[0.77,1.23]
   
Total (95% CI)       100% 0.98[0.77,1.23]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.21(P=0.84)  
Favours intervention 1 Favours control
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Analysis 1.2.   Comparison 1 Overall survival, Outcome 2 Morbidity.
Study or subgroup Dietary in-
tervention
Usual Care Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
1.2.1 Number of cancer events  
Pierce 2007 256/1546 262/1561 100% 0.99[0.84,1.15]
Subtotal (95% CI) 1546 1561 100% 0.99[0.84,1.15]
Total events: 256 (Dietary intervention), 262 (Usual Care)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.17(P=0.87)  
Dietary intervention 20.5 1.50.7 1 Usual care
 
 
Comparison 2.   Dietary changes





Statistical method Effect size
1 Mean energy intake (kcal) 7   Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 Energy intake (kcal) at 3
months
3 115 Mean Difference (IV, Random, 95% CI) -52.61 [-209.23,
104.02]
1.2 Energy intake (kcal) at 6
months
4 3236 Mean Difference (IV, Random, 95% CI) -47.67 [-142.33, 46.99]
1.3 Energy intake (kcal) at
12 months
5 3283 Mean Difference (IV, Random, 95% CI) -59.13 [-156.05, 37.79]
2 Adjusted mean energy in-
take (kcal)
1   Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Energy intake (kcal) at 3
months
1 67 Mean Difference (IV, Random, 95% CI) -637.0 [-819.79,
-454.21]
2.2 Energy intake (kcal) at 6
months
1 61 Mean Difference (IV, Random, 95% CI) -548.1 [-753.22,
-342.98]
3 Subgroup analysis energy
intake (kcal) BMI > 25 kg/m2
at 3 months
2 97 Mean Difference (IV, Random, 95% CI) -51.81 [-283.08,
179.45]
4 Subgroup analysis energy
intake (kcal) BMI > 25 kg/m2
at 6 months
2 93 Mean Difference (IV, Random, 95% CI) -49.00 [-269.75,
171.74]
5 Mean fruit servings (per
day)
3   Mean Difference (IV, Random, 95% CI) Subtotals only
5.1 Fruit servings (per day)
at 3 months
1 67 Mean Difference (IV, Random, 95% CI) 0.10 [-0.82, 1.02]
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Statistical method Effect size
5.2 Fruit servings (per day)
at 6 months
2 3157 Mean Difference (IV, Random, 95% CI) 0.62 [0.08, 1.16]
5.3 Fruit servings (per day)
at 12 months
3 3205 Mean Difference (IV, Random, 95% CI) 0.47 [-0.13, 1.07]
6 Fruit servings for each
cancer site at 6 months
2   Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 Uterine cancer 1 69 Mean Difference (IV, Random, 95% CI) 0.20 [-0.57, 0.97]
6.2 Breast cancer 1 3088 Mean Difference (IV, Random, 95% CI) 0.80 [0.58, 1.02]
7 Fruit servings for each
cancer site at 12 months
3   Mean Difference (IV, Random, 95% CI) Subtotals only
7.1 Uterine cancer 1 59 Mean Difference (IV, Random, 95% CI) 0.30 [-0.80, 1.40]
7.2 Breast cancer 2 3146 Mean Difference (IV, Random, 95% CI) 0.46 [-0.40, 1.31]
8 Fruit servings in different
ethnic groups: breast can-
cer at 12 months
2   Mean Difference (IV, Random, 95% CI) Subtotals only
8.1 Hispanic population 1 58 Mean Difference (IV, Random, 95% CI) -0.10 [-0.98, 0.78]
8.2 Mixed (85% white) popu-
lation
1 3088 Mean Difference (IV, Random, 95% CI) 0.80 [0.64, 0.96]
9 Adjusted mean vegetable
servings (per day)
1   Mean Difference (IV, Random, 95% CI) Subtotals only
9.1 Vegetable servings (per
day) at 3 months
1 67 Mean Difference (IV, Random, 95% CI) 0.60 [-0.23, 1.43]
9.2 Vegetable servings (per
day) at 6 months
1 61 Mean Difference (IV, Random, 95% CI) 0.80 [-0.03, 1.63]
9.3 Vegetable servings (per
day) at 12 months
1 58 Mean Difference (IV, Random, 95% CI) 1.10 [0.35, 1.85]
10 Vegatable servings: uter-
ine cancer
1   Mean Difference (IV, Random, 95% CI) Subtotals only
10.1 Vegatable intake at 3
months
1 67 Mean Difference (IV, Random, 95% CI) 1.20 [0.00, 2.40]
10.2 Vegatable intake at 6
months
1 69 Mean Difference (IV, Random, 95% CI) 0.80 [-0.37, 1.97]
10.3 Vegatable intake at 12
months
1 59 Mean Difference (IV, Random, 95% CI) 0.30 [-0.85, 1.45]
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Statistical method Effect size
11 Vegatable servings:
breast cancer
2   Mean Difference (IV, Random, 95% CI) Subtotals only
11.1 Vegetable intake at 3
months
1 30 Mean Difference (IV, Random, 95% CI) 3.7 [2.64, 4.76]
11.2 Vegetable intake at 6
months
1 3088 Mean Difference (IV, Random, 95% CI) 4.5 [4.49, 4.51]
11.3 Vegetable intake at 12
months
1 3088 Mean Difference (IV, Random, 95% CI) 3.90 [3.89, 3.91]
12 Mean fruit and vegetable
servings (per day)
5   Mean Difference (IV, Random, 95% CI) Subtotals only
12.1 Fruit and vegetable
servings (per day) at 3
months
1 67 Mean Difference (IV, Random, 95% CI) 1.20 [-0.24, 2.64]
12.2 Fruit and vegetable
servings (per day) at 6
months
3 276 Mean Difference (IV, Random, 95% CI) 0.45 [-0.04, 0.94]
12.3 Fruit and vegetable
servings (per day) at 12
months
5 834 Mean Difference (IV, Random, 95% CI) 0.41 [0.10, 0.71]
13 Adjusted mean fruit and
vegetable servings (per day)
1   Mean Difference (IV, Random, 95% CI) Subtotals only
13.1 Fruit and vegetable
servings (per day) at 3
months
1 67 Mean Difference (IV, Random, 95% CI) 0.20 [-0.91, 1.31]
13.2 Fruit and vegetable
servings (per day) at 6
months
1 61 Mean Difference (IV, Random, 95% CI) 1.10 [-0.01, 2.21]
14 Fibre 3   Mean Difference (IV, Random, 95% CI) Subtotals only
14.1 Fibre intake at 3
months
1 18 Mean Difference (IV, Random, 95% CI) 6.0 [0.73, 11.27]
14.2 Fibre intake at 6
months
2 3127 Mean Difference (IV, Random, 95% CI) 4.79 [-4.72, 14.29]
14.3 Fibre intake at 12
months
2 3127 Mean Difference (IV, Random, 95% CI) 5.12 [-0.66, 10.90]
15 Fibre intake in partici-
pants on weight reduction
1   Mean Difference (IV, Random, 95% CI) Subtotals only
15.1 6 months 1 39 Mean Difference (IV, Random, 95% CI) -0.20 [-3.52, 3.12]
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Statistical method Effect size
15.2 12 months 1 39 Mean Difference (IV, Random, 95% CI) 2.10 [0.24, 3.96]
16 Fibre intake in partic-
ipants advised on health
eating
1   Mean Difference (IV, Random, 95% CI) Subtotals only
16.1 6 months 1 3088 Mean Difference (IV, Random, 95% CI) 9.5 [8.52, 10.48]
16.2 12 months 1 3088 Mean Difference (IV, Random, 95% CI) 8.0 [7.30, 8.70]
17 Diet Quality Index 3   Mean Difference (IV, Random, 95% CI) Subtotals only
17.1 Diet Quality Index at 6
months
1 182 Mean Difference (IV, Random, 95% CI) 5.20 [1.04, 9.36]
17.2 Diet Quality Index at 12
months
3 747 Mean Difference (IV, Random, 95% CI) 3.46 [1.54, 5.38]
18 Diet Quality Index 1 45 Std. Mean Difference (IV, Random, 95% CI) 0.90 [0.29, 1.52]
 
 
Analysis 2.1.   Comparison 2 Dietary changes, Outcome 1 Mean energy intake (kcal).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.1.1 Energy intake (kcal) at 3 months  
Bourke 2011 9 1755 (395) 9 1802 (361) 20.07% -47[-396.6,302.6]
Gruenigen 2012 41 1553 (449) 26 1724 (533) 40.31% -171[-417.7,75.7]
Zick 2017 15 1665 (359) 15 1600 (336) 39.62% 65[-183.83,313.83]
Subtotal *** 65   50   100% -52.61[-209.23,104.02]
Heterogeneity: Tau2=0; Chi2=1.74, df=2(P=0.42); I2=0%  
Test for overall effect: Z=0.66(P=0.51)  
   
2.1.2 Energy intake (kcal) at 6 months  
Demark-Wahnefried 2014 23 1195 (365) 17 1337 (452) 11.17% -142[-403.57,119.57]
Greenlee 2013 22 912 (416) 17 1030 (354) 12.74% -118[-359.94,123.94]
Gruenigen 2012 41 1635 (579) 28 1845 (625) 9.26% -210[-501.55,81.55]
Pierce 2007 1537 1619 (549) 1551 1615 (591) 66.83% 4[-36.23,44.23]
Subtotal *** 1623   1613   100% -47.67[-142.33,46.99]
Heterogeneity: Tau2=3069.15; Chi2=3.98, df=3(P=0.26); I2=24.62%  
Test for overall effect: Z=0.99(P=0.32)  
   
2.1.3 Energy intake (kcal) at 12 months  
Demark-Wahnefried 2014 23 1189 (429) 17 1400 (487) 9.1% -211[-501.4,79.4]
Greenlee 2013 21 1100 (267) 17 1065 (252) 20.29% 35[-130.5,200.5]





Gruenigen 2012 35 1607 (496) 24 1807 (632) 8.55% -200[-501.55,101.55]
Pierce 2007 1537 1603 (392) 1551 1605 (433) 47.56% -2[-31.13,27.13]
Dietary intervention 1000500-1000 -500 0 Usual care
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Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Subtotal *** 1645   1638   100% -59.13[-156.05,37.79]
Heterogeneity: Tau2=4921.1; Chi2=6.94, df=4(P=0.14); I2=42.35%  
Test for overall effect: Z=1.2(P=0.23)  
Dietary intervention 1000500-1000 -500 0 Usual care
 
 
Analysis 2.2.   Comparison 2 Dietary changes, Outcome 2 Adjusted mean energy intake (kcal).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.2.1 Energy intake (kcal) at 3 months  





Subtotal *** 31   36   100% -637[-819.79,-454.21]
Heterogeneity: Not applicable  
Test for overall effect: Z=6.83(P<0.0001)  
   
2.2.2 Energy intake (kcal) at 6 months  





Subtotal *** 30   31   100% -548.1[-753.22,-342.98]
Heterogeneity: Not applicable  
Test for overall effect: Z=5.24(P<0.0001)  
Dietary intervention 1000500-1000 -500 0 Usual care
 
 
Analysis 2.3.   Comparison 2 Dietary changes, Outcome 3 Subgroup
analysis energy intake (kcal) BMI > 25 kg/m2 at 3 months.
Study or subgroup Dietary in-
tervention
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Gruenigen 2012 41 1553 (449) 26 1724 (553) 49.5% -171[-424.12,82.12]
Zick 2017 15 1665 (359) 15 1600 (336) 50.5% 65[-183.83,313.83]
   
Total *** 56   41   100% -51.81[-283.08,179.45]
Heterogeneity: Tau2=11449.28; Chi2=1.7, df=1(P=0.19); I2=41.11%  
Test for overall effect: Z=0.44(P=0.66)  
Dietary intervention 500250-500 -250 0 Control
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Analysis 2.4.   Comparison 2 Dietary changes, Outcome 4 Subgroup
analysis energy intake (kcal) BMI > 25 kg/m2 at 6 months.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Greenlee 2013 17 1100 (267) 17 1065 (252) 64.25% 35[-139.52,209.52]
Gruenigen 2012 35 1607 (496) 24 1807 (632) 35.75% -200[-501.55,101.55]
   
Total *** 52   41   100% -49[-269.75,171.74]
Heterogeneity: Tau2=11812.15; Chi2=1.75, df=1(P=0.19); I2=42.78%  
Test for overall effect: Z=0.44(P=0.66)  
Dietary intervention 500250-500 -250 0 control
 
 
Analysis 2.5.   Comparison 2 Dietary changes, Outcome 5 Mean fruit servings (per day).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.5.1 Fruit servings (per day) at 3 months  
Gruenigen 2012 41 2.1 (2) 26 2 (1.8) 100% 0.1[-0.82,1.02]
Subtotal *** 41   26   100% 0.1[-0.82,1.02]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.21(P=0.83)  
   
2.5.2 Fruit servings (per day) at 6 months  
Gruenigen 2012 41 1.9 (1.6) 28 1.7 (1.6) 30.41% 0.2[-0.57,0.97]
Pierce 2007 1537 4.4 (3.1) 1551 3.6 (3.2) 69.59% 0.8[0.58,1.02]
Subtotal *** 1578   1579   100% 0.62[0.08,1.16]
Heterogeneity: Tau2=0.1; Chi2=2.16, df=1(P=0.14); I2=53.69%  
Test for overall effect: Z=2.24(P=0.03)  
   
2.5.3 Fruit servings (per day) at 12 months  
Greenlee 2015 29 2.7 (1.5) 29 2.8 (1.9) 25.58% -0.1[-0.98,0.78]
Gruenigen 2012 35 2.1 (2.5) 24 1.8 (1.8) 19.62% 0.3[-0.8,1.4]
Pierce 2007 1537 4.2 (2.4) 1551 3.4 (2) 54.8% 0.8[0.64,0.96]
Subtotal *** 1601   1604   100% 0.47[-0.13,1.07]
Heterogeneity: Tau2=0.17; Chi2=4.59, df=2(P=0.1); I2=56.39%  
Test for overall effect: Z=1.54(P=0.12)  
Usual care 10.5-1 -0.5 0 Dietary intervention
 
 
Analysis 2.6.   Comparison 2 Dietary changes, Outcome 6 Fruit servings for each cancer site at 6 months.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.6.1 Uterine cancer  
Gruenigen 2012 41 1.9 (1.6) 28 1.7 (1.6) 100% 0.2[-0.57,0.97]
Subtotal *** 41   28   100% 0.2[-0.57,0.97]
Heterogeneity: Not applicable  
Usual care 10.5-1 -0.5 0 Dietary intervention
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Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Test for overall effect: Z=0.51(P=0.61)  
   
2.6.2 Breast cancer  
Pierce 2007 1537 4.4 (3.1) 1551 3.6 (3.2) 100% 0.8[0.58,1.02]
Subtotal *** 1537   1551   100% 0.8[0.58,1.02]
Heterogeneity: Not applicable  
Test for overall effect: Z=7.06(P<0.0001)  
Test for subgroup differences: Chi2=2.16, df=1 (P=0.14), I2=53.69%  
Usual care 10.5-1 -0.5 0 Dietary intervention
 
 
Analysis 2.7.   Comparison 2 Dietary changes, Outcome 7 Fruit servings for each cancer site at 12 months.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.7.1 Uterine cancer  
Gruenigen 2012 35 2.1 (2.5) 24 1.8 (1.8) 100% 0.3[-0.8,1.4]
Subtotal *** 35   24   100% 0.3[-0.8,1.4]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.54(P=0.59)  
   
2.7.2 Breast cancer  
Greenlee 2015 29 2.7 (1.5) 29 2.8 (1.9) 37.92% -0.1[-0.98,0.78]
Pierce 2007 1537 4.2 (2.4) 1551 3.4 (2) 62.08% 0.8[0.64,0.96]
Subtotal *** 1566   1580   100% 0.46[-0.4,1.31]
Heterogeneity: Tau2=0.3; Chi2=3.89, df=1(P=0.05); I2=74.27%  
Test for overall effect: Z=1.05(P=0.29)  
Usual care 52.5-5 -2.5 0 Dietary intervention
 
 
Analysis 2.8.   Comparison 2 Dietary changes, Outcome 8 Fruit
servings in di7erent ethnic groups: breast cancer at 12 months.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.8.1 Hispanic population  
Greenlee 2015 29 2.7 (1.5) 29 2.8 (1.9) 100% -0.1[-0.98,0.78]
Subtotal *** 29   29   100% -0.1[-0.98,0.78]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.22(P=0.82)  
   
2.8.2 Mixed (85% white) population  
Pierce 2007 1537 4.2 (2.4) 1551 3.4 (2) 100% 0.8[0.64,0.96]
Subtotal *** 1537   1551   100% 0.8[0.64,0.96]
Heterogeneity: Not applicable  
Test for overall effect: Z=10.06(P<0.0001)  
Usual care 10.5-1 -0.5 0 Dietary intervention
Dietary interventions for adult cancer survivors (Review)









Cochrane Database of Systematic Reviews
 
 
Analysis 2.9.   Comparison 2 Dietary changes, Outcome 9 Adjusted mean vegetable servings (per day).
Study or subgroup Dietary intake Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.9.1 Vegetable servings (per day) at 3 months  
Greenlee 2015 31 3.4 (1.7) 36 2.8 (1.8) 100% 0.6[-0.23,1.43]
Subtotal *** 31   36   100% 0.6[-0.23,1.43]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.41(P=0.16)  
   
2.9.2 Vegetable servings (per day) at 6 months  
Greenlee 2015 30 4.1 (1.6) 31 3.3 (1.7) 100% 0.8[-0.03,1.63]
Subtotal *** 30   31   100% 0.8[-0.03,1.63]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.89(P=0.06)  
   
2.9.3 Vegetable servings (per day) at 12 months  
Greenlee 2015 29 4.1 (1.4) 29 3 (1.5) 100% 1.1[0.35,1.85]
Subtotal *** 29   29   100% 1.1[0.35,1.85]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.89(P=0)  
Usual care 21-2 -1 0 Dietary intervention
 
 
Analysis 2.10.   Comparison 2 Dietary changes, Outcome 10 Vegatable servings: uterine cancer.
Study or subgroup Intervention Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.10.1 Vegatable intake at 3 months  
Gruenigen 2012 41 4.2 (2.9) 26 3 (2.1) 100% 1.2[0,2.4]
Subtotal *** 41   26   100% 1.2[0,2.4]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.96(P=0.05)  
   
2.10.2 Vegatable intake at 6 months  
Gruenigen 2012 41 4 (2.5) 28 3.2 (2.4) 100% 0.8[-0.37,1.97]
Subtotal *** 41   28   100% 0.8[-0.37,1.97]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.34(P=0.18)  
   
2.10.3 Vegatable intake at 12 months  
Gruenigen 2012 35 3.7 (2.5) 24 3.4 (2) 100% 0.3[-0.85,1.45]
Subtotal *** 35   24   100% 0.3[-0.85,1.45]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.51(P=0.61)  
control 21-2 -1 0 intervetion
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Analysis 2.11.   Comparison 2 Dietary changes, Outcome 11 Vegatable servings: breast cancer.
Study or subgroup Experimental Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.11.1 Vegetable intake at 3 months  
Zick 2017 15 5.7 (1.9) 15 2 (0.9) 100% 3.7[2.64,4.76]
Subtotal *** 15   15   100% 3.7[2.64,4.76]
Heterogeneity: Not applicable  
Test for overall effect: Z=6.82(P<0.0001)  
   
2.11.2 Vegetable intake at 6 months  
Pierce 2007 1537 8.4 (0.1) 1551 3.9 (0.1) 100% 4.5[4.49,4.51]
Subtotal *** 1537   1551   100% 4.5[4.49,4.51]
Heterogeneity: Not applicable  
Test for overall effect: Z=1196.09(P<0.0001)  
   
2.11.3 Vegetable intake at 12 months  
Pierce 2007 1537 7.8 (0.1) 1551 3.9 (0.1) 100% 3.9[3.89,3.91]
Subtotal *** 1537   1551   100% 3.9[3.89,3.91]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1486.66(P<0.0001)  
control 2010-20 -10 0 intervention
 
 
Analysis 2.12.   Comparison 2 Dietary changes, Outcome 12 Mean fruit and vegetable servings (per day).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.12.1 Fruit and vegetable servings (per day) at 3 months  
Gruenigen 2012 41 6.2 (3.5) 26 5 (2.5) 100% 1.2[-0.24,2.64]
Subtotal *** 41   26   100% 1.2[-0.24,2.64]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.63(P=0.1)  
   
2.12.2 Fruit and vegetable servings (per day) at 6 months  
Demark-Wahnefried 2006 82 3.6 (2) 86 3.2 (1.8) 72.63% 0.4[-0.18,0.98]
Greenlee 2013 22 3.2 (2.5) 17 2.9 (1.3) 16.37% 0.3[-0.91,1.51]
Gruenigen 2012 41 5.9 (3.2) 28 4.9 (3) 10.99% 1[-0.48,2.48]
Subtotal *** 145   131   100% 0.45[-0.04,0.94]
Heterogeneity: Tau2=0; Chi2=0.62, df=2(P=0.73); I2=0%  
Test for overall effect: Z=1.79(P=0.07)  
   
2.12.3 Fruit and vegetable servings (per day) at 12 months  
Demark-Wahnefried 2006 77 3.5 (2.1) 83 3.6 (2.1) 22.21% -0.1[-0.75,0.55]
Demark-Wahnefried 2007 253 6.1 (2.8) 266 5.6 (2.6) 43.47% 0.5[0.03,0.97]
Greenlee 2013 21 3.3 (1.1) 17 2.8 (0.9) 23.29% 0.5[-0.14,1.14]
Greenlee 2015 29 6.8 (2.2) 29 5.8 (2.3) 7.02% 1[-0.16,2.16]
Gruenigen 2012 35 5.6 (3.6) 24 5 (2.4) 4.02% 0.6[-0.93,2.13]
Subtotal *** 415   419   100% 0.41[0.1,0.71]
Heterogeneity: Tau2=0; Chi2=3.63, df=4(P=0.46); I2=0%  
Test for overall effect: Z=2.59(P=0.01)  
Test for subgroup differences: Chi2=1.12, df=1 (P=0.57), I2=0%  
Usual care 21-2 -1 0 Dietary intervention
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Analysis 2.13.   Comparison 2 Dietary changes, Outcome 13 Adjusted mean fruit and vegetable servings (per day).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.13.1 Fruit and vegetable servings (per day) at 3 months  
Greenlee 2015 31 5.8 (2.2) 36 5.6 (2.4) 100% 0.2[-0.91,1.31]
Subtotal *** 31   36   100% 0.2[-0.91,1.31]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.35(P=0.72)  
   
2.13.2 Fruit and vegetable servings (per day) at 6 months  
Greenlee 2015 30 6.8 (2.2) 31 5.7 (2.2) 100% 1.1[-0.01,2.21]
Subtotal *** 30   31   100% 1.1[-0.01,2.21]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.94(P=0.05)  
Usual care 21-2 -1 0 Dietary intervention
 
 
Analysis 2.14.   Comparison 2 Dietary changes, Outcome 14 Fibre.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.14.1 Fibre intake at 3 months  
Bourke 2011 9 19 (7) 9 13 (4) 100% 6[0.73,11.27]
Subtotal *** 9   9   100% 6[0.73,11.27]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.23(P=0.03)  
   
2.14.2 Fibre intake at 6 months  
Greenlee 2013 22 10.3 (6.6) 17 10.5 (3.9) 48.61% -0.2[-3.52,3.12]
Pierce 2007 1537 30.9 (15.7) 1551 21.4 (11.8) 51.39% 9.5[8.52,10.48]
Subtotal *** 1559   1568   100% 4.79[-4.72,14.29]
Heterogeneity: Tau2=45.48; Chi2=30.11, df=1(P<0.0001); I2=96.68%  
Test for overall effect: Z=0.99(P=0.32)  
   
2.14.3 Fibre intake at 12 months  
Greenlee 2013 22 12.3 (3.6) 17 10.2 (2.3) 48.89% 2.1[0.24,3.96]
Pierce 2007 1537 29 (11) 1551 21 (8.7) 51.11% 8[7.3,8.7]
Subtotal *** 1559   1568   100% 5.12[-0.66,10.9]
Heterogeneity: Tau2=16.89; Chi2=33.89, df=1(P<0.0001); I2=97.05%  
Test for overall effect: Z=1.73(P=0.08)  
Control 105-10 -5 0 Dietary intervention
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Analysis 2.15.   Comparison 2 Dietary changes, Outcome 15 Fibre intake in participants on weight reduction.
Study or subgroup Dietary in-
tervention
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.15.1 6 months  
Greenlee 2013 22 10.3 (6.6) 17 10.5 (3.9) 100% -0.2[-3.52,3.12]
Subtotal *** 22   17   100% -0.2[-3.52,3.12]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.12(P=0.91)  
   
2.15.2 12 months  
Greenlee 2013 22 12.3 (3.6) 17 10.2 (2.3) 100% 2.1[0.24,3.96]
Subtotal *** 22   17   100% 2.1[0.24,3.96]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.21(P=0.03)  
Control 52.5-5 -2.5 0 Dietary intervention
 
 
Analysis 2.16.   Comparison 2 Dietary changes, Outcome 16 Fibre intake in participants advised on health eating.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.16.1 6 months  
Pierce 2007 1537 30.9 (15.7) 1551 21.4 (11.8) 100% 9.5[8.52,10.48]
Subtotal *** 1537   1551   100% 9.5[8.52,10.48]
Heterogeneity: Not applicable  
Test for overall effect: Z=19(P<0.0001)  
   
2.16.2 12 months  
Pierce 2007 1537 29 (11) 1551 21 (8.7) 100% 8[7.3,8.7]
Subtotal *** 1537   1551   100% 8[7.3,8.7]
Heterogeneity: Not applicable  
Test for overall effect: Z=22.48(P<0.0001)  
Dietary intervention 2010-20 -10 0 Control
 
 
Analysis 2.17.   Comparison 2 Dietary changes, Outcome 17 Diet Quality Index.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.17.1 Diet Quality Index at 6 months  
Demark-Wahnefried 2006 89 69.8 (13.9) 93 64.6 (14.7) 100% 5.2[1.04,9.36]
Subtotal *** 89   93   100% 5.2[1.04,9.36]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.45(P=0.01)  
   
2.17.2 Diet Quality Index at 12 months  
Demark-Wahnefried 2006 89 67.5 (13.6) 93 66.6 (13.1) 21.77% 0.9[-2.98,4.78]
Demark-Wahnefried 2007 253 72.8 (10.6) 266 68.7 (10.9) 69.97% 4.1[2.25,5.95]
Usual care 105-10 -5 0 Dietary intervention
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Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Demark-Wahnefried 2014 23 63.7 (11.9) 23 58.9 (10.7) 8.25% 4.8[-1.74,11.34]
Subtotal *** 365   382   100% 3.46[1.54,5.38]
Heterogeneity: Tau2=0.48; Chi2=2.27, df=2(P=0.32); I2=11.81%  
Test for overall effect: Z=3.53(P=0)  
Test for subgroup differences: Chi2=0.55, df=1 (P=0.46), I2=0%  
Usual care 105-10 -5 0 Dietary intervention
 
 
Analysis 2.18.   Comparison 2 Dietary changes, Outcome 18 Diet Quality Index.
Study or subgroup Dietary In-
tervention
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Kim 2011 23 6.1 (1.7) 22 4.6 (1.6) 100% 0.9[0.29,1.52]
   
Total *** 23   22   100% 0.9[0.29,1.52]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.87(P=0)  
Dietary Interention 21-2 -1 0 Control
 
 
Comparison 3.   Changes in anthropometry





Statistical method Effect size
1 Mean weight (kg) 10   Mean Difference (IV, Random,
95% CI)
Subtotals only
1.1 Weight at 3 months 6 247 Mean Difference (IV, Random,
95% CI)
-3.52 [-7.34, 0.29]
1.2 Weight at 6 months 3 190 Mean Difference (IV, Random,
95% CI)
-2.84 [-6.95, 1.28]
1.3 Weight at 12 months 5 3287 Mean Difference (IV, Random,
95% CI)
-0.80 [-2.01, 0.41]
2 Adjusted mean weight (kg) 1   Mean Difference (IV, Random,
95% CI)
Subtotals only
2.1 Weight at 6 months 1 55 Mean Difference (IV, Random,
95% CI)
-7.0 [-17.40, 3.40]
3 Weight change 2   Mean Difference (IV, Fixed,
95% CI)
Subtotals only
3.1 Weight change at 6 months 1 90 Mean Difference (IV, Fixed,
95% CI)
-3.6 [-5.56, -1.64]
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Statistical method Effect size
3.2 Weight change at 12 months 1 641 Mean Difference (IV, Fixed,
95% CI)
0.23 [-0.31, 0.77]
4 Adjusted mean body mass index (kg/m2) 1   Mean Difference (IV, Random,
95% CI)
Subtotals only
4.1 Body mass index at 6 months 1 53 Mean Difference (IV, Random,
95% CI)
-4.10 [-8.12, -0.08]
5 Mean body mass index (kg/m2) 10   Mean Difference (IV, Random,
95% CI)
Subtotals only
5.1 Body mass index at 3 months 6 247 Mean Difference (IV, Random,
95% CI)
-1.80 [-2.95, -0.65]
5.2 Body mass index at 6 months 1 168 Mean Difference (IV, Random,
95% CI)
-0.70 [-2.26, 0.86]
5.3 Body mass index at 12 months 4 777 Mean Difference (IV, Random,
95% CI)
-0.79 [-1.50, -0.07]
6 Mean difference body mass index (kg/m2) 2   Mean Difference (IV, Fixed,
95% CI)
Subtotals only
6.1 Body mass index at 6 months 1 410 Mean Difference (IV, Fixed,
95% CI)
-0.6 [-1.15, -0.05]
6.2 Body mass index at 12 months 2 1051 Mean Difference (IV, Fixed,
95% CI)
-0.44 [-0.64, -0.25]
7 Weight loss 1   Mean Difference (IV, Random,
95% CI)
Subtotals only
7.1 Weight loss at 3 months 1 170 Mean Difference (IV, Random,
95% CI)
1.0 [-0.47, 2.47]
7.2 Weight loss at 6 months 1 170 Mean Difference (IV, Random,
95% CI)
-1.60 [-3.06, -0.14]
8 Lean body tissue 1   Mean Difference (IV, Random,
95% CI)
Subtotals only
8.1 Lean body mass at 3 months 1 76 Mean Difference (IV, Random,
95% CI)
-0.30 [-2.41, 1.81]
9 Body fat percentage 2   Mean Difference (IV, Random,
95% CI)
Subtotals only
9.1 Body fat percentage at 3 months 2 99 Mean Difference (IV, Random,
95% CI)
-4.97 [-7.47, -2.48]
10 Change in body fat percentage 1   Mean Difference (IV, Random,
95% CI)
Subtotals only
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Statistical method Effect size
10.1 Change in body fat percentage at 6
months
1 39 Mean Difference (IV, Random,
95% CI)
-0.01 [-0.05, 0.03]
11 Mean waist-to-hip ratio 7   Mean Difference (IV, Random,
95% CI)
Subtotals only
11.1 Waist-to-hip ratio at 3 months 5 181 Mean Difference (IV, Random,
95% CI)
-0.03 [-0.06, 0.01]
11.2 Waist-to-hip ratio at 6 months 2 118 Mean Difference (IV, Random,
95% CI)
-0.02 [-0.05, 0.01]
11.3 Waist-to-hip ratio at 12 months 2 106 Mean Difference (IV, Random,
95% CI)
-0.01 [-0.04, 0.02]
12 Waist-to-hip ratio for each cancer site at 3
months
5   Mean Difference (IV, Random,
95% CI)
Subtotals only
12.1 Colon cancer 1 18 Mean Difference (IV, Random,
95% CI)
-0.11 [-0.17, -0.05]
12.2 Breast cancer 4 163 Mean Difference (IV, Random,
95% CI)
-0.01 [-0.02, 0.01]
13 Hip circumference change scores 2   Mean Difference (IV, Random,
95% CI)
Subtotals only
13.1 Hip circumference change at 3 months 1 44 Mean Difference (IV, Random,
95% CI)
1.81 [0.77, 2.85]
13.2 Hip circumference change at 6 months 2 134 Mean Difference (IV, Random,
95% CI)
-3.13 [-5.01, -1.26]
13.3 Hip circumference change at 12 months 1 44 Mean Difference (IV, Random,
95% CI)
1.09 [-1.69, 3.87]
14 Waist circumference change scores 2   Std. Mean Difference (IV, Ran-
dom, 95% CI)
Subtotals only
14.1 Waist circumference change at 3 months 1 44 Std. Mean Difference (IV, Ran-
dom, 95% CI)
-0.67 [-1.28, -0.06]
14.2 Waist circumference change at 6 months 2 134 Std. Mean Difference (IV, Ran-
dom, 95% CI)
-0.67 [-1.02, -0.32]
14.3 Waist circumference change at 12
months
1 44 Std. Mean Difference (IV, Ran-
dom, 95% CI)
-0.15 [-0.74, 0.44]
15 Adjusted mean waist circumference (cm) 1   Mean Difference (IV, Random,
95% CI)
Subtotals only
15.1 Waist circumference at 6 months 1 50 Mean Difference (IV, Random,
95% CI)
-3.90 [-11.11, 3.31]
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Statistical method Effect size
16 Mean hip circumference (cm) 2   Mean Difference (IV, Random,
95% CI)
Subtotals only
16.1 Hip circumference at 3 months 1 76 Mean Difference (IV, Random,
95% CI)
-5.40 [-10.06, -0.74]
16.2 Hip circumference at 6 months 1 50 Mean Difference (IV, Random,
95% CI)
-3.20 [-10.96, 4.56]
16.3 Hip circumference at 12 months 1 49 Mean Difference (IV, Random,
95% CI)
-4.0 [-11.43, 3.43]
17 Mean waist circumference (cm) 4   Mean Difference (IV, Random,
95% CI)
Subtotals only
17.1 Waist ratio at 3 months 2 143 Mean Difference (IV, Random,
95% CI)
-4.00 [-12.53, 4.53]
17.2 Waist ratio at 6 months 2 109 Mean Difference (IV, Random,
95% CI)
-0.33 [-4.79, 4.14]





Analysis 3.1.   Comparison 3 Changes in anthropometry, Outcome 1 Mean weight (kg).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.1.1 Weight at 3 months  
Bourke 2011 8 76 (9.9) 9 76.8 (11.8) 13.64% -0.8[-11.12,9.52]
Greenlee 2013 22 83 (10.1) 20 83.7 (13.5) 27.51% -0.7[-7.97,6.57]
Gruenigen 2012 41 93.2 (19.4) 26 93.2 (23.2) 12.66% 0[-10.71,10.71]
Mefferd 2007 47 78 (12.6) 29 85.8 (15) 33.96% -7.8[-14.34,-1.26]
Sheppard 2016 10 97.4 (20) 12 98 (19.5) 5.28% -0.6[-17.19,15.99]
Swisher 2015 13 77.2 (10.3) 10 85 (21.5) 6.95% -7.8[-22.25,6.65]
Subtotal *** 141   106   100% -3.52[-7.34,0.29]
Heterogeneity: Tau2=0; Chi2=3.36, df=5(P=0.64); I2=0%  
Test for overall effect: Z=1.81(P=0.07)  
   
3.1.2 Weight at 6 months  
Greenlee 2013 22 82.2 (9.4) 20 82.4 (12.8) 36.09% -0.2[-7.05,6.65]
Gruenigen 2012 41 91.8 (19.3) 28 94.6 (23.8) 15.03% -2.8[-13.41,7.81]
Scott 2013 41 76.3 (9.3) 38 81.1 (16.2) 48.87% -4.8[-10.69,1.09]
Subtotal *** 104   86   100% -2.84[-6.95,1.28]
Heterogeneity: Tau2=0; Chi2=1, df=2(P=0.61); I2=0%  
Test for overall effect: Z=1.35(P=0.18)  
   
3.1.3 Weight at 12 months  
Dietary intervention 2010-20 -10 0 Usual care
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Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Demark-Wahnefried 2014 23 79.7 (10.2) 17 80.7 (10.1) 3.62% -1[-7.36,5.36]
Greenlee 2013 22 83.3 (9.3) 20 81.7 (11.5) 3.62% 1.6[-4.76,7.96]
Greenlee 2015 29 74.2 (17.8) 29 78.1 (15.9) 1.94% -3.9[-12.59,4.79]
Gruenigen 2012 35 92.7 (20.1) 24 95.4 (25.4) 0.99% -2.7[-14.85,9.45]
Pierce 2007 1537 73 (17.7) 1551 73.8 (18.5) 89.83% -0.8[-2.08,0.48]
Subtotal *** 1646   1641   100% -0.8[-2.01,0.41]
Heterogeneity: Tau2=0; Chi2=1.13, df=4(P=0.89); I2=0%  
Test for overall effect: Z=1.29(P=0.2)  
Test for subgroup differences: Chi2=2.46, df=1 (P=0.29), I2=18.64%  
Dietary intervention 2010-20 -10 0 Usual care
 
 
Analysis 3.2.   Comparison 3 Changes in anthropometry, Outcome 2 Adjusted mean weight (kg).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.2.1 Weight at 6 months  
Greenlee 2015 28 74.3 (19.6) 27 81.3 (19.7) 100% -7[-17.4,3.4]
Subtotal *** 28   27   100% -7[-17.4,3.4]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.32(P=0.19)  
Dietary intervention 4020-40 -20 0 Usual care
 
 
Analysis 3.3.   Comparison 3 Changes in anthropometry, Outcome 3 Weight change.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
3.3.1 Weight change at 6 months  
Reeves 2017 45 -4.7 (4.6) 45 -1.1 (4.9) 100% -3.6[-5.56,-1.64]
Subtotal *** 45   45   100% -3.6[-5.56,-1.64]
Heterogeneity: Not applicable  
Test for overall effect: Z=3.59(P=0)  
   
3.3.2 Weight change at 12 months  
Morey 2009 319 -0.7 (3.4) 322 -0.9 (3.6) 100% 0.23[-0.31,0.77]
Subtotal *** 319   322   100% 0.23[-0.31,0.77]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.83(P=0.4)  
Dietary intervention 2010-20 -10 0 Control
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Analysis 3.4.   Comparison 3 Changes in anthropometry, Outcome 4 Adjusted mean body mass index (kg/m2).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.4.1 Body mass index at 6 months  
Greenlee 2015 27 29.1 (7.8) 26 33.2 (7.1) 100% -4.1[-8.12,-0.08]
Subtotal *** 27   26   100% -4.1[-8.12,-0.08]
Heterogeneity: Not applicable  
Test for overall effect: Z=2(P=0.05)  
Dietary intervention 105-10 -5 0 Usual care
 
 
Analysis 3.5.   Comparison 3 Changes in anthropometry, Outcome 5 Mean body mass index (kg/m2).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.5.1 Body mass index at 3 months  
Bourke 2011 8 26.5 (3.3) 9 26.8 (3.6) 12.31% -0.3[-3.58,2.98]
Mefferd 2007 47 28.7 (4.2) 29 31.2 (5.1) 27.1% -2.5[-4.71,-0.29]
Scott 2013 41 29 (3.4) 38 30.4 (5.4) 32.85% -1.4[-3.41,0.61]
Sheppard 2016 12 34 (5) 10 37 (8.7) 3.57% -3[-9.09,3.09]
Swisher 2015 13 29.3 (3.4) 10 32.2 (7.1) 5.81% -2.9[-7.67,1.87]
Zick 2017 15 27.2 (3.9) 15 29.1 (3.6) 18.36% -1.9[-4.59,0.79]
Subtotal *** 136   111   100% -1.8[-2.95,-0.65]
Heterogeneity: Tau2=0; Chi2=1.7, df=5(P=0.89); I2=0%  
Test for overall effect: Z=3.06(P=0)  
   
3.5.2 Body mass index at 6 months  
Demark-Wahnefried 2006 82 27.6 (5.3) 86 28.3 (5) 100% -0.7[-2.26,0.86]
Subtotal *** 82   86   100% -0.7[-2.26,0.86]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.88(P=0.38)  
   
3.5.3 Body mass index at 12 months  
Demark-Wahnefried 2006 77 27.6 (5.2) 83 28.7 (5.2) 19.6% -1.1[-2.71,0.51]
Demark-Wahnefried 2007 253 27.1 (5) 266 27.8 (5.3) 64.9% -0.7[-1.59,0.19]
Demark-Wahnefried 2014 23 30.1 (4) 17 30.4 (3.1) 10.52% -0.3[-2.5,1.9]
Greenlee 2015 29 29.9 (6.6) 29 31.6 (5.8) 4.98% -1.7[-4.9,1.5]
Subtotal *** 382   395   100% -0.79[-1.5,-0.07]
Heterogeneity: Tau2=0; Chi2=0.68, df=3(P=0.88); I2=0%  
Test for overall effect: Z=2.16(P=0.03)  
Test for subgroup differences: Chi2=2.33, df=1 (P=0.31), I2=14.29%  
Dietary intervention 52.5-5 -2.5 0 Usual care
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Analysis 3.6.   Comparison 3 Changes in anthropometry, Outcome 6 Mean di7erence body mass index (kg/m2).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
3.6.1 Body mass index at 6 months  
Hawkes 2013 205 0.1 (2.9) 205 0.7 (2.9) 100% -0.6[-1.15,-0.05]
Subtotal *** 205   205   100% -0.6[-1.15,-0.05]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.12(P=0.03)  
   
3.6.2 Body mass index at 12 months  
Hawkes 2013 205 0.4 (2.9) 205 1.3 (2.9) 12.39% -0.9[-1.45,-0.35]
Morey 2009 319 -0.7 (1.2) 322 -0.3 (1.4) 87.61% -0.38[-0.59,-0.17]
Subtotal *** 524   527   100% -0.44[-0.64,-0.25]
Heterogeneity: Tau2=0; Chi2=2.97, df=1(P=0.08); I2=66.32%  
Test for overall effect: Z=4.47(P<0.0001)  
Dietary intervention 21-2 -1 0 Control
 
 
Analysis 3.7.   Comparison 3 Changes in anthropometry, Outcome 7 Weight loss.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.7.1 Weight loss at 3 months  
Befort 2016 85 -12.2 (4.3) 85 -13.2 (5.4) 100% 1[-0.47,2.47]
Subtotal *** 85   85   100% 1[-0.47,2.47]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.34(P=0.18)  
   
3.7.2 Weight loss at 6 months  
Befort 2016 85 3.3 (4.8) 85 4.9 (4.9) 100% -1.6[-3.06,-0.14]
Subtotal *** 85   85   100% -1.6[-3.06,-0.14]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.15(P=0.03)  
Dietary intervention 105-10 -5 0 Control
 
 
Analysis 3.8.   Comparison 3 Changes in anthropometry, Outcome 8 Lean body tissue.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.8.1 Lean body mass at 3 months  
Mefferd 2007 47 40.7 (4.3) 29 41 (4.7) 100% -0.3[-2.41,1.81]
Subtotal *** 47   29   100% -0.3[-2.41,1.81]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.28(P=0.78)  
Dietary intervention 105-10 -5 0 Control
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Analysis 3.9.   Comparison 3 Changes in anthropometry, Outcome 9 Body fat percentage.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.9.1 Body fat percentage at 3 months  
Mefferd 2007 47 42.7 (7.1) 29 47.9 (6.2) 67.64% -5.2[-8.24,-2.16]
Swisher 2015 13 31.2 (5.6) 10 35.7 (5.1) 32.36% -4.5[-8.89,-0.11]
Subtotal *** 60   39   100% -4.97[-7.47,-2.48]
Heterogeneity: Tau2=0; Chi2=0.07, df=1(P=0.8); I2=0%  
Test for overall effect: Z=3.9(P<0.0001)  
Dietary intervention 2010-20 -10 0 Usual care
 
 
Analysis 3.10.   Comparison 3 Changes in anthropometry, Outcome 10 Change in body fat percentage.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.10.1 Change in body fat percentage at 6 months  
Greenlee 2013 22 -0 (0.1) 17 -0 (0) 100% -0.01[-0.05,0.03]
Subtotal *** 22   17   100% -0.01[-0.05,0.03]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.54(P=0.59)  
Dietary intervention 0.10.05-0.1 -0.05 0 control
 
 
Analysis 3.11.   Comparison 3 Changes in anthropometry, Outcome 11 Mean waist-to-hip ratio.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.11.1 Waist-to-hip ratio at 3 months  
Bourke 2011 9 0.8 (0.1) 9 0.9 (0.1) 15.57% -0.11[-0.17,-0.05]
Greenlee 2013 22 0 (0) 20 0 (0) 30.7% 0[-0.02,0.02]
Mefferd 2007 47 0.9 (0.1) 29 0.9 (0.1) 21.16% -0.03[-0.08,0.02]
Sheppard 2016 10 0.9 (0.1) 12 0.9 (0.1) 16.14% -0.01[-0.07,0.05]
Swisher 2015 13 0.9 (0.1) 10 0.9 (0.1) 16.43% -0.02[-0.08,0.04]
Subtotal *** 101   80   100% -0.03[-0.06,0.01]
Heterogeneity: Tau2=0; Chi2=10.93, df=4(P=0.03); I2=63.42%  
Test for overall effect: Z=1.6(P=0.11)  
   
3.11.2 Waist-to-hip ratio at 6 months  
Greenlee 2013 22 -0 (0.1) 17 -0 (0) 49.17% -0.01[-0.05,0.03]
Scott 2013 41 0.8 (0.1) 38 0.8 (0.1) 50.83% -0.03[-0.07,0.01]
Subtotal *** 63   55   100% -0.02[-0.05,0.01]
Heterogeneity: Tau2=0; Chi2=0.59, df=1(P=0.44); I2=0%  
Test for overall effect: Z=1.55(P=0.12)  
   
3.11.3 Waist-to-hip ratio at 12 months  
Greenlee 2013 21 -0 (0.1) 17 -0 (0) 62.21% -0.01[-0.05,0.03]
Greenlee 2015 33 0.9 (0.1) 35 0.9 (0.1) 37.79% 0[-0.05,0.05]
Dietary intervention 0.20.1-0.2 -0.1 0 Usual care
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Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Subtotal *** 54   52   100% -0.01[-0.04,0.02]
Heterogeneity: Tau2=0; Chi2=0.11, df=1(P=0.75); I2=0%  
Test for overall effect: Z=0.42(P=0.68)  
Test for subgroup differences: Chi2=0.99, df=1 (P=0.61), I2=0%  
Dietary intervention 0.20.1-0.2 -0.1 0 Usual care
 
 
Analysis 3.12.   Comparison 3 Changes in anthropometry,
Outcome 12 Waist-to-hip ratio for each cancer site at 3 months.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.12.1 Colon cancer  
Bourke 2011 9 0.8 (0.1) 9 0.9 (0.1) 100% -0.11[-0.17,-0.05]
Subtotal *** 9   9   100% -0.11[-0.17,-0.05]
Heterogeneity: Not applicable  
Test for overall effect: Z=3.33(P=0)  
   
3.12.2 Breast cancer  
Greenlee 2013 22 0 (0) 20 0 (0) 78.3% 0[-0.02,0.02]
Mefferd 2007 47 0.9 (0.1) 29 0.9 (0.1) 13.79% -0.03[-0.08,0.02]
Sheppard 2016 10 0.9 (0.9) 12 0.9 (0.1) 0.09% -0.01[-0.59,0.57]
Swisher 2015 13 0.9 (0.1) 10 0.9 (0.1) 7.82% -0.02[-0.08,0.04]
Subtotal *** 92   71   100% -0.01[-0.02,0.01]
Heterogeneity: Tau2=0; Chi2=1.6, df=3(P=0.66); I2=0%  
Test for overall effect: Z=0.65(P=0.51)  
Dietary intervention 0.50.25-0.5 -0.25 0 Usual care
 
 
Analysis 3.13.   Comparison 3 Changes in anthropometry, Outcome 13 Hip circumference change scores.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.13.1 Hip circumference change at 3 months  
Greenlee 2013 22 1.8 (2.1) 22 -0 (1.4) 100% 1.81[0.77,2.85]
Subtotal *** 22   22   100% 1.81[0.77,2.85]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=3.4(P=0)  
   
3.13.2 Hip circumference change at 6 months  
Greenlee 2013 22 -1.2 (5.6) 22 0.5 (4) 32.67% -1.76[-4.64,1.12]
Reeves 2017 45 -4.7 (3.7) 45 -0.9 (4.3) 67.33% -3.8[-5.46,-2.14]
Subtotal *** 67   67   100% -3.13[-5.01,-1.26]
Heterogeneity: Tau2=0.65; Chi2=1.45, df=1(P=0.23); I2=31.03%  
Test for overall effect: Z=3.28(P=0)  
   
Dietary intervention 105-10 -5 0 Control
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Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.13.3 Hip circumference change at 12 months  
Greenlee 2013 22 -0.9 (5.7) 22 -1.9 (3.4) 100% 1.09[-1.69,3.87]
Subtotal *** 22   22   100% 1.09[-1.69,3.87]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.77(P=0.44)  
Dietary intervention 105-10 -5 0 Control
 
 
Analysis 3.14.   Comparison 3 Changes in anthropometry, Outcome 14 Waist circumference change scores.
Study or subgroup Dietary in-
tervention
Usual care Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.14.1 Waist circumference change at 3 months  
Greenlee 2013 22 -1.9 (1.7) 22 0.2 (4) 100% -0.67[-1.28,-0.06]
Subtotal *** 22   22   100% -0.67[-1.28,-0.06]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.17(P=0.03)  
   
3.14.2 Waist circumference change at 6 months  
Greenlee 2013 22 -3.6 (4.8) 22 -1.3 (4.3) 33.7% -0.5[-1.1,0.1]
Reeves 2017 45 -3.6 (5.3) 45 0.6 (5.7) 66.3% -0.76[-1.19,-0.33]
Subtotal *** 67   67   100% -0.67[-1.02,-0.32]
Heterogeneity: Tau2=0; Chi2=0.47, df=1(P=0.49); I2=0%  
Test for overall effect: Z=3.77(P=0)  
   
3.14.3 Waist circumference change at 12 months  
Greenlee 2013 22 -3.1 (5) 22 -2.4 (3.7) 100% -0.15[-0.74,0.44]
Subtotal *** 22   22   100% -0.15[-0.74,0.44]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.5(P=0.61)  
Dietary intervention 21-2 -1 0 Control
 
 
Analysis 3.15.   Comparison 3 Changes in anthropometry, Outcome 15 Adjusted mean waist circumference (cm).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.15.1 Waist circumference at 6 months  
Greenlee 2015 25 94.9 (13) 25 98.8 (13) 100% -3.9[-11.11,3.31]
Subtotal *** 25   25   100% -3.9[-11.11,3.31]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.06(P=0.29)  
Dietary intervention 105-10 -5 0 Usual care
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Analysis 3.16.   Comparison 3 Changes in anthropometry, Outcome 16 Mean hip circumference (cm).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.16.1 Hip circumference at 3 months  
Mefferd 2007 47 110.3 (9.5) 29 115.7 (10.4) 100% -5.4[-10.06,-0.74]
Subtotal *** 47   29   100% -5.4[-10.06,-0.74]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.27(P=0.02)  
   
3.16.2 Hip circumference at 6 months  
Greenlee 2015 25 109.2 (14) 25 112.4 (14) 100% -3.2[-10.96,4.56]
Subtotal *** 25   25   100% -3.2[-10.96,4.56]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.81(P=0.42)  
   
3.16.3 Hip circumference at 12 months  
Greenlee 2015 23 108.7 (13.8) 26 112.7 (12.6) 100% -4[-11.43,3.43]
Subtotal *** 23   26   100% -4[-11.43,3.43]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.05(P=0.29)  
Dietary intervention 105-10 -5 0 Control
 
 
Analysis 3.17.   Comparison 3 Changes in anthropometry, Outcome 17 Mean waist circumference (cm).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
3.17.1 Waist ratio at 3 months  
Gruenigen 2012 41 105.4 (12.4) 26 104.9 (16.5) 48.18% 0.51[-6.88,7.9]
Mefferd 2007 47 94.8 (13.2) 29 103 (15) 51.82% -8.2[-14.84,-1.56]
Subtotal *** 88   55   100% -4[-12.53,4.53]
Heterogeneity: Tau2=25.08; Chi2=2.95, df=1(P=0.09); I2=66.12%  
Test for overall effect: Z=0.92(P=0.36)  
   
3.17.2 Waist ratio at 6 months  
Demark-Wahnefried 2014 23 92.6 (8.7) 17 93.8 (9.1) 63.59% -1.2[-6.8,4.4]
Gruenigen 2012 41 104.3 (15.4) 28 103.1 (15.4) 36.41% 1.2[-6.2,8.6]
Subtotal *** 64   45   100% -0.33[-4.79,4.14]
Heterogeneity: Tau2=0; Chi2=0.26, df=1(P=0.61); I2=0%  
Test for overall effect: Z=0.14(P=0.89)  
   
3.17.3 Waist ratio at 12 months  
Demark-Wahnefried 2014 23 90.7 (7.4) 17 93.7 (9.7) 44.61% -3[-8.51,2.51]
Greenlee 2015 23 92.8 (12.4) 26 100.3 (13) 29.45% -7.5[-14.62,-0.38]
Gruenigen 2012 35 104.3 (12.7) 24 103.6 (16) 25.95% 0.7[-6.96,8.36]
Subtotal *** 81   67   100% -3.36[-7.55,0.82]
Heterogeneity: Tau2=2.32; Chi2=2.4, df=2(P=0.3); I2=16.51%  
Test for overall effect: Z=1.57(P=0.12)  
Dietary intervention 105-10 -5 0 Control
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Comparison 4.   Quality of Life





Statistical method Effect size
1 FACT-G QoL 2   Mean Difference (IV, Fixed, 95%
CI)
Subtotals only
1.1 FACT-G at 6 months 1 168 Mean Difference (IV, Fixed, 95%
CI)
-2.5 [-5.80, 0.80]
1.2 FACT-G QoL at 12 months 2 685 Mean Difference (IV, Fixed, 95%
CI)
-0.52 [-2.31, 1.26]
2 FACT-C QoL 1   Mean Difference (IV, Random,
95% CI)
Subtotals only
2.1 FACT-C at 3 months 1 18 Mean Difference (IV, Random,
95% CI)
14.0 [2.87, 25.13]
3 FACT-B QoL 2   Mean Difference (IV, Fixed, 95%
CI)
Subtotals only
3.1 FACT-B at 3 months 1 23 Mean Difference (IV, Fixed, 95%
CI)
15.60 [-4.96, 36.16]
3.2 FACT-B at 6 months 1 90 Mean Difference (IV, Fixed, 95%
CI)
4.90 [-0.80, 10.60]
4 SF-36 QoL physical function score 1   Mean Difference (IV, Random,
95% CI)
Subtotals only
4.1 SF-36 QoL at 6 months 1 168 Mean Difference (IV, Random,
95% CI)
2.20 [-4.62, 9.02]
4.2 SF-36 QoL at 12 months 1 160 Mean Difference (IV, Random,
95% CI)
-0.20 [-7.42, 7.02]
5 SF-36 QoL mean change physical 4   Mean Difference (IV, Random,
95% CI)
Subtotals only
5.1 SF-36 at 6 months 2 500 Mean Difference (IV, Random,
95% CI)
-0.15 [-1.59, 1.28]
5.2 SF-36 at 12 months 3 1091 Mean Difference (IV, Random,
95% CI)
1.91 [0.45, 3.37]
6 SF-36 QoL mean change mental 3   Mean Difference (IV, Random,
95% CI)
Subtotals only
6.1 SF-36 mean change at at 6 months 1 410 Mean Difference (IV, Random,
95% CI)
0.7 [-0.96, 2.36]
6.2 SF-36 mean change at 12 months 3 1091 Mean Difference (IV, Random,
95% CI)
-0.11 [-3.29, 3.08]
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Statistical method Effect size
7 SF-36 QoL mean change mental for each
cancer site at 12 months
3   Mean Difference (IV, Random,
95% CI)
Subtotals only
7.1 Breast cancer 1 40 Mean Difference (IV, Random,
95% CI)
-4.3 [-9.69, 1.09]
7.2 Colorectal cancer 1 410 Mean Difference (IV, Random,
95% CI)
-0.7 [-2.64, 1.24]
7.3 Breast, colorectal, and prostate can-
cer
1 641 Mean Difference (IV, Random,
95% CI)
7.04 [5.25, 8.83]
8 Cancer-related fatigue 1   Mean Difference (IV, Fixed, 95%
CI)
Subtotals only
8.1 Cancer-related fatigue at 6 months 1 410 Mean Difference (IV, Fixed, 95%
CI)
1.4 [-0.26, 3.06]
8.2 Cancer related fatigue at 12 months 1 410 Mean Difference (IV, Fixed, 95%
CI)
1.0 [-0.81, 2.81]
9 Global QoL questionnaire 3   Mean Difference (IV, Random,
95% CI)
Subtotals only
9.1 Global QoL at 3 months 2 220 Mean Difference (IV, Random,
95% CI)
4.71 [2.22, 7.21]
9.2 Global QoL at 6 months 1 80 Mean Difference (IV, Random,
95% CI)
33.97 [28.97, 38.97]





Analysis 4.1.   Comparison 4 Quality of Life, Outcome 1 FACT-G QoL.
Study or subgroup Experimental Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
4.1.1 FACT-G at 6 months  
Demark-Wahnefried 2006 82 90.7 (12.4) 86 93.2 (9.1) 100% -2.5[-5.8,0.8]
Subtotal *** 82   86   100% -2.5[-5.8,0.8]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.48(P=0.14)  
   
4.1.2 FACT-G QoL at 12 months  
Demark-Wahnefried 2006 83 91.4 (12.1) 83 93.3 (10.1) 27.58% -1.9[-5.29,1.49]
Demark-Wahnefried 2007 253 93 (12.4) 266 93 (11.9) 72.42% 0[-2.09,2.09]
Subtotal *** 336   349   100% -0.52[-2.31,1.26]
Heterogeneity: Tau2=0; Chi2=0.87, df=1(P=0.35); I2=0%  
Test for overall effect: Z=0.58(P=0.56)  
Control 52.5-5 -2.5 0 Dietary intervention
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Study or subgroup Experimental Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Test for subgroup differences: Chi2=1.07, df=1 (P=0.3), I2=6.16%  
Control 52.5-5 -2.5 0 Dietary intervention
 
 
Analysis 4.2.   Comparison 4 Quality of Life, Outcome 2 FACT-C QoL.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
4.2.1 FACT-C at 3 months  
Bourke 2011 9 120 (11) 9 106 (13) 100% 14[2.87,25.13]
Subtotal *** 9   9   100% 14[2.87,25.13]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.47(P=0.01)  
Usual care 2010-20 -10 0 Dietary intervention
 
 
Analysis 4.3.   Comparison 4 Quality of Life, Outcome 3 FACT-B QoL.
Study or subgroup Experimental Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
4.3.1 FACT-B at 3 months  
Swisher 2015 13 119.6 (14.6) 10 104 (30.6) 100% 15.6[-4.96,36.16]
Subtotal *** 13   10   100% 15.6[-4.96,36.16]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.49(P=0.14)  
   
4.3.2 FACT-B at 6 months  
Scott 2013 47 119 (12.8) 43 114.1 (14.6) 100% 4.9[-0.8,10.6]
Subtotal *** 47   43   100% 4.9[-0.8,10.6]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.69(P=0.09)  
Control 4020-40 -20 0 Intervention
 
 
Analysis 4.4.   Comparison 4 Quality of Life, Outcome 4 SF-36 QoL physical function score.
Study or subgroup Experimental Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
4.4.1 SF-36 QoL at 6 months  
Demark-Wahnefried 2006 82 70.7 (22.6) 86 68.5 (22.5) 100% 2.2[-4.62,9.02]
Subtotal *** 82   86   100% 2.2[-4.62,9.02]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.63(P=0.53)  
   
4.4.2 SF-36 QoL at 12 months  
Demark-Wahnefried 2006 83 67 (23.5) 77 67.2 (23.1) 100% -0.2[-7.42,7.02]
Control 105-10 -5 0 Dietary intervention
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Study or subgroup Experimental Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Subtotal *** 83   77   100% -0.2[-7.42,7.02]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.05(P=0.96)  
Control 105-10 -5 0 Dietary intervention
 
 
Analysis 4.5.   Comparison 4 Quality of Life, Outcome 5 SF-36 QoL mean change physical.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
4.5.1 SF-36 at 6 months  
Hawkes 2013 205 3.4 (8.6) 205 3.4 (8.6) 74.18% 0[-1.66,1.66]
Reeves 2017 45 3.4 (6.7) 45 4 (7) 25.82% -0.6[-3.42,2.22]
Subtotal *** 250   250   100% -0.15[-1.59,1.28]
Heterogeneity: Tau2=0; Chi2=0.13, df=1(P=0.72); I2=0%  
Test for overall effect: Z=0.21(P=0.83)  
   
4.5.2 SF-36 at 12 months  
Demark-Wahnefried 2014 23 2.2 (10.4) 17 0.9 (4.9) 9.07% 1.3[-3.55,6.15]
Hawkes 2013 205 4.8 (10) 205 3.2 (10) 56.85% 1.6[-0.34,3.54]
Morey 2009 319 -2.2 (16.1) 322 -4.8 (16.2) 34.08% 2.6[0.1,5.1]
Subtotal *** 547   544   100% 1.91[0.45,3.37]
Heterogeneity: Tau2=0; Chi2=0.45, df=2(P=0.8); I2=0%  
Test for overall effect: Z=2.57(P=0.01)  
Usual care 105-10 -5 0 Dietary intervention
 
 
Analysis 4.6.   Comparison 4 Quality of Life, Outcome 6 SF-36 QoL mean change mental.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
4.6.1 SF-36 mean change at at 6 months  
Hawkes 2013 205 1.9 (8.6) 205 1.2 (8.6) 100% 0.7[-0.96,2.36]
Subtotal *** 205   205   100% 0.7[-0.96,2.36]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.82(P=0.41)  
   
4.6.2 SF-36 mean change at 12 months  
Demark-Wahnefried 2014 23 -1.9 (10) 17 2.4 (7.4) 19.92% -4.3[-9.69,1.09]
Hawkes 2013 205 0.3 (10) 205 1 (10) 39.6% -0.7[-2.64,1.24]
Morey 2009 319 0.5 (9.5) 322 -2 (13.3) 40.47% 2.54[0.75,4.33]
Subtotal *** 547   544   100% -0.11[-3.29,3.08]
Heterogeneity: Tau2=5.7; Chi2=9.37, df=2(P=0.01); I2=78.66%  
Test for overall effect: Z=0.07(P=0.95)  
Test for subgroup differences: Chi2=0.19, df=1 (P=0.66), I2=0%  
Usual care 105-10 -5 0 Dietary intervention
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Analysis 4.7.   Comparison 4 Quality of Life, Outcome 7 SF-36
QoL mean change mental for each cancer site at 12 months.
Study or subgroup Dietary in-
tervnetion
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
4.7.1 Breast cancer  
Demark-Wahnefried 2014 23 -1.9 (10) 17 2.4 (7.4) 100% -4.3[-9.69,1.09]
Subtotal *** 23   17   100% -4.3[-9.69,1.09]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.56(P=0.12)  
   
4.7.2 Colorectal cancer  
Hawkes 2013 205 0.3 (10) 205 1 (10) 100% -0.7[-2.64,1.24]
Subtotal *** 205   205   100% -0.7[-2.64,1.24]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.71(P=0.48)  
   
4.7.3 Breast, colorectal, and prostate cancer  
Morey 2009 319 5 (9.5) 322 -2 (13.3) 100% 7.04[5.25,8.83]
Subtotal *** 319   322   100% 7.04[5.25,8.83]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=7.72(P<0.0001)  
Usual care 105-10 -5 0 Dietary intervention
 
 
Analysis 4.8.   Comparison 4 Quality of Life, Outcome 8 Cancer-related fatigue.
Study or subgroup Control Dietray in-
tervention
Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
4.8.1 Cancer-related fatigue at 6 months  
Hawkes 2013 205 3.6 (8.6) 205 2.2 (8.6) 100% 1.4[-0.26,3.06]
Subtotal *** 205   205   100% 1.4[-0.26,3.06]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.65(P=0.1)  
   
4.8.2 Cancer related fatigue at 12 months  
Hawkes 2013 205 3.9 (10) 205 2.9 (8.6) 100% 1[-0.81,2.81]
Subtotal *** 205   205   100% 1[-0.81,2.81]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.09(P=0.28)  
Control 52.5-5 -2.5 0 Dietary intervention
 
 
Analysis 4.9.   Comparison 4 Quality of Life, Outcome 9 Global QoL questionnaire.
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
4.9.1 Global QoL at 3 months  
Usual care 5025-50 -25 0 Dietary intervention
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Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Kim 2011 23 73.3 (3.7) 22 68 (3.5) 82% 5.31[3.22,7.4]
Yun 2017 115 67.7 (18.7) 60 65.7 (17.5) 18% 2[-3.59,7.59]
Subtotal *** 138   82   100% 4.71[2.22,7.21]
Heterogeneity: Tau2=0.84; Chi2=1.18, df=1(P=0.28); I2=15.32%  
Test for overall effect: Z=3.71(P=0)  
   
4.9.2 Global QoL at 6 months  
Ghavami 2017 40 91.3 (8) 40 57.3 (14) 100% 33.97[28.97,38.97]
Subtotal *** 40   40   100% 33.97[28.97,38.97]
Heterogeneity: Not applicable  
Test for overall effect: Z=13.32(P<0.0001)  
   
4.9.3 Global QoL at 12 months  
Yun 2017 117 70.1 (17.1) 57 65.3 (17.9) 100% 4.8[-0.79,10.39]
Subtotal *** 117   57   100% 4.8[-0.79,10.39]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.68(P=0.09)  
Usual care 5025-50 -25 0 Dietary intervention
 
 
Comparison 5.   Biochemical measures





Statistical method Effect size
1 Total cholesterol (mg/dl) 2   Mean Difference (IV, Random,
95% CI)
Subtotals only
1.1 Total cholesterol at 3 months 1 76 Mean Difference (IV, Random,
95% CI)
-18.20 [-38.27, 1.87]
1.2 Total cholesterol at 6 months 1 83 Mean Difference (IV, Random,
95% CI)
5.94 [2.45, 9.43]





Analysis 5.1.   Comparison 5 Biochemical measures, Outcome 1 Total cholesterol (mg/dl).
Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
5.1.1 Total cholesterol at 3 months  
Mefferd 2007 47 191.3 (33.4) 29 209.5 (48.5) 100% -18.2[-38.27,1.87]
Subtotal *** 47   29   100% -18.2[-38.27,1.87]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.78(P=0.08)  
Dieatry intervention 5025-50 -25 0 Usual care
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Study or subgroup Dietary in-
tervention
Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
   
5.1.2 Total cholesterol at 6 months  
Scott 2013 43 99.5 (8.8) 40 93.5 (7.4) 100% 5.94[2.45,9.43]
Subtotal *** 43   40   100% 5.94[2.45,9.43]
Heterogeneity: Not applicable  
Test for overall effect: Z=3.33(P=0)  
Dieatry intervention 5025-50 -25 0 Usual care
 
 
Analysis 5.2.   Comparison 5 Biochemical measures, Outcome 2 Triglycerides (mg/dl) at 3 months.




Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Mefferd 2007 47 134.8 (74.2) 29 175.4 (80.6) 100% -40.6[-76.8,-4.4]
   
Total *** 47   29   100% -40.6[-76.8,-4.4]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.2(P=0.03)  
Dietary intervention 200100-200 -100 0 Usual care
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Table 1.   Characteristics of dietary interventions, outcomes, and length of follow-up  (Continued)
 
 















Adjusted means 3 -637 - 819.79 to -454.21 67 NA Very low Analysis 2.2
Adjusted means 6 -548.1 - 753.22 to -342.98 61 NA Very low Analysis 2.2




BMI > 25 kg/m2 6 -49 - 269.75 to 171.74 93 43 Very low Analysis 2.4
Uterine cancer 6 0.2 - 0.57 to 0.97 69 NA Very low Analysis 2.6
Uterine cancer 12 0.3 - 0.80 to 1.40 59 NA Very low Analysis 2.7
Fruit serv-
ings (day)
Breast cancer 6 0.8 0.58 to 1.02 3088 NA Moderate Analysis 2.6

































































































































Breast cancer 12 0.46 - 0.40 to 1.31 3146 74 Moderate Analysis 2.7
Hispanic popu-
lation
12 -0.1 - 0.98 to 0.78 58 NA Very low Analysis 2.8
Mixed popula-
tion
12 0.8 0.64 to 0.96 3088 NA Moderate Analysis 2.3




Adjusted means 6 1.10 -0.01 to 2.21 61 NA Very low Analysis 2.13
Weight reduc-
tion advice
6 -0.20 -3.52 to 3.12 39 NA Very low Analysis 2.15
Weight reduc-
tion advice
12 2.10 0.24 to 3.96 39 NA Very low Analysis 2.15
Healthy eating
advice





12 8.00 7.30 to 8.70 3088 NA Moderate Analysis 2.16
Table 2.   Dietary changes: adjusted and subgroup analyses of secondary outcomes  (Continued)




















Body weight (kg) Adjusted
mean





6 -3.6 -5.56 to 1.64 90 NA Low Analysis 3.3






































































































































12 0.23 -0.31 to 0.77 641 NA Low Analysis 3.3
Breast
cancer
3 1 -0.47 to 2.47 170 NA Moderate Analysis 3.7Weight loss (kg)
Breast
cancer
6 -1.6 -3.06 to -0.14 170 NA Moderate Analysis 3.7
Mean dif-
ference
6 -0.6 -1.15 to -0.05 410 NA Low Analysis 3.6
Mean dif-
ference




6 -4.1 -8.12 to -0.08 53 NA Very low Analysis 3.4
Colon can-
cer
3 -0.11 -0.17 to -0.05 18 NA Very low Analysis 3.12Waist-to-hip ratio
Breast
cancer
3 -0.01 -0.02 to 0.01 163 0 Low Analysis 3.12
Breast
cancer
3 -0.67 -1.28 to -0.06 44 NA Very low Analysis 3.14
Breast
cancer
6 -0.67 -1.02 to -0.32 134 10 Low Analysis 3.14
Breast
cancer










3 1.81 0.77 to 2.85 44 NA Very low Analysis 3.13



































































































































6 -3.13 -5.01 to -1.26 134 31 Very low Analysis 3.13
Breast
cancer
12 1.09 -1.69 to 3.87 44 NA Very low Analysis 4.7
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Anticipated absolute effects* (95% CI)Outcomes


















































































*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the
relative effect of the intervention (and its 95% CI).
CI: confidence interval; FACT-B: Functional Assessment of Cancer Therapy - Breast; FACT-G: Functional Assessment of Cancer Therapy
- General; MD: mean difference; QoL: quality of life; RCT: randomised controlled trial; SF-36: Short Form 36.
GRADE Working Group grades of evidence.
High-certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate-certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the ef-
fect, but there is a possibility that it is substantially different.
Low-certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the
effect.
Very low-certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the
estimate of effect.
Table 4.   Dietary intervention compared to usual care for people living beyond cancer: quality of life 
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aDowngraded two levels for risk of bias.
bDowngraded one level as CI is not narrow.
cDowngraded one level for risk of bias.
dDowngraded one level due to lack of precision because of small sample size.
eDowngraded one level due to inability to assess for consistency across studies as only one study.
fDowngraded one level due to inconsistencies across studies.
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Breast and prostate cancer 6 2.2 -4.62 to 9.02 168 NA Very low Analysis 4.4SF-36 QoL phys-
ical domain
Breast and prostate cancer 12 -0.20 -7.42 to 7.02 160 NA Very low Analysis 4.4
Breast cancer 12 -4.3 -9.96 to 1.09 40 NA Very low Analysis 4.7




Breast, prostate, and colorec-
tal cancer
12 7.04 5.25 to 8.83 641 NA Low Analysis 4.7
Table 5.   Patient outcomes: adjusted and subgroup analyses of secondary outcomes 
NA: not applicable.
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Dietary intervention compared to usual care for people living beyond cancer: biochemical outcomes




Anticipated absolute effects* (95%
CI)
Outcomes



























































*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the
relative effect of the intervention (and its 95% CI).
CI: confidence interval; MD: mean difference; RCT: randomised controlled trial.
GRADE Working Group grades of evidence.
High-certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate-certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the ef-
fect, but there is a possibility that it is substantially different.
Low-certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the
effect.
Very low-certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the
estimate of effect.
Table 6.   Dietary intervention compared to usual care for people living beyond cancer: biochemical outcomes 
aDowngraded one level for risk of bias.
bDowngraded one level due to lack of precision because of small sample size.
cDowngraded one level due to inability to assess consistency across studies.
 
 
Dietary intervention compared to control for people living beyond cancer: mortality and morbidity
Patient or population: people living beyond cancer
Setting: community
Table 7.   Dietary intervention compared to control for people living beyond cancer: mortality and morbidity 
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Intervention: dietary intervention
Comparison: control
Anticipated absolute effects* (95% CI)Outcomes



































*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the
relative effect of the intervention (and its 95% CI).
CI: confidence interval; HR: hazard ratio; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence.
High-certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate-certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the ef-
fect, but there is a possibility that it is substantially different.
Low-certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the
effect.
Very low-certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the
estimate of effect.
Table 7.   Dietary intervention compared to control for people living beyond cancer: mortality and morbidity  (Continued)
aInability to rate consistency as only one study.
bConfidence intervals are not narrow and no overlap is associated with effect estimates.
 
 
Dietary intervention compared to usual care for people living beyond cancer: dietary outcomes




Anticipated absolute effects* (95% CI)Outcomes






























Table 8.   Dietary intervention compared to usual care for people living beyond cancer: dietary outcomes 
Dietary interventions for adult cancer survivors (Review)









Cochrane Database of Systematic Reviews
Fruit and vegetable servings
assessed as servings
Follow-up: 12 months
Mean fruit and vegetable









































*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the
relative effect of the intervention (and its 95% CI).
CI: confidence interval; MD: mean difference; RCT: randomised controlled trial.
GRADE Working Group grades of evidence.
High-certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate-certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the ef-
fect, but there is a possibility that it is substantially different.
Low-certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the
effect.
Very low-certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the
estimate of effect.
Table 8.   Dietary intervention compared to usual care for people living beyond cancer: dietary outcomes  (Continued)
aDowngraded one level due to wide variation in effect estimates across studies.
bDowngraded one level due to indirectness.
cDowngraded two levels for high level of inconsistency between studies.
dDowngraded one level as CI is not narrow.
eDowngraded one level due to risk of bias.
 
 
Dietary intervention compared to usual care for people living beyond cancer: anthropometry outcomes




Anticipated absolute effects* (95% CI)Outcomes
























Table 9.   Dietary intervention compared to usual care for people living beyond cancer: anthropometry outcomes 
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Mean body mass in-


























*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the
relative effect of the intervention (and its 95% CI).
CI: confidence interval; MD: mean difference; RCT: randomised controlled trial.
GRADE Working Group grades of evidence.
High-certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate-certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the ef-
fect, but there is a possibility that it is substantially different.
Low-certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the
effect.
Very low-certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the
estimate of effect.
Table 9.   Dietary intervention compared to usual care for people living beyond cancer: anthropometry
outc mes  (Continued)
aDowngraded one level due to risk of bias assessment.
bDowngraded one level for indirectness as studies included only Hispanic women.
cDowngraded one level due to imprecision because of small sample size.
 
 
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor: [Neoplasms] explode all trees
#2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*):ti,ab
#3 #1 or #2
#4 MeSH descriptor: [Diet] explode all trees
#5 MeSH descriptor: [Nutrition Assessment] explode all trees
#6 MeSH descriptor: [Nutrition Therapy] explode all trees
#7 MeSH descriptor: [Nutrition Disorders] explode all trees
#8 MeSH descriptor: [Food Habits] explode all trees
#9 MeSH descriptor: [Food Preferences] explode all trees
#10 MeSH descriptor: [Food] explode all trees
#11 (diet* or nutrition* or nutrient* or food* or feed* or eat* or drink*):ti,ab
#12 (fat* or carbohydrate* or protein* or fruit* or vegetable* or fibre* or fiber* or fish* or meat* or poultry or dairy or salt* or sugar* or
cereal* or nut* or seed* or alcohol* or caffeine):ti
#13 (macrobiotic or ketogenic or vegetarian or (low adj (glycemic* or glycaemic*))):ti
#14 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13
#15 MeSH descriptor: [Survivors] explode all trees
#16 (survivor* or survival*):ti,ab
#17 #15 or #16
#18 #3 and #14 and #17
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Appendix 2. MEDLINE Ovid search strategy
1 exp neoplasms/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).ti,ab.
3 1 or 2
4 exp diet/
5 exp nutrition assessment/
6 exp nutrition therapy/
7 exp nutrition disorders/
8 exp food habits/
9 food preferences/
10 exp food/
11 (diet* or nutrition* or nutrient* or food* or feed* or eat* or drink*).ti,ab.
12 (fat* or carbohydrate* or protein* or fruit* or vegetable* or fibre* or fiber* or fish* or meat* or poultry or dairy or salt* or sugar* or
cereal* or nut* or seed* or alcohol* or caffeine).ti.
13 (macrobiotic or ketogenic or vegetarian or (low adj (glycemic* or glycaemic*))).ti.
14 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13
15 survivors/
16 (survivor* or survival*).ti,ab.
17 15 or 16
18 3 and 14 and 17
19 randomized controlled trial.pt.
20 controlled clinical trial.pt.
21 randomized.ab.
22 placebo.ab.
23 clinical trials as topic.sh.
24 randomly.ab.
25 trial.ti.
26 19 or 20 or 21 or 22 or 23 or 24 or 25
27 18 and 26
28 exp animals/ not humans.sh.
29 27 not 28
key:
[mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supple-
mentary concept, unique identifier]
Appendix 3. Embase search strategy
1 exp neoplasm/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).ti,ab.
3 1 or 2
4 exp nutrition/
5 exp nutritional disorder/
6 (diet* or nutrition* or nutrient* or food* or feed* or eat* or drink*).ti,ab.
7 (fat* or carbohydrate* or protein* or fruit* or vegetable* or fibre* or fiber* or fish* or meat* or poultry or dairy or salt* or sugar* or cereal*
or nut* or seed* or alcohol* or caffeine).ti.
8 (macrobiotic or ketogenic or vegetarian or (low adj (glycemic* or glycaemic*))).ti.
9 4 or 5 or 6 or 7 or 8
10 cancer survivor/
11 (survivor* or survival*).ti,ab.
12 10 or 11
13 3 and 9 and 12
14 crossover procedure/
15 double-blind procedure/




20 (crossover* or cross over* or cross-over*).mp.
21 placebo*.mp.
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22 (double* adj blind*).mp.




27 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26
28 13 and 27
key:




Appendix 4. AMED Ovid search strategy
1 exp neoplasms/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).ti,ab.
3 1 or 2
4 Diet/
5 exp nutrition assessment/
6 exp Nutrition Therapy/




11 (diet* or nutrition* or nutrient* or food* or feed* or eat* or drink*).ti,ab.
12 (fat* or carbohydrate* or protein* or fruit* or vegetable* or fibre* or fiber* or fish* or meat* or poultry or dairy or salt* or sugar* or
cereal* or nut* or seed* or alcohol* or caffeine).ti,ab.
13 (macrobiotic or ketogenic or vegetarian or (low adj (glycemic* or glycaemic*))).ti,ab.
14 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13
15 survivors/
16 (survivors or survival*).ti,ab.
17 15 or 16
18 3 and 14 and 17
19 randomized controlled trial.pt.
20 controlled clinical trial.pt.
21 randomized.ab.
22 placebo.ab.
23 clinical trials as topic.sh.
24 randomly.ab.
25 trial.ti.
26 19 or 20 or 21 or 22 or 23 or 24 or 25
27 18 and 26
28 exp animals/ not humans.sh.
29 27 not 28





All text search with Boolean/phase selected
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Diet and nutrition
All fields searched MeSH Terms
Appendix 7. Data extraction sheet
 
Form version/date
Version 2, 1 Feb 2016
Review Title
Dietary Interventions in Adult Cancer Survivors
Date form completed
 
Name of review author completing this form
 






Funding (including source, amount, if stated).
 
Notes (Unpublished – for own use) Eg. References to be followed up, source of information (especially if multiple reports of same trial, or






Aim of intervention (As stated in the trial report/s. What was the problem that this intervention was designed to address?)
 
Aim of study (As stated in the trial report/s. What was the trial designed to assess?)
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Study design
 
Methods of recruitment of participants (How were potential participants approached and invited to participate?)
 
Inclusion/exclusion criteria for participation in study
 




Statistical methods and their appropriateness (if relevant)
 
Consumer involvement (eg. In design of study and/or intervention; in delivery of intervention; in evaluation of intervention; in in-






Description (eg. Patients/consumers; carers; parents of patients/consumers; health professionals; well people in the community)
 
Geographic location (eg. City/State/Country)
 
Setting (eg. Community, home, primary health centre, acute care hospital, extended care facility)
 
Number: (Eligible, excluded, refused to take part, randomised to intervention, randomised to control, excluded post randomisa-
tion, withdrawn, lost to follow-up, died, included in analysis, included for each outcome)
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Location of treated tumour
 
Therapy previously received for cancer
 
Cancer staging or classification
 
Baseline: proportion of overweight/obese survivors (defined by BMI > 25 kg/m2or nutritional assessment tool)
 














Details of intervention, including theoretical basis (with key references), aim, content, type (nutritional education, weight
management), delivery method (written, telephone, face-to-face, Internet), setting, behaviour change techniques employed
(motivational interviewing, goal setting). (Capture this information for each arm of the study, eg. Intervention A, Intervention
B…)
 
Details of control/usual or routine care
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Details of co-interventions in all groups (co-interventions may be separate from the intervention of interest for this review, or
they may be other similar elements in a suite of interventions having a common purpose. Record all relevant information)
 
Delivery of intervention (eg. stages, timing, frequency, duration) (for each intervention included in the study, eg. Intervention A;
Intervention B…)
 
Details of providers (Who delivers the intervention?; number of providers; training of providers in delivery of intervention)
 
Intervention quality (if relevant): (Record any information on the quality of the intervention - assessed by study authors, by oth-
ers, or by you - such as the evidence base of the intervention, or the quality of sta7 training for intervention delivery)
 






Principal and secondary outcome measures (tick [P] all those included in this study and state if primary or secondary)
· Overall survival [ ]
· Incidence of secondary malignancy or other cancer [ ]
· Incidence of comorbidities [ ]
· Dietary changes measured by diaries, FFQ, recall or assessment methodology [ ]
· Changes in weight/anthropometry (incl hip:waist, skin folds, function) [ ]
· Quality of life [ ]
· Biochemical measure (lipid profiles, serum glucose) [ ]
· No. of healthy eating changes made to habitual eating patterns [ ]
· Other (please state):
Methods of assessing outcome measures (eg, phone survey, questionnaire, physical measurements (for each outcome)). State
unit of measure or scale used (if scale, state direction)
 
Validity and reliability of outcome measures
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Methods of follow-up for non-respondents
 
Timing of outcome assessment (including frequency, length of follow-up (for each outcome))
 













Describe the method used to generate the allocation sequence in suffi-
cient detail to allow an assessment of whether it should produce compara-
ble groups.
(Adequate: random number table, computer generated.
Inadequate: alternation, DOB, date of admission, hospital number)
If you are including only RCTs in your review, papers marked ‘high risk’ should








Describe the method used to conceal the allocation sequence in sufficient
detail to determine whether intervention allocations could have been
foreseen in advance of, or during, enrolment. (Decision to accept or re-
ject a participant must be made without knowledge of the treatment as-
signed)
(Adequate: centralised randomisation or sequentially numbered opaque
envelopes
Inadequate: open list of random numbers, coin toss, alternation









Describe all measures used, if any, to blind study participants and person-
nel from knowledge of which intervention a participant received. Provide








for each main out-
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Describe all measures used, if any, to blind outcome assessors from
knowledge of which intervention a participant received. Provide any in-
formation relating to whether the intended blinding was effective. If the








for each main out-






Describe the completeness of outcome data for each main outcome, in-
cluding attrition and exclusions from the analysis. State whether attrition
and exclusions were reported, the numbers in each intervention group
(compared with total randomised participants), reasons for attrition/ex-
clusions where reported, and any re-inclusions in analyses performed by







for each main out-





State how the possibility of selective outcome reporting was examined by









State any important concerns about bias not addressed in the other do-
mains in the tool.
If particular questions/entries were pre-specified in the review’s protocol,
responses should be provided for each question/entry
(early stopping, baseline imbalances, choice of design, funding source)










Notes (These are published in the table Characteristics of Included Studies)
 
For example:
· Contact with author (Yes (information obtained)/No) (SEE NOTE ON PAGE 1)
· Power calculation?
· Record if the study was translated from a language other than English.





All data are numbers (of patients/units), not percentages
Dichotomous outcomes
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Intervention group* Control groupOutcome Timing of outcome as-
sessment (days/months)
Observed (n) Total (N) Observed (n) Total (N)
Notes
             
             
             
             
             
             
  (Continued)
 
*Note: add additional columns if there is more than one intervention group, eg. Intervention Group A, Intervention Group B…
Continuous outcomes
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*Mean / Mean change Standard deviation N *Mean / Mean change Standard deviation N
Notes
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*delete as appropriate
Appendix 8. Reports for included studies
• For the 'FRESH START' trial there were seven reports identified. The study design and primary study report for the "FRESHSTART" trial
was reported in Demark-Wahnefried 2007.
• For the 'CANCHANGE' study there were eight reports identified, the primary study report used in this review was Hawkes 2013.
• For the study on exercise and hypocaloric eating there were three trial reports, the primary report was Scott 2013.
• For the 'Leading the Way in Exercise and Diet' (LEAD) study there were four reports, Demark-Wahnefried 2006 was the primary report.
• For the 'Daughters and Mothers Against Breast Cancer' (DAMES) study there was one other report identified Demark-Wahnefried 2014
was the primary report.
• For the 'Women's Healthy Eating and Living' (WHEL) study there were 17 trial reports identified. The primary report was Pierce 2007.
• For the 'Survivors of Uterine Cancer Empowered by Exercise and Healthy Eating' (SUCCEED) study there were seven reports identified
and the primary report was Gruenigen 2012.
• For the 'Reach out to Enhance Wellness' (RENEW) study there were two reports identified. The primary report was Morey 2009.
• For the 'Lifestyle Exercise and Nutrition' (LEAN) study there were three reports identified and the primary report was Harrigan 2016.
• For the study by Greenlee 2013, there were five reports identified.
• For the study by Greenlee 2015 there were two other report identified.
• For the study by Reeves 2017 there was one other report identified.
• For the study by Djuric 2002 there were two other reports identified.
• For the study by Befort 2016 there was one other reported identified.
• For the study by Ghavami 2017 there was one other reported identified.
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narrative review. SB wrote the discussion and the abstract. MP advised on statistics. All review authors have inputted on how the data were
analysed. The methodological aspects of the systematic review protocol have been commented on by CT, and SL and MP have reviewed
the plan for data analysis. AMS and SB undertook all risk of bias assessments.
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
For all outcomes, we reported differences between intervention and control groups for all variables - not changes from baseline to different
time points. We have amended the method to reflect this. We reported outcomes for the last time point measured as there was a large
amount of inconsistency in the evidence base between frequency of measurements at different time points and in the number of time
points reported in studies included in the review. Outcomes for dietary intake reported included total energy, dietary fibre, and fruits and
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vegetables. We did not report data on fat, protein, or carbohydrate, or on micronutrients, as nutrients were often reported in different
ways. We did not report nutrients expressed as a percentage of energy. This excluded other nutrients including protein, carbohydrate,
and micronutrients reported.
Studies that compared multiple interventions to control: we did not compare the different interventions with one other, only each inter-
vention versus control (weight watchers trial; Djuric 2002). We excluded studies with no control group that provided usual care or made
written information available to the general public.
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